# Project configuration parameters
# Items must follow format <item: subitem> OR <item:>
project_info:
  project_dir: enter project directory
  version: 1.2.0
  hipaa: 'deid'

date_range:
  start_date: 01/01/2012
  end_date: 12/31/2021

bo_docs:
  cohort: enter cohort bo document name
  stage: omop

load:
# Comment line to ignore data elements under each omop table with sub-items.
  person:
  death:
  visit_occurrence:
  condition_occurrence:
    #do not comment - all sub-items below are needed for condition_occurrence.
    condition: Diagnosis codes from coding detail
    admit_icd9: ICD9 Admit diagnosis decimal
    admit_icd10: ICD10 Admit diagnosis decimal
    principal_icd9: ICD9 Principal diagnosis decimal
    principal_icd10: ICD10 Principal diagnosis decimal
  procedure_occurrence:
    icd: ICD coded procedures
    cpt: CPT coded procedures
  drug_exposure: 
    order: Medication orders
    admin: Medication administration
  measurement: 
    bp: Blood pressure 
    bp_artline: Invasive blood pressure
    bp_noninvasive: Non-invasive blood pressure
    bp_cvp: 
    bp_cvp_mean: 
    bp_map_artline: Mean arterial pressure invasive methods
    bp_map_cuff: Mean arterial pressure manual (Cuff)
    bp_map_noninvasive: Mean arterial pressure non-invasive methods
    bp_pap_mean: Pulmonary Artery Pressure
    heart_rate: Heart rate
    height: Height
    lab: Laboratory results
    pain: Pain scale
    pain_jax: 
    pain_peds: 
    qtcb: Q-T interval corrected Bazett
    res_dev: Respiratory device
    res_etco2: Carbon dioxide [Partial pressure] in Exhaled gas at end expiration
    res_etco2_on: 
    res_fio2: Inhaled oxygen concentration
    gcs: Glasgow coma score total
    gcs_peds: 
    res_o2: Inhaled oxygen flow rate
    res_o2_ml: 
    res_peep: PEEP Respiratory system
    res_pip: Peak inspiratory pressure
    res_resp: Breath rate spontaneous, mechanical, and respiratory rate
    # res_resp_adultmech: Deprecated
    res_resp_adultspont: 
    # res_resp_pedsmech: Deprecated
    res_resp_pedsspont:
    res_resp_mech:  
    res_spo2: Oxygen saturation in arterial blood by pulse oximetry
    res_tidal: Tidal volume setting 
    res_tidal_mech: Volume exhaled maximum ventilator alarm
    res_tidal_spont: 
    res_vent_mode: Ventilation mode adults
    res_vent_start:
    res_vent_end: 
    res_vent_mode_peds: Ventilation mode pediatric
    res_vent_start_peds: 
    res_vent_end_peds: 
    rothman: Rothman index calculated
    sofa: Sequential organ failure assessment score
    temp: Body temperature
    weight: Body weight
    lvef: left ventricular ejection fraction
    bmi: body mass index
  observation:
    icu: Intensive care unit stay
    lda: LDA intubation type and LDA intubation start and end times
    vent: Dependence on mechanical ventilator
    payer: Healthcare payer
    smoking: Tobacco smoking behavior 
    zipcode: Patient postal code
  provider:
  care_site:
  location:

db_connections: 
  omop:
    server: dwsrsrch01.shands.ufl.edu
    database: enter database name
  bo_metadata:
    server: edw.shands.ufl.edu
    database: DWS_METADATA

vocabularies:
  - JAX
  - Revenue Code
  - NAACCR
  - LOINC
  - ICDO3
  - NFC
  - Gender
  - MDC
  - SPL
  - CPT4
  - CCAM
  - OPS
  - Currency
  - ABMS
  - VA Product     ??????????????????????????????????
  - MMI
  - MeSH
  - ICD10
  - MEDRT
  - VA Class
  - Medicare Specialty
  - OPCS4
  - OMOP Extension
  - NUCC
  - CVX
  - HES Specialty
  - HemOnc
  - SNOMED
  - NDC
  - dm+d
  - RxNorm Extension
  - ICD9Proc
  - CMS Place of Service
  - Race
  - ICD9CM
  - Supplier
  - Episode Type
  - ICD10PCS
  - ICD10CM
  - NCIt
  - Specimen Type
  - EphMRA ATC
  - Cancer Modifier
  - GCN_SEQNO
  - Provider
  - RxNorm
  - ATC
  - CTD
  - Ethnicity
  - GGR
  - HCPCS
  - APC
  - CIViC
  - DRG
  - NDFRT


loinc:
  10331-7: Rh [Type] in Blood
  10368-9: Lead [Mass/volume] in Capillary blood
  10466-1: Anion gap 3 in Serum or Plasma
  10834-0: Globulin [Mass/volume] in Serum by calculation
  10839-9: Troponin I.cardiac [Mass/volume] in Serum or Plasma
  10900-9: Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay
  10912-4: Lead [Mass/volume] in Serum or Plasma
  11011-4: Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
  11053-6: Lactate dehydrogenase [Enzymatic activity/volume] in Red Blood Cells
  11064-3: Urea nitrogen [Mass/volume] in Serum or Plasma --post dialysis
  11258-1: Hepatitis B virus DNA [Units/volume] in Serum
  11259-9: Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
  11558-4: pH of Blood
  11572-5: Rheumatoid factor [Units/volume] in Serum or Plasma
  11573-3: Rheumatoid factor IgM [Units/volume] in Serum
  11579-0: Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L
  11580-8: Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.005 mIU/L
  12185-5: aPTT in Control Blood by Coagulation assay
  12187-1: Creatine kinase.MB/Creatine kinase.total in Serum or Plasma by Electrophoresis
  12195-4: Creatinine renal clearance/1.73 sq M in 24 hour Urine and Serum or Plasma
  12227-5: Leukocytes [#/volume] corrected for nucleated erythrocytes in Blood
  12961-9: Urea nitrogen [Mass/volume] in Arterial blood
  12962-7: Urea nitrogen [Mass/volume] in Venous blood
  12963-5: Urea nitrogen [Mass/volume] in Peripheral blood
  1305-2: D Ag [Presence] in Blood
  13226-6: Cytomegalovirus IgM Ab [Units/volume] in Cerebral spinal fluid
  13249-8: Herpes simplex virus 1+2 IgG Ab [Units/volume] in Cerebral spinal fluid
  13251-4: Herpes simplex virus 1 IgM Ab [Units/volume] in Cerebral spinal fluid
  13279-5: Rubella virus IgG Ab [Units/volume] in Serum --1st specimen
  13281-1: Rubella virus IgG Ab [Units/volume] in Cerebral spinal fluid
  13282-9: Rubella virus IgM Ab [Units/volume] in Cerebral spinal fluid
  13457-7: Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation
  13488-2: aPTT in Control Platelet poor plasma by Coagulation assay
  13949-3: Cytomegalovirus IgG Ab [Presence] in Serum or Plasma by Immunoassay
  13952-7: Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay
  13955-0: Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay
  13969-1: Creatine kinase.MB [Mass/volume] in Serum or Plasma
  14118-4: Lactate [Mass/volume] in Serum or Plasma
  14196-0: Reticulocytes [#/volume] in Blood
  14403-0: Lactate dehydrogenase [Enzymatic activity/volume] in Gastric fluid
  14580-5: ABO group [Type] in Blood from Newborn
  14627-4: Bicarbonate [Moles/volume] in Venous blood
  14631-6: Bilirubin.total [Moles/volume] in Serum or Plasma
  14634-0: C reactive protein [Titer] in Serum or Plasma
  14682-9: Creatinine [Moles/volume] in Serum or Plasma
  14723-1: Ferritin [Moles/volume] in Serum or Plasma
  14757-9: Glucose [Moles/volume] in Serum or Plasma --2 hours post 100 g glucose PO
  14759-5: Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
  14775-1: Hemoglobin [Mass/volume] in Arterial blood by Oximetry
  14803-1: Lactate dehydrogenase [Enzymatic activity/volume] in Body fluid by Lactate to pyruvate reaction
  14804-9: Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
  14805-6: Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Pyruvate to lactate reaction
  14908-8: Rh [Type] in Blood from Newborn
  14929-4: Triiodothyronine (T3).reverse [Moles/volume] in Serum or Plasma
  14957-5: Microalbumin [Mass/volume] in Urine
  14979-9: aPTT in Platelet poor plasma by Coagulation assay
  14995-5: Glucose [Moles/volume] in Serum or Plasma --2 hours post 75 g glucose PO
  1514-9: Glucose [Mass/volume] in Serum or Plasma --2 hours post 100 g glucose PO
  15179-5: Fibrin D-dimer [Presence] in Platelet poor plasma
  1518-0: Glucose [Mass/volume] in Serum or Plasma --2 hours post 75 g glucose PO
  15205-8: Rheumatoid factor [Units/volume] in Serum by Nephelometry
  1558-6: Fasting glucose [Mass/volume] in Serum or Plasma
  16128-1: Hepatitis C virus Ab [Presence] in Serum
  16324-6: Alanine aminotransferase [Enzymatic activity/volume] in Red Blood Cells
  16412-9: Aspartate aminotransferase [Enzymatic activity/volume] in Red Blood Cells
  16461-6: Bicarbonate [Moles/volume] in Red Blood Cells
  16503-5: C reactive protein [Mass/volume] in Body fluid
  16630-6: aPTT in Control Blood by Coagulation 1:1 saline
  16631-4: aPTT in Blood by Coagulation 1:1 saline
  16715-5: Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma by Immunofluorescence
  16717-1: Cytomegalovirus Ag [Presence] in Urine by Immunoassay
  16719-7: Cytomegalovirus inclusion bodies [Presence] in Urine by Microscopic observation
  16859-1: Fibrinogen [Presence] in Platelet poor plasma
  16933-4: Hepatitis B virus core Ab [Presence] in Serum
  16934-2: Hepatitis B virus polymerase DNA [Presence] in Blood by NAA with probe detection
  16935-9: Hepatitis B virus surface Ab [Units/volume] in Serum
  16944-1: Herpes simplex virus IgM Ab [Units/volume] in Serum
  16955-7: Herpes simplex virus 2 IgG Ab [Presence] in Serum by Immunoblot
  16957-3: Herpes simplex virus 2 IgG Ab [Units/volume] in Serum --1st specimen
  1742-6: Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
  1743-4: Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P
  1744-2: Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P
  1751-7: Albumin [Mass/volume] in Serum or Plasma
  1754-1: Albumin [Mass/volume] in Urine
  17551-3: Rubella virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
  1759-0: Albumin/Globulin [Mass Ratio] in Serum or Plasma
  1783-0: Alkaline phosphatase [Enzymatic activity/volume] in Blood
  17849-1: Reticulocytes/100 erythrocytes in Blood by Automated count
  17850-9: Herpes simplex virus 1 IgG Ab [Presence] in Serum
  17851-7: Herpes simplex virus 2 IgG Ab [Presence] in Serum
  17855-8: Hemoglobin A1c/Hemoglobin.total in Blood by calculation
  17857-4: Rheumatoid factor [Titer] in Serum
  17861-6: Calcium [Mass/volume] in Serum or Plasma
  17863-2: Calcium.ionized [Mass/volume] in Serum or Plasma
  17864-0: Calcium.ionized [Mass/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
  1798-8: Amylase [Enzymatic activity/volume] in Serum or Plasma
  18184-2: Erythrocyte sedimentation rate by 2H Westergren method
  18262-6: Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay
  1834-1: Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
  18348-3: Toxoplasma gondii IgM Ab [Units/volume] in Cerebral spinal fluid
  1920-8: Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
  19213-8: pH of Mixed venous blood
  19224-5: Oxygen saturation in Mixed venous blood
  19230-2: Bicarbonate [Moles/volume] standard in Arterial blood
  19231-0: Bicarbonate [Moles/volume] standard in Capillary blood
  19232-8: Bicarbonate [Moles/volume] standard in Venous blood
  19233-6: Bicarbonate [Moles/volume] standard in Mixed venous blood
  19255-9: Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
  1959-6: Bicarbonate [Moles/volume] in Blood
  1960-4: Bicarbonate [Moles/volume] in Arterial blood
  1961-2: Bicarbonate [Moles/volume] in Capillary blood
  1962-0: Bicarbonate [Moles/volume] in Plasma
  1963-8: Bicarbonate [Moles/volume] in Serum or Plasma
  1968-7: Bilirubin.direct [Mass/volume] in Serum or Plasma
  1971-1: Bilirubin.indirect [Mass/volume] in Serum or Plasma
  1975-2: Bilirubin.total [Mass/volume] in Serum or Plasma
  1977-8: Bilirubin.total [Presence] in Urine
  1978-6: Bilirubin.total [Mass/volume] in Urine
  1988-5: C reactive protein [Mass/volume] in Serum or Plasma
  1992-7: Calcitonin [Mass/volume] in Serum or Plasma
  1994-3: Calcium.ionized [Moles/volume] in Blood
  1995-0: Calcium.ionized [Moles/volume] in Serum or Plasma
  2019-8: Carbon dioxide [Partial pressure] in Arterial blood
  2026-3: Carbon dioxide, total [Moles/volume] in Arterial blood
  2028-9: Carbon dioxide, total [Moles/volume] in Serum or Plasma
  20409-9: Erythrocytes [#/volume] in Urine by Test strip
  20416-4: Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
  20436-2: Glucose [Mass/volume] in Serum or Plasma --2 hours post dose glucose
  20447-9: HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
  20450-3: Alpha-1-Fetoprotein [Multiple of the median] in Serum or Plasma
  20454-5: Protein [Presence] in Urine by Test strip
  20464-4: Toxoplasma gondii Ab [Interpretation] in Serum
  20507-0: Reagin Ab [Presence] in Serum by RPR
  20508-8: Reagin Ab [Units/volume] in Serum by RPR
  20509-6: Hemoglobin [Mass/volume] in Blood by calculation
  20564-1: Oxygen saturation in Blood
  20565-8: Carbon dioxide, total [Moles/volume] in Blood
  20567-4: Ferritin [Mass/volume] in Serum or Plasma by Immunoassay
  20570-8: Hematocrit [Volume Fraction] of Blood
  20585-6: Lymphocytes [#/volume] in Specimen by Automated count
  20624-3: Creatinine [Mass/volume] in 24 hour Urine
  2069-3: Chloride [Moles/volume] in Blood
  2075-0: Chloride [Moles/volume] in Serum or Plasma
  2085-9: Cholesterol in HDL [Mass/volume] in Serum or Plasma
  2089-1: Cholesterol in LDL [Mass/volume] in Serum or Plasma
  2093-3: Cholesterol [Mass/volume] in Serum or Plasma
  21000-5: Erythrocyte distribution width [Entitic volume] by Automated count
  21232-4: Creatinine [Mass/volume] in Arterial blood
  21327-2: Herpes simplex virus 2 IgM Ab [Titer] in Serum
  21482-5: Protein [Mass/volume] in 24 hour Urine
  2157-6: Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
  21570-7: Toxoplasma gondii IgG Ab [Presence] in Serum by Sabin dye test
  2160-0: Creatinine [Mass/volume] in Serum or Plasma
  2161-8: Creatinine [Mass/volume] in Urine
  2162-6: Creatinine [Mass/time] in 24 hour Urine
  2164-2: Creatinine renal clearance in 24 hour Urine and Serum or Plasma
  22243-0: Cytomegalovirus IgG Ab [Units/volume] in Cerebral spinal fluid
  22244-8: Cytomegalovirus IgG Ab [Presence] in Serum or Plasma
  22316-4: Hepatitis B virus core Ab [Units/volume] in Serum
  22322-2: Hepatitis B virus surface Ab [Presence] in Serum
  22459-2: Reagin Ab [Presence] in Cerebral spinal fluid
  22496-4: Rubella virus Ab [Presence] in Serum
  22580-5: Toxoplasma gondii IgG Ab [Presence] in Serum
  2276-4: Ferritin [Mass/volume] in Serum or Plasma
  2283-0: Folate [Mass/volume] in Red Blood Cells
  2324-2: Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
  2336-6: Globulin [Mass/volume] in Serum
  2339-0: Glucose [Mass/volume] in Blood
  2340-8: Glucose [Mass/volume] in Blood by Automated test strip
  2345-7: Glucose [Mass/volume] in Serum or Plasma
  23761-0: Neutrophils/100 leukocytes in Blood by Manual count
  23811-3: Alpha-1-Fetoprotein [Multiple of the median] adjusted in Serum or Plasma
  23869-1: Hepatitis B virus DNA [Mass/volume] (viral load) in Serum by Probe
  23876-6: HIV 1 RNA [Units/volume] (viral load) in Plasma by Probe with signal amplification
  24113-3: Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay
  24116-6: Rubella virus IgM Ab [Presence] in Serum or Plasma by Immunoassay
  24119-0: Cytomegalovirus IgM Ab [Presence] in Serum or Plasma by Immunoassay
  24373-3: Ferritin [Mass/volume] in Blood
  24467-3: CD3+CD4+ (T4 helper) cells [#/volume] in Blood
  2498-4: Iron [Mass/volume] in Serum or Plasma
  2500-7: Iron binding capacity [Mass/volume] in Serum or Plasma
  2502-3: Iron saturation [Mass Fraction] in Serum or Plasma
  2524-7: Lactate [Moles/volume] in Serum or Plasma
  2528-8: Lactate dehydrogenase [Enzymatic activity/volume] in Cerebral spinal fluid
  2529-6: Lactate dehydrogenase [Enzymatic activity/volume] in Body fluid
  2530-4: Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid
  2531-2: Lactate dehydrogenase [Enzymatic activity/volume] in Peritoneal fluid
  2532-0: Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
  2533-8: Lactate dehydrogenase [Enzymatic activity/volume] in Synovial fluid
  2534-6: Lactate dehydrogenase [Enzymatic activity/volume] in Urine
  25420-1: Rubella virus IgM Ab [Presence] in Serum by Latex agglutination
  25514-1: Rubella virus IgG Ab [Presence] in Serum
  25542-2: Toxoplasma gondii IgM Ab [Presence] in Serum
  25668-5: Glucose [Moles/volume] in Serum or Plasma --2 hours post XXX challenge
  2571-8: Triglyceride [Mass/volume] in Serum or Plasma
  25836-8: HIV 1 RNA [#/volume] (viral load) in Specimen by NAA with probe detection
  2601-3: Magnesium [Moles/volume] in Serum or Plasma
  2638-5: Myelin basic protein [Mass/volume] in Cerebral spinal fluid
  26444-0: Basophils [#/volume] in Blood
  26449-9: Eosinophils [#/volume] in Blood
  26450-7: Eosinophils/100 leukocytes in Blood
  26453-1: Erythrocytes [#/volume] in Blood
  26464-8: Leukocytes [#/volume] in Blood
  26474-7: Lymphocytes [#/volume] in Blood
  26478-8: Lymphocytes/100 leukocytes in Blood
  26484-6: Monocytes [#/volume] in Blood
  26485-3: Monocytes/100 leukocytes in Blood
  26498-6: Myelocytes/100 leukocytes in Blood
  26499-4: Neutrophils [#/volume] in Blood
  26511-6: Neutrophils/100 leukocytes in Blood
  26515-7: Platelets [#/volume] in Blood
  26523-1: Promyelocytes [#/volume] in Blood
  26524-9: Promyelocytes/100 leukocytes in Blood
  26881-3: Interleukin 6 [Mass/volume] in Serum or Plasma
  26927-4: Herpes simplex virus 2 IgM Ab [Titer] in Serum by Immunofluorescence
  2703-7: Oxygen [Partial pressure] in Arterial blood
  2708-6: Oxygen saturation in Arterial blood
  2709-4: Oxygen saturation in Capillary blood
  2711-0: Oxygen saturation in Venous blood
  2713-6: Oxygen saturation Calculated from oxygen partial pressure in Blood
  27353-2: Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin
  2744-1: pH of Arterial blood
  2745-8: pH of Capillary blood
  2746-6: pH of Venous blood
  2777-1: Phosphate [Mass/volume] in Serum or Plasma
  27948-9: Herpes simplex virus 1+2 IgG Ab [Units/volume] in Serum by Immunoassay
  28001-6: Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot
  2823-3: Potassium [Moles/volume] in Serum or Plasma
  28539-5: MCH [Entitic mass]
  28540-3: MCHC [Mass/volume]
  28541-1: Metamyelocytes/100 leukocytes in Blood
  2862-1: Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
  28640-1: Bicarbonate [Moles/volume] in Arterial cord blood
  28641-9: Bicarbonate [Moles/volume] in Venous cord blood
  28657-5: Coagulation factor X activated actual/normal in Platelet poor plasma by Chromogenic method
  2885-2: Protein [Mass/volume] in Serum or Plasma
  2888-6: Protein [Mass/volume] in Urine
  2889-4: Protein [Mass/time] in 24 hour Urine
  29263-1: Fibrin degradation products [Presence] in Blood by Agglutination
  2947-0: Sodium [Moles/volume] in Blood
  2951-2: Sodium [Moles/volume] in Serum or Plasma
  29539-4: 'HIV 1 RNA [Log #/volume] (viral load) in Plasma by Probe with signal amplification'
  29541-0: 'HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection'
  29574-1: Thyrotropin [Presence] in DBS
  29575-8: Thyrotropin [Units/volume] in DBS
  29610-3: Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
  29615-2: Hepatitis B virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
  2965-2: Specific gravity of Urine
  29991-7: Fibrin+Fibrinogen fragments [Mass/volume] in Serum by Latex agglutination
  30003-8: Microalbumin [Mass/volume] in 24 hour Urine
  30004-6: Creatinine [Mass/volume] in Urine by Test strip
  30009-5: Fibrin+Fibrinogen fragments [Mass/volume] in Serum
  30038-4: Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
  3016-3: Thyrotropin [Units/volume] in Serum or Plasma
  30180-4: Basophils/100 leukocytes in Blood
  30226-5: Fibrin+Fibrinogen fragments [Mass/volume] in Platelet poor plasma
  30239-8: Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P
  3024-7: Thyroxine (T4) free [Mass/volume] in Serum or Plasma
  3026-2: Thyroxine (T4) [Mass/volume] in Serum or Plasma
  30313-1: Hemoglobin [Mass/volume] in Arterial blood
  30325-5: Cytomegalovirus IgM Ab [Presence] in Serum or Plasma
  3034-6: Transferrin [Mass/volume] in Serum or Plasma
  30341-2: Erythrocyte sedimentation rate
  30350-3: Hemoglobin [Mass/volume] in Venous blood
  30352-9: Hemoglobin [Mass/volume] in Capillary blood
  30384-2: Erythrocyte distribution width [Entitic volume]
  30385-9: Erythrocyte distribution width [Ratio]
  3040-3: Lipase [Enzymatic activity/volume] in Serum or Plasma
  30428-7: MCV [Entitic volume]
  30433-7: Metamyelocytes [#/volume] in Blood
  30446-9: Myelocytes [#/volume] in Blood
  3050-2: Triiodothyronine resin uptake (T3RU) in Serum or Plasma
  3051-0: Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma
  3052-8: Triiodothyronine (T3).reverse [Mass/volume] in Serum or Plasma
  30522-7: C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
  3053-6: Triiodothyronine (T3) [Mass/volume] in Serum or Plasma
  3084-1: Urate [Mass/volume] in Serum or Plasma
  30902-1: Fibrinogen [Mass/volume] in Platelet poor plasma by Heat denaturation
  30934-4: Natriuretic peptide B [Mass/volume] in Serum or Plasma
  3094-0: Urea nitrogen [Mass/volume] in Serum or Plasma
  3097-3: Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma
  31066-4: Herpes simplex virus 1 IgG Ab [Units/volume] in Body fluid
  31100-1: Hematocrit [Volume Fraction] of Blood by Impedance
  31112-6: Reticulocytes/100 erythrocytes in Blood by Manual
  31144-9: Thyroxine (T4) [Mass/volume] in DBS
  31146-4: Reagin Ab [Titer] in Cerebral spinal fluid by VDRL
  31147-2: Reagin Ab [Titer] in Serum by RPR
  31156-3: Hemoglobin Barts/Hemoglobin.total in Blood
  31178-7: Toxoplasma gondii IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
  31204-1: Hepatitis B virus core IgM Ab [Presence] in Serum
  31411-2: Herpes simplex virus 1+2 IgG Ab [Units/volume] in Serum
  3173-2: aPTT in Blood by Coagulation assay
  31796-6: Cytomegalovirus Ag [Presence] in Urine
  32133-1: Lactate [Moles/volume] in Plasma venous
  3217-7: Coagulation factor X activated [Units/volume] in Platelet poor plasma by Coagulation assay
  3218-5: Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
  32215-6: Thyroxine (T4) free index in Serum or Plasma by calculation
  32286-7: Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection
  32307-1: Chloride [Moles/volume] in Specimen
  32324-6: Lactate dehydrogenase [Enzymatic activity/volume] in Specimen
  32354-3: Hematocrit [Volume Fraction] of Arterial blood
  3246-6: Fibrin D-dimer [Units/volume] in Platelet poor plasma by Immunoassay
  3251-6: Fibrin+Fibrinogen fragments [Units/volume] in Platelet poor plasma by Latex agglutination
  32515-9: CD3+CD4+ (T4 helper) cells [#/volume] in Specimen
  3252-4: Fibrin+Fibrinogen fragments [Units/volume] in Serum by Latex agglutination
  3255-7: Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
  3256-5: Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
  32623-1: Platelet mean volume [Entitic volume] in Blood by Automated count
  32673-6: Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
  32687-6: Herpes simplex virus 1 IgM Ab [Presence] in Serum
  32693-4: Lactate [Moles/volume] in Blood
  32713-0: Potassium [Moles/volume] in Arterial blood
  32717-1: Sodium [Moles/volume] in Arterial blood
  32771-8: Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
  3289-6: Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
  33006-8: Cytomegalovirus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
  33037-3: Anion gap in Serum or Plasma
  33204-9: Troponin T.cardiac [Presence] in Serum or Plasma
  33254-4: pH of Arterial blood adjusted to patient's actual temperature
  33256-9: Leukocytes [#/volume] corrected for nucleated erythrocytes in Blood by Automated count
  33291-6: Herpes simplex virus 1 IgG Ab [Presence] in Serum by Immunoblot
  33313-8: Rheumatoid factor IgA [Units/volume] in Serum
  33314-6: Rheumatoid factor IgG [Units/volume] in Serum
  33336-9: Toxoplasma gondii IgM Ab [Presence] in Serum by Agglutination
  33367-4: Lactate dehydrogenase [Enzymatic activity/volume] in Pericardial fluid
  33616-4: Cytomegalovirus early Ag [Presence] in Urine
  33762-6: Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
  33910-1: Rheumatoid factor [Presence] in Serum
  33914-3: Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD)
  33959-8: Procalcitonin [Mass/volume] in Serum or Plasma
  33984-6: Coagulation factor X activity actual/normal in Platelet poor plasma by Chromogenic method
  34581-9: Calcium.ionized [Moles/volume] in Arterial blood
  34714-6: INR in Blood by Coagulation assay
  34961-3: Rh [Type] in Blood by Confirmatory method
  35281-5: Toxoplasma gondii IgG Ab [Presence] in Serum by Immunofluorescence
  35591-7: Creatinine renal clearance predicted by Cockcroft-Gault formula
  35592-5: Creatinine renal clearance/1.73 sq M.predicted by Cockcroft-Gault formula, BSA formula
  35648-5: C reactive protein [Quintile] in Serum or Plasma by High sensitivity method
  35674-1: Creatinine [Mass/volume] in Urine collected for unspecified duration
  35875-4: Herpes simplex virus 1+2 Ab [Units/volume] in Cerebral spinal fluid
  38180-6: Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection
  38483-4: Creatinine [Mass/volume] in Blood
  38506-2: Thyroxine (T4) [Presence] in DBS
  38875-1: INR in Platelet poor plasma or blood by Coagulation assay
  39485-8: pH of Capillary blood adjusted to patient's actual temperature
  39486-6: pH of Venous blood adjusted to patient's actual temperature
  39571-5: Herpes simplex virus 1+2 IgM Ab [Titer] in Cerebral spinal fluid
  40045-7: Glucose [Mass/volume] in Serum or Plasma --2 days post XXX challenge
  40323-8: Glucose [Moles/volume] in Serum or Plasma --2 hours post dose triple bolus
  40466-5: Herpes simplex virus 1 IgM Ab [Presence] in Serum by Immunofluorescence
  40665-2: Reticulocytes [#/volume] in Blood by Manual count
  40667-8: Rubella virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
  40677-7: Toxoplasma gondii IgG Ab [Presence] in Serum by Immunoassay
  40678-5: Toxoplasma gondii IgM Ab [Presence] in Serum or Plasma by Immunoassay
  41024-1: Glucose [Mass/volume] in Serum or Plasma --2 hours post 50 g glucose PO
  41399-7: Herpes simplex virus 1+2 IgM Ab [Units/volume] in Serum by Immunoassay
  41652-9: Glucose [Mass/volume] in Venous blood
  41653-7: Glucose [Mass/volume] in Capillary blood by Glucometer
  41654-5: Hematocrit [Volume Fraction] of Venous blood
  42507-4: Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
  42593-4: Calcium [Moles/volume] in Capillary blood
  42595-9: Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
  42606-4: Herpes simplex virus 2 IgM Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
  42638-7: Prothrombin time (PT) in Platelet poor plasma by Coagulation 1:1 saline
  42719-5: Bilirubin.total [Mass/volume] in Blood
  42757-5: Troponin I.cardiac [Mass/volume] in Blood
  42908-4: Hematocrit [Volume Fraction] of Capillary blood
  43026-4: Herpes simplex virus 2 IgM Ab [Presence] in Cerebral spinal fluid
  43030-6: Herpes simplex virus 1+2 IgM Ab [Units/volume] in Serum
  43180-9: Herpes simplex virus 2 IgG Ab [Presence] in Serum or Plasma by Immunoassay
  43279-9: Hepatitis B Virus YMDD [Presence] in Serum or Plasma by NAA with probe detection
  43396-1: Cholesterol non HDL [Mass/volume] in Serum or Plasma
  43402-7: Erythrocyte sedimentation rate by 15 minute reading
  43700-4: Cytomegalovirus [Presence] in Urine by Shell vial culture
  43734-3: aPTT in Platelet poor plasma by Coagulation 1:1 saline
  43810-1: Rubella virus Ab [Presence] in Serum by Immunoassay
  44494-3: Herpes simplex virus 2 IgM Ab [Presence] in Serum by Immunoassay
  44817-5: Cytomegalovirus IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
  45062-7: C reactive protein [Mass/volume] in Cerebral spinal fluid
  45066-8: Creatinine and Glomerular filtration rate.predicted panel - Serum, Plasma or Blood
  45161-7: 'Hepatitis B virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection'
  45210-2: Herpes simplex virus 2 IgM Ab [Presence] in Serum by Immunofluorescence
  4537-7: Erythrocyte sedimentation rate by Westergren method
  4538-5: Erythrocyte sedimentation rate by Wintrobe method
  4539-3: Erythrocyte sedimentation rate Zeta by Zetafuge
  4544-3: Hematocrit [Volume Fraction] of Blood by Automated count
  4545-0: Hematocrit [Volume Fraction] of Blood by Centrifugation
  4548-4: Hemoglobin A1c/Hemoglobin.total in Blood
  46109-5: Rubella virus IgM Ab [Titer] in Cerebral spinal fluid
  4621-9: Hemoglobin S [Presence] in Blood
  4625-0: Hemoglobin S/Hemoglobin.total in Blood
  46417-2: Prothrombin time (PT) in Capillary blood by Coagulation assay
  46418-0: INR in Capillary blood by Coagulation assay
  47213-4: Cholesterol in LDL real size pattern [Identifier] in Serum or Plasma
  47252-2: 'Hepatitis C virus RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection'
  47390-0: Toxoplasma gondii IgG Ab [Units/volume] in Serum by Sabin dye test
  47678-8: Lactate dehydrogenase [Enzymatic activity/volume] in 24 hour Urine
  47863-6: Lactate dehydrogenase [Enzymatic activity/time] in 24 hour Urine
  48058-2: Fibrin D-dimer DDU [Mass/volume] in Platelet poor plasma by Immunoassay
  48065-7: Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
  48066-5: Fibrin D-dimer DDU [Mass/volume] in Platelet poor plasma
  48067-3: Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma by Immunoassay
  48141-6: Ferritin [Entitic mass] in Red Blood Cells
  48159-8: Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay
  48398-2: Hepatitis B virus DNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection
  48421-2: C reactive protein [Mass/volume] in Capillary blood
  48425-3: Troponin T.cardiac [Mass/volume] in Blood
  48426-1: Troponin T.cardiac [Presence] in Blood
  48642-3: Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
  48643-1: Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
  48664-7: Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation.derived
  49058-1: aPTT in Blood drawn from CRRT circuit by Coagulation assay
  49134-0: Glucose [Mass/volume] in Blood --2 hours post dose glucose
  49136-5: Creatine kinase.MB/Creatine kinase.total [Ratio] in Serum or Plasma
  49347-8: Cytomegalovirus DNA [#/volume] (viral load) in Urine by NAA with probe detection
  49497-1: Platelets [#/volume] in Blood by Estimate
  49498-9: Leukocytes [#/volume] in Blood by Estimate
  49539-0: Cytomegalovirus IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
  49551-5: Creatine kinase.MB [Mass/volume] in Blood
  49563-0: Troponin I.cardiac [Mass/volume] in Serum or Plasma by Detection limit <= 0.01 ng/mL
  49701-6: pH of Blood adjusted to patient's actual temperature
  49731-3: Herpes simplex virus 1+2 IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
  49732-1: Interleukin 6 [Mass/volume] in Body fluid
  49919-4: Interleukin 6 [Mass/volume] in Cerebral spinal fluid
  4999-9: Cytomegalovirus DNA [Presence] in Urine by NAA with probe detection
  50044-7: Glomerular filtration rate/1.73 sq M.predicted among females [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
  5010-4: Hepatitis C virus RNA [Presence] in Blood by NAA with probe detection
  50210-4: Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Cystatin-based formula
  50380-5: Creatinine renal clearance/1.73 sq M.predicted among females by Cockcroft-Gault formula, BSA formula
  50381-3: Creatinine renal clearance/1.73 sq M.predicted among males by Cockcroft-Gault formula, BSA formula
  50384-7: Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (Schwartz)
  50551-1: Bilirubin.total [Presence] in Urine by Automated test strip
  50754-1: aPTT in Pooled Platelet poor plasma by Coagulation assay
  50758-2: Herpes simplex virus 1 IgM Ab [Titer] in Serum by Immunofluorescence
  50980-2: pH of Mixed venous blood adjusted to patient's actual temperature
  5124-3: Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
  5126-8: Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma by Immunoassay
  51731-8: Oxygen saturation Calculated from oxygen partial pressure in Venous blood
  51732-6: Oxygen saturation Calculated from oxygen partial pressure in Capillary blood
  51733-4: Oxygen saturation Calculated from oxygen partial pressure in Arterial blood
  5187-0: Hepatitis B virus core Ab [Units/volume] in Serum by Immunoassay
  51914-0: Hepatitis B virus core IgG+IgM Ab [Presence] in Serum
  51916-5: Herpes simplex virus 1 IgG Ab [Presence] in Serum or Plasma by Immunoassay
  5193-8: Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay
  5195-3: Hepatitis B virus surface Ag [Presence] in Serum
  5196-1: Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay
  5199-5: Hepatitis C virus Ab [Presence] in Serum by Immunoblot
  5206-8: Herpes simplex virus 1 IgG Ab [Units/volume] in Serum by Immunoassay
  5207-6: Herpes simplex virus 1 IgM Ab [Units/volume] in Serum by Immunoassay
  5209-2: Herpes simplex virus 2 IgG Ab [Units/volume] in Serum by Immunoassay
  5210-0: Herpes simplex virus 2 IgM Ab [Units/volume] in Serum by Immunoassay
  52122-9: Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --post heparin neutralization
  52129-4: INR in Platelet poor plasma by Coagulation assay --post heparin neutralization
  5289-4: Reagin Ab [Units/volume] in Cerebral spinal fluid by VDRL
  5290-2: Reagin Ab [Presence] in Cerebral spinal fluid by VDRL
  5291-0: Reagin Ab [Units/volume] in Serum by VDRL
  5292-8: Reagin Ab [Presence] in Serum by VDRL
  52981-8: Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
  52984-2: Cytomegalovirus IgG Ab avidity [Ratio] in Serum or Plasma by Immunoassay
  5331-4: Rubella virus Ab [Presence] in Serum by Hemagglutination inhibition
  5332-2: Rubella virus Ab [Presence] in Serum by Latex agglutination
  53326-5: Specific gravity of Urine by Automated test strip
  5334-8: Rubella virus IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
  5335-5: Rubella virus IgM Ab [Units/volume] in Serum by Immunoassay
  53553-4: Glucose mean value [Moles/volume] in Blood Estimated from glycated hemoglobin
  53560-9: Herpes simplex virus IgM Ab [Units/volume] in Serum by Immunoassay
  5388-4: Toxoplasma gondii IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
  5390-0: Toxoplasma gondii IgM Ab [Units/volume] in Serum by Immunoassay
  53962-7: Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma
  54163-1: Cytomegalovirus DNA [#/volume] (viral load) in Urine by Probe and target amplification method detection limit = 200 copies/ml
  54206-8: 'Cytomegalovirus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection'
  54218-3: CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
  54347-0: Albumin [Moles/volume] in Serum or Plasma
  54363-7: Bilirubin.total [Moles/volume] in Blood
  55782-7: Hemoglobin [Mass/volume] in Blood by Oximetry
  5671-3: Lead [Mass/volume] in Blood
  5770-3: Bilirubin.total [Presence] in Urine by Test strip
  57743-7: ABO group [Type] in Blood by Confirmatory method
  57747-8: Erythrocytes [#/volume] in Urine by Automated test strip
  57899-7: Triiodothyronine (T3)/Triiodothyronine (T3).reverse [Ratio] in Serum or Plasma
  5811-5: Specific gravity of Urine by Test strip
  5837-0: Cytomegalovirus [Presence] in Urine by Organism specific culture
  58450-8: Bilirubin [Presence] in Urine by Confirmatory method
  58452-4: Hepatitis B virus surface Ag [Units/volume] in Serum
  58784-0: Herpes simplex virus 1 IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
  5901-4: Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay
  5902-2: Prothrombin time (PT)
  5905-5: Monocytes/100 leukocytes in Blood by Automated count
  59052-1: HIV 1+Hepatitis C virus RNA+Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
  59182-6: C reactive protein [Mass/volume] in Cerebral spinal fluid by High sensitivity method
  5964-2: Prothrombin time (PT) in Blood by Coagulation assay
  59794-8: Glucose [Molar concentration difference] in Serum or Plasma --2 hours post XXX challenge
  59826-8: Creatinine [Moles/volume] in Blood
  59827-6: Bilirubin.total [Mass/volume] in Arterial blood
  59828-4: Bilirubin.total [Mass/volume] in Venous blood
  60017-1: Lactate dehydrogenase [Enzymatic activity/volume] in Body fluid by Pyruvate to lactate reaction
  60018-9: Lactate dehydrogenase [Enzymatic activity/volume] in Pericardial fluid by Pyruvate to lactate reaction
  60019-7: Lactate dehydrogenase [Enzymatic activity/volume] in Pericardial fluid by Lactate to pyruvate reaction
  60020-5: Lactate dehydrogenase [Enzymatic activity/volume] in Peritoneal fluid by Pyruvate to lactate reaction
  60021-3: Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Pyruvate to lactate reaction
  60022-1: Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
  60023-9: Lactate dehydrogenase [Enzymatic activity/volume] in Cerebral spinal fluid by Pyruvate to lactate reaction
  60024-7: Lactate dehydrogenase [Enzymatic activity/volume] in Cerebral spinal fluid by Lactate to pyruvate reaction
  60474-4: Reticulocytes [#/volume] in Blood by Automated count
  61151-7: Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method
  61152-5: Albumin [Mass/volume] in Serum or Plasma by Bromocresol purple (BCP) dye binding method
  62234-0: Albumin [Moles/volume] in Serum or Plasma by Bromocresol purple (BCP) dye binding method
  62235-7: Albumin [Moles/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method
  62238-1: Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
  6298-4: Potassium [Moles/volume] in Blood
  6299-2: Urea nitrogen [Mass/volume] in Blood
  6301-6: INR in Platelet poor plasma by Coagulation assay
  63432-9: Herpes simplex virus 1+2 IgM Ab [Units/volume] in Cerebral spinal fluid
  63462-6: Rubella virus IgG Ab [Presence] in Serum by Latex agglutination
  6597-9: Troponin T.cardiac [Mass/volume] in Venous blood
  6598-7: Troponin T.cardiac [Mass/volume] in Serum or Plasma
  6690-2: Leukocytes [#/volume] in Blood by Automated count
  67151-1: Troponin T.cardiac [Mass/volume] in Serum or Plasma by High sensitivity method
  6768-6: Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
  68387-0: Lactate dehydrogenase [Enzymatic activity/volume] in Peritoneal fluid by Lactate to pyruvate reaction
  68452-2: Lactate dehydrogenase [Enzymatic activity/volume] in Synovial fluid by Pyruvate to lactate reaction
  68453-0: Lactate dehydrogenase [Enzymatic activity/volume] in Synovial fluid by Lactate to pyruvate reaction
  6864-3: Hemoglobin S [Presence] in Blood by Solubility test
  6892-4: Thyroxine (T4) free [Mass/volume] in Serum or Plasma by Dialysis
  6921-1: Cytomegalovirus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
  69405-9: Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
  69964-5: Bicarbonate [Moles/volume] standard in Plasma
  70154-0: Hepatitis B virus surface Ag in Serum or Plasma by Confirmatory method
  70199-5: Bilirubin.total [Moles/volume] in Urine
  704-7: Basophils [#/volume] in Blood by Automated count
  705-4: Basophils [#/volume] in Blood by Manual count
  706-2: Basophils/100 leukocytes in Blood by Automated count
  707-0: Basophils/100 leukocytes in Blood by Manual count
  70969-1: Glomerular filtration rate/1.73 sq M.predicted among males [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
  711-2: Eosinophils [#/volume] in Blood by Automated count
  712-0: Eosinophils [#/volume] in Blood by Manual count
  713-8: Eosinophils/100 leukocytes in Blood by Automated count
  714-6: Eosinophils/100 leukocytes in Blood by Manual count
  71426-1: C reactive protein [Mass/volume] in Blood by High sensitivity method
  71427-9: Fibrin D-dimer FEU [Mass/volume] in Blood by Immunoassay
  718-7: Hemoglobin [Mass/volume] in Blood
  71841-1: Oxygen saturation [Pure mass fraction] Calculated from oxygen partial pressure in Venous blood
  71842-9: Oxygen saturation [Pure mass fraction] Calculated from oxygen partial pressure in Capillary blood
  71843-7: Oxygen saturation [Pure mass fraction] Calculated from oxygen partial pressure in Arterial blood
  71844-5: Oxygen saturation [Pure mass fraction] Calculated from oxygen partial pressure in Blood
  71845-2: Oxygen saturation [Pure mass fraction] in Venous blood
  71846-0: Oxygen saturation [Pure mass fraction] in Mixed venous blood
  71851-0: Oxygen saturation [Pure mass fraction] in Capillary blood
  71852-8: Oxygen saturation [Pure mass fraction] in Arterial blood
  71853-6: Oxygen saturation [Pure mass fraction] in Blood
  72171-2: Glucose tolerance 2 hours panel - Serum or Plasma
  72925-1: Bilirubin.total [Moles/volume] in Amniotic fluid
  731-0: Lymphocytes [#/volume] in Blood by Automated count
  732-8: Lymphocytes [#/volume] in Blood by Manual count
  73559-7: Herpes simplex virus 1 IgG Ab [Titer] in Serum by Immunofluorescence
  736-9: Lymphocytes/100 leukocytes in Blood by Automated count
  737-7: Lymphocytes/100 leukocytes in Blood by Manual count
  740-1: Metamyelocytes/100 leukocytes in Blood by Manual count
  74105-8: Oxygen saturation Calculated from oxygen partial pressure in Mixed venous blood
  742-7: Monocytes [#/volume] in Blood by Automated count
  743-5: Monocytes [#/volume] in Blood by Manual count
  744-3: Monocytes/100 leukocytes in Blood by Manual count
  74464-9: Platelets [#/volume] in Capillary blood by Manual count
  749-2: Myelocytes/100 leukocytes in Blood by Manual count
  751-8: Neutrophils [#/volume] in Blood by Automated count
  75241-0: Procalcitonin [Mass/volume] in Serum or Plasma by Immunoassay
  753-4: Neutrophils [#/volume] in Blood by Manual count
  76399-5: Troponin I.cardiac [Presence] in Serum, Plasma or Blood by Rapid immunoassay
  76485-2: C reactive protein [Moles/volume] in Serum or Plasma
  76486-0: C reactive protein [Moles/volume] in Serum or Plasma by High sensitivity method
  76625-3: Alanine aminotransferase [Enzymatic activity/volume] in Blood
  76631-1: Albumin [Mass/volume] in Blood by Bromocresol purple (BCP) dye binding method
  76633-7: Glomerular filtration rate/1.73 sq M.predicted by Creatinine-based formula (MDRD) in Blood
  770-8: Neutrophils/100 leukocytes in Blood by Automated count
  77137-8: Bilirubin.total [Moles/volume] in Serum, Plasma or Blood
  77140-2: Creatinine [Moles/volume] in Serum, Plasma or Blood
  77144-4: Alanine aminotransferase [Enzymatic activity/volume] in Serum, Plasma or Blood
  77147-7: Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
  77148-5: Albumin [Mass/volume] in Serum, Plasma or Blood by Bromocresol purple (BCP) dye binding method
  77307-7: Lead [Mass/volume] in Venous blood
  77397-8: ABO and Rh group [Type] in Blood by Confirmatory method
  776-5: Platelet mean volume [Entitic volume] in Blood by Rees-Ecker
  777-3: Platelets [#/volume] in Blood by Automated count
  778-1: Platelets [#/volume] in Blood by Manual count
  7799-0: Fibrin D-dimer [Units/volume] in Platelet poor plasma
  783-1: Promyelocytes/100 leukocytes in Blood by Manual count
  785-6: MCH [Entitic mass] by Automated count
  7852-7: Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
  7853-5: Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
  786-4: MCHC [Mass/volume] by Automated count
  787-2: MCV [Entitic volume] by Automated count
  788-0: Erythrocyte distribution width [Ratio] by Automated count
  789-8: Erythrocytes [#/volume] in Blood by Automated count
  790-6: Erythrocytes [#/volume] in Blood by Manual count
  7905-3: Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test
  7909-5: Herpes simplex virus 1 IgG Ab [Units/volume] in Serum
  7910-3: Herpes simplex virus 1 IgM Ab [Units/volume] in Serum
  7912-9: Herpes simplex virus 2 IgG Ab [Units/volume] in Serum
  7913-7: Herpes simplex virus 2 IgM Ab [Units/volume] in Serum
  8014-3: Rubella virus IgG Ab [Units/volume] in Serum
  8015-0: Rubella virus IgM Ab [Units/volume] in Serum
  8039-0: Toxoplasma gondii IgG Ab [Units/volume] in Serum
  804-5: Leukocytes [#/volume] in Blood by Manual count
  8040-8: Toxoplasma gondii IgM Ab [Units/volume] in Serum
  8123-2: CD3+CD4+ (T4 helper) cells/100 cells in Blood
  81324-6: Glucose tolerance 2 hours gestational panel - Serum or Plasma
  82477-1: Erythrocyte sedimentation rate by Photometric method
  88112-8: Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P
  882-1: ABO and Rh group [Type] in Blood
  88293-6: Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
  88294-4: Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
  883-9: ABO group [Type] in Blood
  884-7: ABO and Rh group [Type] in Capillary blood
  89576-3: Troponin T.cardiac panel - Serum or Plasma by High sensitivity method
  89577-1: Troponin I.cardiac panel - Serum or Plasma by High sensitivity method
  89579-7: Troponin I.cardiac [Mass/volume] in Serum or Plasma by High sensitivity method
  89871-8: Bilirubin.total [Moles/volume] in Venous blood
  89872-6: Bilirubin.total [Moles/volume] in Arterial blood
  91556-1: Fibrin D-dimer DDU [Mass/volume] in Blood by Immunoassay
  9422-7: Herpes simplex virus IgG Ab [Units/volume] in Serum
  94309-2: SARS-CoV-2 (COVID-19) RNA [Presence] in Specimen by NAA with probe detection
  94500-6: SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory specimen by NAA with probe detection
  9741-0: Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid
  978-7: D Ag [Presence] on Red Blood Cells
  9830-1: Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
  13926-1: Glutamate decarboxylase 65 Ab [Units/volume] in Serum 
  31209-0: Islet cell 512 Ab [Units/volume] in Serum
  56540-8: Glutamate decarboxylase 65 Ab [Units/volume] in Serum by Immunoassay
  56718-0: Islet cell 512 Ab [Units/volume] in Serum by Immunoassay
  72523-4: Glutamate decarboxylase 65 Ab [Presence] in Serum or Plasma by Immunofluorescence
  76651-9: Zinc transporter 8 Ab [Units/volume] in Serum or Plasma by Immunoassay
  8047-3: Varicella zoster birus IgG Ab [Units/volume] in Serum
  5403-1: Varicalla zoster virus IgG Ab [Units/volume] in Serum by Immunoassay
  14683-7: Creatinine [Moles/volume] in Urine 14683-7
  20454-5: Protein [Presence] in Urine by Test strip 20454-5
  20511-2: Creatinine [Interpretation] in Urine 20511-2
  2161-8: Creatinine [Mass/volume] in Urine 2161-8
  27298-9: Protein [Units/volume] in Urine 27298-9
  2887-8: Protein [Presence] in Urine 2887-8
  2888-6: Protein [Mass/volume] in Urine 2888-6
  30002-0: Creatinine [Moles/volume] in Urine by Test strip 30002-0
  32551-4: Protein [Mass] in Urine collected for unspecified duration 32551-4
  33863-2: Cystatin C [Mass/volume] in Serum or Plasma 33863-2
  35663-4: Protein [Mass/volume] in Urine collected for unspecified duration 35663-4
  50561-0: Protein [Mass/volume] in Urine by Automated test strip 50561-0
  53121-0: Protein [Mass/time] in 1 hour Urine 53121-0
  53525-2: Protein [Presence] in Urine by SSA method 53525-2
  57735-3: Protein [Presence] in Urine by Automated test strip 57735-3
  5804-0: Protein [Mass/volume] in Urine by Test strip 5804-0
  13641-6: Codeine [Presence] in Urine by SAMHSA confirm method
  13646-5: Methaqualone [Mass/mass] in Hair
  16389-9: Antidepressants [Identifier] in Serum or Plasma
  16540-7: Deprecated Cannabinoids [Presence] in Serum or Plasma by Confirm method
  16644-7: Codeine Free [Presence] in Serum or Plasma by Confirmatory method
  16743-7: Deprecated Nordiazepam [Presence] in Serum or Plasma
  16754-4: Diamorphine [Mass/volume] in Unknown substance
  16756-9: Diamorphine [Mass/volume] in Serum or Plasma by Confirmatory method
  16774-2: Diethylcarbamazepine [Mass/volume] in Serum or Plasma
  16781-7: Disulfiram [Presence] in Urine
  19351-6: Aprobarbital cutoff [Mass/volume] in Urine for Screen method
  19353-2: Barbital [Presence] in Urine by Screen method
  19360-7: Cocaine [Presence] in Urine by Confirmatory method
  19363-1: Cocaine cutoff [Mass/volume] in Urine for Confirmatory method
  19371-4: Butabarbital cutoff [Mass/volume] in Urine for Screen method
  19373-0: Butalbital [Presence] in Urine by Screen method
  19375-5: Butalbital cutoff [Mass/volume] in Urine for Screen method
  19385-4: chlordiazePOXIDE [Presence] in Urine by Screen method
  19388-8: chlordiazePOXIDE cutoff [Mass/volume] in Urine for Confirmatory method
  19397-9: chlorproMAZINE cutoff [Mass/volume] in Urine for Screen method
  19398-7: chlorproMAZINE cutoff [Mass/volume] in Urine for Confirmatory method
  19406-8: Cocaethylene [Presence] in Urine by Confirmatory method
  19413-4: Codeine cutoff [Mass/volume] in Urine for Screen method
  19414-2: Codeine cutoff [Mass/volume] in Urine for Confirmatory method
  19423-3: Dextromethamphetamine [Presence] in Urine by Screen method
  19429-0: Propoxyphene [Presence] in Urine by Screen method
  19437-3: Propoxyphene + Norpropoxyphene cutoff [Mass/volume] in Urine for Screen method
  19439-9: Diamorphine [Presence] in Urine by Screen method
  19446-4: Dihydrocodeine [Presence] in Urine by Screen method
  19452-2: Dimetamphetamine [Presence] in Urine by Screen method
  19459-7: Ethylamphetamine [Mass/volume] in Urine
  19462-1: Ethylmorphine [Presence] in Urine by Screen method
  19465-4: Ethylmorphine cutoff [Mass/volume] in Urine for Confirmatory method
  19466-2: Flunitrazepam [Presence] in Urine by Screen method
  19469-6: Flunitrazepam cutoff [Mass/volume] in Urine for Confirmatory method
  19478-7: Haloperidol [Presence] in Urine by Screen method
  19481-1: Haloperidol cutoff [Mass/volume] in Urine for Confirmatory method
  19484-5: HYDROcodone cutoff [Mass/volume] in Urine for Screen method
  19488-6: HYDROmorphone cutoff [Mass/volume] in Urine for Confirmatory method
  19493-6: Hydroxyethylflurazepam [Presence] in Urine by Screen method
  19500-8: Ketamine cutoff [Mass/volume] in Urine for Confirmatory method
  19510-7: Levomethamphetamine [Presence] in Urine by Screen method
  19511-5: Levomethamphetamine [Presence] in Urine by Confirmatory method
  19515-6: Levomethamphetamine cutoff [Mass/volume] in Urine for Confirmatory method
  19535-4: Meperidine cutoff [Mass/volume] in Urine for Confirmatory method
  19547-9: Mesoridazine [Presence] in Urine by Confirmatory method
  19548-7: Mesoridazine cutoff [Mass/volume] in Urine for Screen method
  19550-3: Methadone [Presence] in Urine by Screen method
  19571-9: Methylenedioxymethamphetamine cutoff [Mass/volume] in Urine for Screen method
  19577-6: Methylphenidate [Presence] in Urine by Screen method
  19580-0: Methylphenidate cutoff [Mass/volume] in Urine for Confirmatory method
  19593-3: 6-Monoacetylmorphine (6-MAM) [Mass/volume] in Urine by Confirmatory method
  13585-5: Trifluoperazine [Presence] in Serum or Plasma
  13906-3: Deprecated Mesoridazine
  16369-1: Amphetamines [Presence] in Urine by Confirmatory method
  16498-8: Butalbital [Units/volume] in Gastric fluid
  16499-6: Butorphanol [Mass/volume] in Urine by Confirmatory method
  16543-1: Cannabinoids [Mass/volume] in Unknown substance by Confirmatory method
  16748-6: Propoxyphene [Presence] in Serum or Plasma by Confirmatory method
  19355-7: Barbital cutoff [Mass/volume] in Urine for Screen method
  19357-3: Benzoylecgonine cutoff [Mass/volume] in Urine for Screen method
  19358-1: Benzoylecgonine cutoff [Mass/volume] in Urine for Confirmatory method
  19368-0: Butabarbital [Presence] in Urine by Screen method
  19370-6: Butabarbital [Mass/volume] in Urine
  19376-3: Butalbital cutoff [Mass/volume] in Urine for Confirmatory method
  19383-9: Carboxy tetrahydrocannabinol cutoff [Mass/volume] in Urine for Screen method
  19420-9: Dextroamphetamine [Presence] in Urine by Confirmatory method
  19425-8: Dextromethamphetamine [Mass/volume] in Urine by Confirmatory method
  19426-6: Deprecated Dextromethamphetamine [Mass/volume] in Urine
  19431-6: Propoxyphene cutoff [Mass/volume] in Urine for Screen method
  19434-0: Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method
  19435-7: Propoxyphene + Norpropoxyphene [Mass/volume] in Urine by Confirmatory method
  19438-1: Propoxyphene + Norpropoxyphene cutoff [Mass/volume] in Urine for Confirmatory method
  19443-1: diazePAM [Presence] in Urine by Screen method
  19455-5: Dimetamphetamine cutoff [Mass/volume] in Urine for Confirmatory method
  19456-3: Ethylamphetamine [Presence] in Urine by Screen method
  19458-9: Ethylamphetamine [Mass/volume] in Urine by Confirmatory method
  19467-0: Flunitrazepam [Presence] in Urine by Confirmatory method
  19471-2: FLUoxetine [Presence] in Urine by Confirmatory method
  19473-8: FLUoxetine cutoff [Mass/volume] in Urine for Confirmatory method
  19482-9: HYDROcodone [Presence] in Urine by Screen method
  19486-0: HYDROmorphone [Presence] in Urine by Screen method
  19492-8: Hydroxyalprazolam cutoff [Mass/volume] in Urine for Confirmatory method
  19506-5: Deprecated Levomepromazine [Presence] in Urine by Screen method
  19514-9: Levomethamphetamine cutoff [Mass/volume] in Urine for Screen method
  19518-0: Levorphanol cutoff [Mass/volume] in Urine for Screen method
  19519-8: Levorphanol cutoff [Mass/volume] in Urine for Confirmatory method
  19522-2: LORazepam cutoff [Mass/volume] in Urine for Screen method
  19523-0: LORazepam cutoff [Mass/volume] in Urine for Confirmatory method
  19531-3: Lysergate diethylamide cutoff [Mass/volume] in Urine for Confirmatory method
  19554-5: Methamphetamine [Presence] in Urine by Screen method
  19566-9: Methylenedioxyamphetamine [Presence] in Urine by Confirmatory method
  19589-1: Midazolam cutoff [Mass/volume] in Urine for Screen method
  19592-5: Deprecated 6-Monoacetylmorphine [Presence] in Urine by Confirm method
  19595-8: Deprecated 6-Monoacetylmorphine cutoff [Mass/volume] in Urine for Screen method
  19603-0: Morphine Free cutoff [Mass/volume] in Urine for Screen method
  19608-9: Nalbuphine cutoff [Mass/volume] in Urine for Confirmatory method
  19609-7: Naltrexone [Presence] in Urine by Screen method
  19614-7: N-desalkylflurazepam [Presence] in Urine by Screen method
  19630-3: Norfluoxetine cutoff [Mass/volume] in Urine for Screen method
  19636-0: Norpropoxyphene cutoff [Mass/volume] in Urine for Screen method
  19642-8: oxyCODONE [Presence] in Urine by Screen method
  19645-1: oxyCODONE cutoff [Mass/volume] in Urine for Confirmatory method
  13648-1: Morphine [Presence] in Urine by SAMHSA confirm method
  13817-2: Tryptophan/Creatinine [Mass Ratio] in Urine
  16364-2: Amobarbital [Mass/volume] in Gastric fluid
  16446-7: Benzoylecgonine [Presence] in Serum or Plasma by Confirmatory method
  16625-6: clomiPRAMINE [Mass/volume] in Milk
  16746-0: Nortrimipramine [Mass/volume] in Serum or Plasma
  16749-4: Propoxyphene + Norpropoxyphene [Units/volume] in Urine
  19346-6: Amphetamine [Mass/volume] in Urine
  19347-4: Amphetamine cutoff [Mass/volume] in Urine for Screen method
  19348-2: Amphetamine cutoff [Mass/volume] in Urine for Confirmatory method
  19350-8: Aprobarbital [Presence] in Urine by Confirmatory method
  19352-4: Aprobarbital cutoff [Mass/volume] in Urine for Confirmatory method
  19354-0: Barbital [Presence] in Urine by Confirmatory method
  19362-3: Cocaine cutoff [Mass/volume] in Urine for Screen method
  19372-2: Butabarbital cutoff [Mass/volume] in Urine for Confirmatory method
  19378-9: Butorphanol [Presence] in Urine by Confirmatory method
  19382-1: Carboxy tetrahydrocannabinol [Presence] in Urine by Confirmatory method
  19408-4: Cocaethylene [Mass/volume] in Urine
  19411-8: Codeine [Presence] in Urine by Screen method
  19415-9: Tetrahydrocannabinol [Presence] in Urine by Screen method
  19418-3: Tetrahydrocannabinol cutoff [Mass/volume] in Urine for Confirmatory method
  19424-1: Dextromethamphetamine [Presence] in Urine by Confirmatory method
  19427-4: Dextromethamphetamine cutoff [Mass/volume] in Urine for Screen method
  19436-5: Propoxyphene + Norpropoxyphene [Mass/volume] in Urine
  19451-4: Dihydrocodeine cutoff [Mass/volume] in Urine for Confirmatory method
  19468-8: Flunitrazepam cutoff [Mass/volume] in Urine for Screen method
  19475-3: Flurazepam [Presence] in Urine by Confirmatory method
  19476-1: Flurazepam cutoff [Mass/volume] in Urine for Screen method
  19477-9: Flurazepam cutoff [Mass/volume] in Urine for Confirmatory method
  19479-5: Haloperidol [Presence] in Urine by Confirmatory method
  19487-8: HYDROmorphone cutoff [Mass/volume] in Urine for Screen method
  19496-9: Hydroxyethylflurazepam cutoff [Mass/volume] in Urine for Confirmatory method
  19509-9: Deprecated Levomepromazine cutoff [Mass/volume] in Urine for Confirm method
  19512-3: Levomethamphetamine [Mass/volume] in Urine by Confirmatory method
  19520-6: LORazepam [Presence] in Urine by Screen method
  19539-6: Mephobarbital [Mass/volume] in Urine
  19541-2: Mephobarbital cutoff [Mass/volume] in Urine for Confirmatory method
  19552-9: Methadone cutoff [Mass/volume] in Urine for Screen method
  19553-7: Methadone cutoff [Mass/volume] in Urine for Confirmatory method
  19556-0: Methamphetamine cutoff [Mass/volume] in Urine for Screen method
  19558-6: Methaqualone [Presence] in Urine by Screen method
  19567-7: Methylenedioxyamphetamine cutoff [Mass/volume] in Urine for Screen method
  19569-3: Methylenedioxymethamphetamine [Presence] in Urine by Confirmatory method
  19570-1: Methylenedioxymethamphetamine [Mass/volume] in Urine
  19588-3: Midazolam [Mass/volume] in Urine
  19602-2: Morphine Free [Presence] in Urine by Confirmatory method
  19629-5: Norfluoxetine [Presence] in Urine by Confirmatory method
  19637-8: Norpropoxyphene cutoff [Mass/volume] in Urine for Confirmatory method
  19639-4: Oxazepam [Presence] in Urine by Confirmatory method
  19643-6: oxyCODONE [Presence] in Urine by Confirmatory method
  19644-4: oxyCODONE cutoff [Mass/volume] in Urine for Screen method
  19654-3: Para hydroxyamphetamine cutoff [Mass/volume] in Urine for Confirmatory method
  13583-0: Thioridazine [Presence] in Serum or Plasma
  16448-3: Cocaine [Units/volume] in Urine
  16542-3: Cannabinoids [Mass/volume] in Serum or Plasma by Confirmatory method
  16548-0: carBAMazepine [Mass/volume] in Urine
  16624-9: clomiPRAMINE [Units/volume] in Milk
  16632-2: Cocaethylene [Mass/volume] in Urine by Confirmatory method
  16744-5: Deprecated Nordiazepam [Presence] in Urine
  16775-9: Dihydrocodeine Free [Presence] in Serum or Plasma by Confirmatory method
  16793-2: Drugs identified in Unknown substance by Screen method
  19344-1: Amphetamine [Presence] in Urine by Confirmatory method
  19356-5: Barbital cutoff [Mass/volume] in Urine for Confirmatory method
  19379-7: Butorphanol cutoff [Mass/volume] in Urine for Screen method
  19387-0: chlordiazePOXIDE cutoff [Mass/volume] in Urine for Screen method
  19399-5: clonazePAM [Presence] in Urine by Screen method
  19404-3: clonazePAM cutoff [Mass/volume] in Urine for Confirmatory method
  19409-2: Cocaethylene cutoff [Mass/volume] in Urine for Screen method
  19416-7: Tetrahydrocannabinol [Presence] in Urine by Confirmatory method
  19445-6: diazePAM cutoff [Mass/volume] in Urine for Confirmatory method
  19453-0: Dimetamphetamine [Presence] in Urine by Confirmatory method
  19454-8: Dimetamphetamine cutoff [Mass/volume] in Urine for Screen method
  19460-5: Ethylamphetamine cutoff [Mass/volume] in Urine for Screen method
  19483-7: HYDROcodone [Presence] in Urine by Confirmatory method
  19490-2: Hydroxyalprazolam [Presence] in Urine by Confirmatory method
  19491-0: Hydroxyalprazolam cutoff [Mass/volume] in Urine for Screen method
  19494-4: Hydroxyethylflurazepam [Presence] in Urine by Confirmatory method
  19495-1: Hydroxyethylflurazepam cutoff [Mass/volume] in Urine for Screen method
  19501-6: Ketamine cutoff [Mass/volume] in Urine for Screen method
  19516-4: Levorphanol [Presence] in Urine by Screen method
  19530-5: Lysergate diethylamide cutoff [Mass/volume] in Urine for Screen method
  19544-6: Mescaline cutoff [Mass/volume] in Urine for Screen method
  19549-5: Mesoridazine cutoff [Mass/volume] in Urine for Confirmatory method
  19555-2: Methamphetamine [Presence] in Urine by Confirmatory method
  19557-8: Methamphetamine cutoff [Mass/volume] in Urine for Confirmatory method
  19559-4: Methaqualone cutoff [Mass/volume] in Urine for Screen method
  19560-2: Methaqualone cutoff [Mass/volume] in Urine for Confirmatory method
  19568-5: Methylenedioxymethamphetamine [Presence] in Urine by Screen method
  19578-4: Methylphenidate [Presence] in Urine by Confirmatory method
  19579-2: Methylphenidate cutoff [Mass/volume] in Urine for Screen method
  19617-0: N-desalkylflurazepam [Mass/volume] in Urine
  19624-6: Nordiazepam [Presence] in Urine by Screen method
  19635-2: Norpropoxyphene [Mass/volume] in Urine
  19638-6: Oxazepam [Presence] in Urine by Screen method
  19646-9: oxyMORphone [Presence] in Urine by Screen method
  19648-5: oxyMORphone [Mass/volume] in Urine
  19651-9: Para hydroxyamphetamine [Presence] in Urine by Screen method
  19669-1: PHENobarbital cutoff [Mass/volume] in Urine for Confirmatory method
  19700-4: Temazepam cutoff [Mass/volume] in Urine for Screen method
  19712-9: traMADol cutoff [Mass/volume] in Urine for Screen method
  25139-7: Tryptophan/Creatinine [Molar ratio] in Urine
  28061-0: Naloxone [Mass/volume] in Serum or Plasma
  28073-5: 7-Aminoclonazepam [Mass/volume] in Urine
  31016-9: Levoamphetamine/Amphetamines.total in Urine
  3343-1: Amoxapine [Mass/volume] in Urine
  40625-6: Cocaine [Presence] in Specimen
  14573-0: 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
  14574-8: 8-Hydroxyamoxapine [Moles/volume] in Serum or Plasma
  14596-1: Amitriptyline+Nortriptyline [Presence] in Urine
  14600-1: Amoxapine [Moles/volume] in Serum or Plasma
  14645-6: chlorproMAZINE [Moles/volume] in Serum or Plasma
  14651-4: cloBAZam [Moles/volume] in Serum or Plasma
  14654-8: clomiPRAMINE+Norclomipramine [Moles/volume] in Serum or Plasma
  14656-3: cloZAPine [Moles/volume] in Serum or Plasma
  14657-1: cloZAPine+Norclozapine [Moles/volume] in Serum or Plasma
  14691-0: Desipramine [Moles/volume] in Serum or Plasma
  14704-1: Doxepin [Presence] in Gastric fluid
  14706-6: Doxepin [Moles/volume] in Urine
  14774-4: Haloperidol [Moles/volume] in Serum or Plasma
  14794-2: Imipramine+Desipramine [Moles/volume] in Serum or Plasma
  14825-4: Maprotiline [Moles/volume] in Serum or Plasma
  14844-5: 6-Monoacetylmorphine (6-MAM) [Presence] in Serum or Plasma
  14898-1: Protriptyline [Moles/volume] in Serum or Plasma
  14951-8: Volatile drugs positive [Identifier] in Serum or Plasma by Screen method
  17375-7: Norflunitrazepam [Mass/volume] in Blood
  17377-3: Norpropoxyphene [Mass/volume] in Urine by Confirmatory method
  17573-7: Secobarbital [Mass/volume] in Gastric fluid
  20514-6: Deprecated 6-Monoacetylmorphine [Mass/volume] in Urine Confirm
  20519-5: Cocaine [Mass/volume] in Urine by Confirmatory method
  20526-0: Dimetamphetamine [Mass/volume] in Urine by Confirmatory method
  20530-2: Haloperidol [Mass/volume] in Urine by Confirmatory method
  20540-1: Levorphanol [Mass/volume] in Urine by Confirmatory method
  20542-7: Lysergate diethylamide [Mass/volume] in Urine by Confirmatory method
  20548-4: Methylphenidate [Mass/volume] in Urine by Confirmatory method
  20559-1: Temazepam [Mass/volume] in Urine by Confirmatory method
  29148-4: carBAMazepine.bound [Mass/volume] in Serum or Plasma
  34330-1: Lithium [Moles/volume] in 24 hour Urine
  34405-1: Escitalopram [Mass/volume] in Serum or Plasma
  3459-5: chlordiazePOXIDE [Mass/volume] in Urine
  3456-1: chlordiazePOXIDE [Presence] in Serum or Plasma
  34575-1: 8-Hydroxyloxapine [Presence] in Serum, Plasma or Blood
  34578-5: Barbiturates [Presence] in Meconium by Screen method
  3457-9: chlordiazePOXIDE [Mass/volume] in Serum or Plasma
  3458-7: chlordiazePOXIDE [Presence] in Urine
  3472-8: chlorproMAZINE [Presence] in Urine
  14057-4: carBAMazepine free [Mass/volume] in Saliva (oral fluid)
  14061-6: Cyclobenzaprine [Mass/volume] in Urine
  14066-5: Dihydrocodeine [Presence] in Urine
  14067-3: Dihydrocodeine [Mass/volume] in Blood
  14313-1: Tetrahydrocannabinol [Mass/volume] in Urine by Confirmatory method
  14315-6: Benzoylecgonine [Presence] in Urine by Confirmatory method
  14316-4: Benzodiazepines [Presence] in Urine by Screen method
  1692-3: 5-Hydroxyindoleacetate [Mass/volume] in Cerebral spinal fluid
  1694-9: 5-Hydroxyindoleacetate [Mass/volume] in Urine
  17086-0: Lithium [Mass/volume] in Body fluid
  17250-2: Mephobarbital [Mass/volume] in Urine by Confirmatory method
  17260-1: Methamphetamine [Mass/volume] in Serum or Plasma by Confirmatory method
  25412-8: Flunitrazepam [Moles/volume] in Serum or Plasma
  25484-7: Nefazodone [Moles/volume] in Serum or Plasma
  25726-1: OXcarbazepine [Moles/volume] in Serum or Plasma
  18338-4: Nortramadol [Mass/volume] in Urine
  18357-4: Methylenedioxymethamphetamine [Mass/volume] in Blood
  18392-1: Phencyclidine [Presence] in Urine by Confirmatory method
  18477-0: Lithium [Moles/time] in 24 hour Urine
  21556-6: Tetrahydrocannabinol [Presence] in Urine by Screen method >20 ng/mL
  26846-6: Perphenazine [Presence] in Serum or Plasma
  26856-5: Cannabinoids [Mass/mass] in Stool
  26859-9: Phencyclidine [Mass/mass] in Meconium
  26865-6: Codeine [Mass/mass] in Meconium
  26867-2: fentaNYL [Units/volume] in 24 hour Urine
  26911-8: ALPRAZolam [Mass/mass] in Meconium
  26912-6: Hydroxytriazolam [Mass/mass] in Meconium
  26938-1: chlordiazePOXIDE [Mass/mass] in Meconium
  26956-3: Cocaine [Mass/mass] in Meconium
  26959-7: Amphetamine [Mass/mass] in Meconium
  26994-4: Phencyclidine [Mass/volume] in Milk
  27003-3: Mephobarbital [Mass/mass] in Meconium
  27026-4: Benzoylecgonine [Mass/mass] in Meconium
  27029-8: Norpropoxyphene [Mass/mass] in Meconium
  27034-8: Drugs identified in Hair by Screen method
  27074-4: Methylenedioxyethylamphetamine [Mass/volume] in Milk
  27079-3: Methylenedioxyethylamphetamine [Mass/mass] in Stool
  27109-8: PARoxetine [Presence] in Urine
  27131-2: Phencyclidine [Presence] in Vitreous fluid
  27189-0: Methylenedioxyamphetamine [Mass/volume] in Vitreous fluid
  27238-5: Oxazepam [Mass/mass] in Stool
  27242-7: Secobarbital [Mass/mass] in Stool
  27248-4: Benzoylecgonine [Mass/mass] in Stool
  27277-3: Methamphetamine [Mass/volume] in Vitreous fluid
  29868-7: Gamma hydroxybutyrate [Presence] in Urine
  32589-4: Gabapentin [Mass] of Dose
  32598-5: Sertraline [Mass] of Dose
  32643-9: Dextromethamphetamine/Levomethamphetamine [Mass Ratio] in Serum or Plasma
  3542-8: Propoxyphene [Presence] in Serum or Plasma
  35604-8: Cyclobenzaprine [Mass/volume] in Serum or Plasma by Screen method
  35606-3: Desipramine [Mass/volume] in Serum or Plasma by Screen method
  35617-0: Meperidine [Mass/volume] in Serum or Plasma by Screen method
  35621-2: Norclomipramine [Mass/volume] in Serum or Plasma by Screen method
  35624-6: Norfluoxetine [Mass/volume] in Serum or Plasma by Screen method
  35625-3: Normeperidine [Mass/volume] in Serum or Plasma by Screen method
  35626-1: Norpropoxyphene [Mass/volume] in Serum or Plasma by Screen method
  35629-5: Oxazepam [Mass/volume] in Serum or Plasma by Screen method
  3564-2: Dimetamphetamine [Presence] in Urine
  15102-7: Codeine [Moles/volume] in Serum or Plasma
  15370-0: Morphine [Mass/volume] in Meconium
  15401-3: Drugs identified in Blood by Screen method
  18208-9: Cocaine [Mass/volume] in Specimen
  18270-9: Carbamazepine 10,11-Epoxide [Moles/volume] in Serum or Plasma
  20786-0: Drugs identified in Tissue by Screen method
  21091-4: Barbiturates present [Identifier] in Serum or Plasma by Screen method
  26687-4: Amobarbital [Mass/volume] in Vitreous fluid
  26719-5: HYDROcodone [Mass/mass] in Hair
  26743-5: Carboxy tetrahydrocannabinol [Presence] in Serum or Plasma
  26774-0: Flurazepam [Mass/mass] in Hair
  29255-7: Linezolid [Susceptibility] by Disk diffusion (KB)
  29258-1: Linezolid [Susceptibility]
  29285-4: Methadone [Presence] in Gastric fluid
  13588-9: Venlafaxine [Presence] in Serum or Plasma
  16361-8: Amitriptyline [Mass/volume] in Serum or Plasma --trough
  16429-3: Barbiturates [Presence] in Urine by Confirmatory method
  16447-5: Cocaine [Units/volume] in Serum or Plasma
  16495-4: Buprenorphine [Units/volume] in Serum or Plasma
  16496-2: Buprenorphine [Units/volume] in Urine
  16755-1: Diamorphine [Mass/volume] in Urine by Confirmatory method
  16757-7: diazePAM+Nordiazepam [Mass/volume] in Serum or Plasma
  16790-8: Deprecated Doxepin+Desmethyldoxepin [Mass/volume] in Serum or Plasma
  19377-1: Butorphanol [Presence] in Urine by Screen method
  19381-3: Carboxy tetrahydrocannabinol [Presence] in Urine by Screen method
  19386-2: chlordiazePOXIDE [Presence] in Urine by Confirmatory method
  19395-3: chlorproMAZINE [Presence] in Urine by Screen method
  19403-5: clonazePAM cutoff [Mass/volume] in Urine for Screen method
  19410-0: Cocaethylene cutoff [Mass/volume] in Urine for Confirmatory method
  19417-5: Tetrahydrocannabinol cutoff [Mass/volume] in Urine for Screen method
  19421-7: Dextroamphetamine cutoff [Mass/volume] in Urine for Screen method
  19422-5: Dextroamphetamine cutoff [Mass/volume] in Urine for Confirmatory method
  19432-4: Propoxyphene cutoff [Mass/volume] in Urine for Confirmatory method
  19441-5: Diamorphine cutoff [Mass/volume] in Urine for Screen method
  19442-3: Diamorphine cutoff [Mass/volume] in Urine for Confirmatory method
  19450-6: Dihydrocodeine cutoff [Mass/volume] in Urine for Screen method
  19461-3: Ethylamphetamine cutoff [Mass/volume] in Urine for Confirmatory method
  19464-7: Ethylmorphine cutoff [Mass/volume] in Urine for Screen method
  19474-6: Flurazepam [Presence] in Urine by Screen method
  19480-3: Haloperidol cutoff [Mass/volume] in Urine for Screen method
  19485-2: HYDROcodone cutoff [Mass/volume] in Urine for Confirmatory method
  19497-7: Hydroxytriazolam [Presence] in Urine by Screen method
  19499-3: Ketamine [Mass/volume] in Urine by Screen method
  19508-1: Deprecated Levomepromazine cutoff [Mass/volume] in Urine for Screen method
  19532-1: Meperidine [Presence] in Urine by Screen method
  19536-2: Mephobarbital [Presence] in Urine by Screen method
  19537-0: Mephobarbital [Presence] in Urine by Confirmatory method
  19540-4: Mephobarbital cutoff [Mass/volume] in Urine for Screen method
  19546-1: Mesoridazine [Presence] in Urine by Screen method
  19565-1: Methylenedioxyamphetamine [Presence] in Urine by Screen method
  19585-9: Midazolam [Presence] in Urine by Screen method
  19586-7: Midazolam [Presence] in Urine by Confirmatory method
  19590-9: Midazolam cutoff [Mass/volume] in Urine for Confirmatory method
  19596-6: Deprecated 6-Monoacetylmorphine cutoff [Mass/volume] in Urine for Confirm method
  19597-4: Morphine [Presence] in Urine by Screen method
  19600-6: Morphine cutoff [Mass/volume] in Urine for Confirmatory method
  19605-5: Nalbuphine [Presence] in Urine by Screen method
  19611-3: Naltrexone [Mass/volume] in Urine
  19631-1: Norfluoxetine cutoff [Mass/volume] in Urine for Confirmatory method
  19649-3: oxyMORphone cutoff [Mass/volume] in Urine for Screen method
  19687-3: Psilocybin [Presence] in Urine by Confirmatory method
  19691-5: Psilocybin cutoff [Mass/volume] in Urine for Confirmatory method
  19692-3: Secobarbital [Presence] in Urine by Screen method
  19707-9: Thioridazine [Presence] in Urine by Confirmatory method
  19710-3: traMADol [Presence] in Urine by Screen method
  27962-0: Butalbital [Mass/mass] in Meconium
  28038-8: Gamma hydroxybutyrate [Mass/volume] in Blood
  11342-3: History of Other nonmedical drug use Narrative
  18322-8: Norketamine [Mass/volume] in Urine
  18358-2: Methylenedioxymethamphetamine [Mass/volume] in Urine by Confirmatory method
  18385-5: Butalbital [Presence] in Urine by Confirmatory method
  18389-7: Methaqualone [Presence] in Urine by Confirmatory method
  21193-8: chlordiazePOXIDE+Norchlordiazepoxide [Mass/volume] in Serum or Plasma
  21195-3: Chlorzoxazone [Mass/volume] in Urine
  21557-4: Tetrahydrocannabinol [Presence] in Urine by Screen method >100 ng/mL
  26791-4: Amphetamine [Mass/mass] in Stool
  26792-2: Methylenedioxyamphetamine [Mass/mass] in Stool
  26802-9: Midazolam [Mass/mass] in Hair
  26815-1: Cocaethylene [Mass/mass] in Meconium
  26847-4: Haloperidol [Presence] in Serum or Plasma
  26850-8: Oxazepam [Mass/volume] in Vitreous fluid
  26886-2: ALPRAZolam [Mass/mass] in Hair
  26893-8: Tetrahydrocannabinol [Mass/mass] in Meconium
  26898-7: Temazepam [Mass/volume] in Vitreous fluid
  26913-4: Triazolam [Mass/mass] in Meconium
  26918-3: PENTobarbital [Mass/mass] in Hair
  26920-9: Amobarbital [Mass/mass] in Hair
  26937-3: Temazepam [Mass/mass] in Meconium
  26976-1: Hydroxytriazolam [Mass/mass] in Stool
  27002-5: Secobarbital [Mass/mass] in Meconium
  27035-5: Dihydrocodeine+Hydrocodeinone [Mass/mass] in Meconium
  27052-0: Methadone [Mass/volume] in Milk
  27059-5: traZODone [Mass/volume] in Urine
  27064-5: Opiates [Mass/mass] in Stool
  27073-6: Deprecated acetylmorphine [Presence] in Urine
  27136-1: Opiates [Presence] in Vitreous fluid
  27165-0: Hexobarbital [Mass/volume] in Urine
  27193-2: Tetrahydrocannabinol [Mass/volume] in Vitreous fluid
  27204-7: Cocaine [Mass/volume] in Vitreous fluid
  27235-1: PHENobarbital [Mass/mass] in Meconium
  27244-3: Methylenedioxyamphetamine [Mass/mass] in Meconium
  27246-8: Butalbital [Mass/mass] in Stool
  30108-5: Ecgonine methyl ester [Mass/mass] in Meconium
  30109-3: Ecgonine methyl ester [Mass/volume] in Gastric fluid
  30112-7: Amphetamine [Mass/volume] in Serum or Plasma
  32797-3: Drugs identified in Meconium by Screen method
  32859-1: Multiple drug resistance cells/100 cells in Specimen
  3529-5: Deprecated Tetrahydrocannabinol [Presence] in Urine
  3535-2: Desipramine [Mass/volume] in Serum or Plasma --trough
  3536-0: Norclomipramine [Mass/volume] in Serum or Plasma
  3543-6: Propoxyphene [Mass/volume] in Serum or Plasma
  3550-1: diazePAM [Presence] in Urine
  35602-2: clomiPRAMINE [Mass/volume] in Serum or Plasma by Screen method
  35609-7: Doxepin [Mass/volume] in Serum or Plasma by Screen method
  35611-3: Flurazepam [Mass/volume] in Serum or Plasma by Screen method
  35636-0: Amitriptyline [Mass/volume] in Serum or Plasma by Screen method
  15364-3: Codeine [Mass/volume] in Meconium
  15145-6: Methionine+Tryptophan [Presence] in Urine
  18238-6: Lithium [Mass/mass] in Tissue
  26732-8: Carboxy tetrahydrocannabinol [Mass/mass] in Stool
  26744-3: Opiates [Mass/mass] in Meconium by Screen method
  26758-3: Cocaine [Mass/mass] in Stool
  26776-5: QUEtiapine [Mass/volume] in Serum or Plasma
  29209-4: Benzodiazepines [Mass/volume] in Body fluid
  29223-5: PHENobarbital [Mass/volume] in Body fluid
  13933-7: Benzodiazepines [Mass/mass] in Hair
  16360-0: Amitriptyline [Mass/volume] in Serum or Plasma --peak
  16367-5: Deprecated Amphetamine/Methamphetamine [Mass ratio] in Urine Qualitative
  16430-1: Barbiturates [Units/volume] in Urine
  16497-0: Butabarbital [Mass/volume] in Gastric fluid
  16633-0: Cocaine [Presence] in Blood
  19349-0: Aprobarbital [Presence] in Urine by Screen method
  19359-9: Cocaine [Presence] in Urine by Screen method
  19361-5: Deprecated Benzoylmethylecgonine [Mass/volume] in Urine
  19380-5: Butorphanol cutoff [Mass/volume] in Urine for Confirmatory method
  19384-7: Carboxy tetrahydrocannabinol cutoff [Mass/volume] in Urine for Confirmatory method
  19396-1: chlorproMAZINE [Presence] in Urine by Confirmatory method
  19402-7: clonazePAM [Mass/volume] in Urine
  19405-0: Cocaethylene [Presence] in Urine by Screen method
  19419-1: Dextroamphetamine [Presence] in Urine by Screen method
  19428-2: Dextromethamphetamine cutoff [Mass/volume] in Urine for Confirmatory method
  19433-2: Propoxyphene + Norpropoxyphene [Presence] in Urine by Screen method
  19444-9: diazePAM cutoff [Mass/volume] in Urine for Screen method
  19448-0: Dihydrocodeine [Mass/volume] in Urine by Confirmatory method
  19449-8: Dihydrocodeine [Mass/volume] in Urine
  19463-9: Ethylmorphine [Presence] in Urine by Confirmatory method
  19470-4: FLUoxetine [Presence] in Urine by Screen method
  19472-0: FLUoxetine cutoff [Mass/volume] in Urine for Screen method
  19489-4: Hydroxyalprazolam [Presence] in Urine by Screen method
  19507-3: Deprecated Levomepromazine [Presence] in Urine by Confirm method
  19528-9: Lysergate diethylamide [Presence] in Urine by Screen method
  19534-7: Meperidine cutoff [Mass/volume] in Urine for Screen method
  19542-0: Mescaline [Presence] in Urine by Screen method
  19543-8: Mescaline [Presence] in Urine by Confirmatory method
  19545-3: Mescaline cutoff [Mass/volume] in Urine for Confirmatory method
  19572-7: Methylenedioxymethamphetamine cutoff [Mass/volume] in Urine for Confirmatory method
  19591-7: Deprecated 6-Monoacetylmorphine [Presence] in Urine by Screen method
  19604-8: Morphine Free cutoff [Mass/volume] in Urine for Confirmatory method
  19612-1: Naltrexone cutoff [Mass/volume] in Urine for Screen method
  19615-4: N-desalkylflurazepam [Presence] in Urine by Confirmatory method
  19618-8: N-desalkylflurazepam cutoff [Mass/volume] in Urine for Screen method
  19619-6: N-desalkylflurazepam cutoff [Mass/volume] in Urine for Confirmatory method
  19626-1: Nordiazepam cutoff [Mass/volume] in Urine for Screen method
  19628-7: Norfluoxetine [Presence] in Urine by Screen method
  19653-5: Para hydroxyamphetamine cutoff [Mass/volume] in Urine for Screen method
  19666-7: PHENobarbital [Presence] in Urine by Screen method
  19686-5: Psilocybin [Presence] in Urine by Screen method
  19688-1: Psilocybin [Mass/volume] in Urine by Confirmatory method
  19702-0: Deprecated Tetrahydrocannabinol [Presence] in Urine by Screen method
  19706-1: Thioridazine [Presence] in Urine by Screen method
  27912-5: Butalbital [Mass/mass] in Hair
  3069-2: Tryptophan [Presence] in Serum or Plasma
  3071-8: Deprecated Tryptophan [Mass/volume] in Serum or Plasma
  31025-0: Dextroamphetamine/Amphetamines.total in Urine
  3348-0: Amphetamines [Presence] in Serum or Plasma
  33527-3: Methadone.long acting metabolite [Mass/volume] in Urine
  3370-4: Barbital [Mass/volume] in Serum or Plasma
  13455-1: Lithium.plasma/Lithium.RBC [Mass Ratio] in Blood
  12286-1: Drugs identified in Urine by Screen method
  18343-4: 6-Monoacetylmorphine (6-MAM) [Presence] in Serum or Plasma by Screen method
  18355-8: Methylenedioxyamphetamine [Mass/volume] in Urine
  18359-0: Methylenedioxyamphetamine [Mass/volume] in Blood
  18383-0: Alfentanil [Presence] in Urine
  18390-5: Opiates [Presence] in Urine by Confirmatory method
  18721-1: Therapeutic drug monitoring studies (set)
  21431-2: Opiates [Presence] in Urine by Screen method >2000 ng/mL
  26793-0: Methylenedioxymethamphetamine [Mass/mass] in Stool
  26836-7: Hydroxyethylflurazepam [Mass/mass] in Hair
  26840-9: Nordiazepam [Mass/mass] in Hair
  26841-7: N-desalkylflurazepam [Mass/mass] in Hair
  26851-6: LORazepam [Mass/volume] in Vitreous fluid
  26863-1: HYDROcodone [Mass/mass] in Meconium
  26877-1: Hydroxytriazolam [Mass/mass] in Hair
  26895-3: Amphetamines [Mass/mass] in Meconium
  26910-0: Alpha hydroxyalprazolam [Mass/mass] in Meconium
  26930-8: Secobarbital [Mass/mass] in Hair
  26995-1: Carboxy tetrahydrocannabinol [Mass/volume] in Blood
  27024-9: Cannabinoids [Mass/mass] in Meconium
  27041-3: Norpropoxyphene [Mass/mass] in Stool
  27049-6: Secobarbital [Mass/volume] in Milk
  27084-3: 7-Aminoflunitrazepam [Mass/volume] in Urine
  27191-6: PHENobarbital [Mass/volume] in Vitreous fluid
  27192-4: diazePAM [Mass/volume] in Vitreous fluid
  27196-5: HYDROmorphone Free [Mass/volume] in Vitreous fluid
  27224-5: Barbiturates [Presence] in Vitreous fluid
  27245-0: Amobarbital [Mass/mass] in Stool
  27249-2: Temazepam [Mass/mass] in Stool
  27262-5: Methaqualone [Mass/mass] in Meconium
  32574-6: Zaleplon [Mass/volume] in Serum or Plasma
  3528-7: Tetrahydrocannabinol [Mass/volume] in Serum or Plasma
  3544-4: Deprecated Propoxyphene [Presence] in Urine
  35601-4: chlorproMAZINE [Mass/volume] in Serum or Plasma by Screen method
  35605-5: N-desalkylflurazepam [Mass/volume] in Serum or Plasma by Screen method
  35607-1: diazePAM [Mass/volume] in Serum or Plasma by Screen method
  35622-0: Nordiazepam [Mass/volume] in Serum or Plasma by Screen method
  35634-5: Secobarbital [Mass/volume] in Serum or Plasma by Screen method
  35635-2: traZODone [Mass/volume] in Serum or Plasma by Screen method
  15009-4: 5-Hydroxyindoleacetate [Moles/volume] in Urine
  15100-1: Barbiturates [Moles/volume] in Serum or Plasma
  15110-0: Morphine [Moles/volume] in Serum or Plasma
  15111-8: Tricyclic antidepressants [Moles/volume] in Serum or Plasma
  15372-6: Nordiazepam [Mass/volume] in Urine
  15404-7: Levomethamphetamine/Amphetamines.total in Urine
  15405-4: Methamphetamine [Mass/volume] in Meconium
  20785-2: Drugs identified in Serum or Plasma by Screen method
  20787-8: Drugs identified in Specimen by Screen method
  21050-0: Deprecated Acetylmorphine [Mass/volume] in Urine
  21062-5: Allobarbital [Mass/volume] in Serum or Plasma
  26689-0: Butabarbital [Mass/volume] in Vitreous fluid
  26733-6: Butabarbital [Mass/mass] in Stool
  26764-1: Cannabinoids [Presence] in Hair
  29219-3: FLUoxetine [Mass/volume] in Body fluid
  29294-6: Methadone [Mass/volume] in Gastric fluid
  29384-5: diazePAM [Mass/volume] in Gastric fluid
  29403-3: Thiothixene [Mass/volume] in Urine
  10343-2: Temazepam [Mass/volume] in Serum or Plasma
  12786-0: HYDROcodone Free [Mass/volume] in Serum or Plasma
  12309-1: Naltrexone [Presence] in Urine
  12321-6: Trifluoperazine [Presence] in Urine
  12333-1: Butorphanol [Presence] in Urine
  12355-4: Phencyclidine [Presence] in Stool
  12356-2: Methadone [Presence] in Stool
  12358-8: Barbiturates [Presence] in Stool
  12359-6: Benzodiazepines [Presence] in Stool
  12373-7: Deprecated Norchlordiazepoxide [Mass/volume] in Serum or Plasma
  12375-2: cloZAPine+Norclozapine [Mass/volume] in Serum or Plasma
  12376-0: Deprecated Norclozapine [Mass/volume] in Serum or Plasma
  12415-6: Selegiline [Mass/volume] in Serum or Plasma
  12432-1: Hydroxytriazolam [Mass/volume] in Urine
  12443-8: Trimipramine [Mass/volume] in Urine
  3839-8: Nalbuphine [Presence] in Urine
  3868-7: Norfluoxetine [Mass/volume] in Serum or Plasma
  3870-3: Norpropoxyphene [Presence] in Serum or Plasma
  3873-7: Nortriptyline [Presence] in Serum or Plasma
  4111-1: ALPRAZolam [Mass] of Dose
  4120-2: Amitriptyline [Mass] of Dose
  4137-6: Barbiturates [Mass] of Dose
  41467-2: Benzodiazepines/Creatinine [Mass Ratio] in Urine
  41468-0: Barbiturates/Creatinine [Mass Ratio] in Urine
  41473-0: Carbamazepine 10,11-Epoxide [Mass/volume] in DBS
  4147-5: Buprenorphine [Mass] of Dose
  4148-3: Butabarbital [Mass] of Dose
  44036-2: Analgesics Non-narcotic [Presence] in Urine
  44049-5: Tetrahydrocannabinol [Mass/volume] in Serum or Plasma by Confirmatory method
  44358-0: Gamma hydroxybutyrate/Creatinine [Mass Ratio] in Urine
  46972-6: Deprecated 6-monoacetylmorphine free [Mass/volume] in Serum or Plasma by Confirm method
  46974-2: oxyMORphone Free [Mass/volume] in Serum or Plasma by Confirmatory method
  46980-9: N-desalkylflurazepam [Mass/volume] in Serum or Plasma by Confirmatory method
  47097-1: Carbamazepine 10,11-epoxide free [Moles/volume] in Serum or Plasma
  47115-1: LORazepam [Moles/volume] in Urine
  47118-5: Maprotiline [Moles/volume] in Urine
  47124-3: PHENobarbital [Moles/volume] in Gastric fluid
  47131-8: Thioridazine [Moles/volume] in Gastric fluid
  47132-6: Thioridazine [Moles/volume] in Urine
  47133-4: Trimipramine [Moles/volume] in Gastric fluid
  49747-9: Cocaine+Benzoylecgonine [Presence] in Serum or Plasma by Screen method
  49750-3: Dihydrocodeine Free+Hydrocodol Free [Mass/volume] in Serum or Plasma
  49751-1: Norbuprenorphine [Mass/volume] in Urine by Confirmatory method
  49752-9: Buprenorphine [Mass/volume] in Urine by Confirmatory method
  49830-3: Norcodeine [Mass/volume] in Serum or Plasma
  52472-8: Allergies and Adverse Drug Reactions
  58015-9: Nortrimipramine [Presence] in Urine
  58188-4: Psychotropic drug use - addressed in care plan [MDSv3]
  3786-1: Methaqualone [Presence] in Urine
  3810-9: Methylphenidate [Mass/time] in 24 hour Urine
  3829-9: Morphine Free [Mass/volume] in Urine
  40806-2: Opiates [Presence] in Saliva (oral fluid) by Screen method
  4083-2: Trimipramine [Mass/volume] in Serum or Plasma
  4084-0: Trimipramine [Presence] in Urine
  4097-2: Volatile drugs positive [Identifier] in Urine by Screen method
  41020-9: Flunitrazepam [Presence] in Urine
  41021-7: Cocaine [Presence] in Hair
  58399-7: Norpropoxyphene/Creatinine [Mass Ratio] in Urine
  14601-9: Amoxapine+8-Hydroxyamoxapine [Moles/volume] in Serum or Plasma
  14624-1: Barbiturates [Presence] in Gastric fluid
  14692-8: Desipramine [Moles/volume] in Urine
  14707-4: Doxepin+Nordoxepin [Moles/volume] in Serum or Plasma
  14834-6: Methamphetamine [Presence] in Gastric fluid
  17376-5: Norpropoxyphene [Presence] in Urine by Confirmatory method
  17436-7: PHENobarbital [Mass/volume] in Gastric fluid
  17719-6: traMADol [Mass/volume] in Urine
  17752-7: Tryptophan [Presence] in Urine
  20413-1: Cannabinoids [Mass/volume] in Urine by Confirmatory method
  20523-7: chlorproMAZINE [Mass/volume] in Urine by Confirmatory method
  20527-8: Ethylmorphine [Mass/volume] in Urine by Confirmatory method
  20532-8: Hydroxyethylflurazepam [Mass/volume] in Urine by Confirmatory method
  20533-6: Hydroxytriazolam [Presence] in Urine by Confirmatory method
  20554-2: Para hydroxyamphetamine [Mass/volume] in Urine by Confirmatory method
  20659-9: Tryptophan [Moles/volume] in Serum or Plasma
  26021-6: Nordiazepam [Moles/volume] in Serum or Plasma
  29147-6: Carbamazepine 10,11-Epoxide.bound [Mass/volume] in Serum or Plasma
  34365-7: Primidone+PHENobarbital [Moles/volume] in Serum or Plasma
  34390-5: FDA product label Human OTC drug label
  34427-5: Methadone.R [Mass/volume] in Serum or Plasma
  14056-6: Carbamazepine 10,11-epoxide free [Mass/volume] in Serum or Plasma
  14267-9: Methylenedioxymethamphetamine [Presence] in Urine
  14310-7: Phencyclidine [Presence] in Urine by Screen method >25 ng/mL
  14311-5: Phencyclidine [Presence] in Urine by Confirm method >20 ng/mL
  14314-9: Benzoylecgonine [Presence] in Urine by Screen method
  16858-3: fentaNYL [Mass/volume] in Body fluid
  17088-6: LORazepam [Mass/volume] in Urine by Confirmatory method
  17290-8: Morphine [Presence] in Serum or Plasma by Confirmatory method
  17318-7: Nalbuphine [Mass/volume] in Serum or Plasma
  17320-3: Nefazodone [Mass/volume] in Urine
  25462-3: Lithium [Moles/volume] in Red Blood Cells
  25472-2: Mesoridazine [Moles/volume] in Serum or Plasma
  25546-3: Tryptophan [Moles/time] in 24 hour Urine
  25560-4: Allobarbital [Moles/volume] in Serum or Plasma
  25589-3: Citalopram [Moles/volume] in Serum or Plasma
  31080-5: Cannabinoids [Presence] in Meconium by Screen method
  3413-2: Buprenorphine [Mass/volume] in Serum or Plasma
  3415-7: Buprenorphine [Mass/volume] in Urine
  3420-7: Butalbital [Presence] in Serum or Plasma
  3421-5: Butalbital [Presence] in Urine
  59623-9: chlordiazePOXIDE [Mass/mass] in Stool by Confirmatory method
  59628-8: cloBAZam [Mass/volume] in Body fluid
  59631-2: cloBAZam [Mass/mass] in Meconium by Confirmatory method
  59643-7: Cocaethylene [Mass/volume] in Serum or Plasma by Confirmatory method
  59651-0: N-desalkylflurazepam [Mass/mass] in Stool by Confirmatory method
  59665-0: Estazolam [Mass/volume] in Blood by Confirmatory method
  59668-4: Estazolam [Mass/volume] in Serum or Plasma by Confirmatory method
  59671-8: Estazolam [Mass/mass] in Tissue by Confirmatory method
  59673-4: fentaNYL [Presence] in Urine by Screen method
  59678-3: Flurazepam [Mass/mass] in Tissue
  59684-1: Hydroxyethylflurazepam [Mass/volume] in Body fluid
  59685-8: Hydroxyethylflurazepam [Mass/volume] in Body fluid by Confirmatory method
  59689-0: Hydroxyethylflurazepam [Mass/mass] in Tissue by Confirmatory method
  40379-0: Maprotiline [Presence] in Gastric fluid
  14594-6: Amitriptyline+Nortriptyline [Presence] in Gastric fluid
  14598-7: Amitriptyline+Nortriptyline [Moles/volume] in Serum or Plasma
  14653-0: clomiPRAMINE [Moles/volume] in Urine
  14728-0: FLUoxetine [Moles/volume] in Serum or Plasma
  14730-6: Flurazepam+N-desalkylflurazepam [Moles/volume] in Serum or Plasma
  14792-6: Imipramine+Desipramine [Presence] in Serum or Plasma
  14793-4: Imipramine+Desipramine [Presence] in Urine
  14855-1: Norfluoxetine [Moles/volume] in Serum or Plasma
  14925-2: traZODone [Moles/volume] in Serum or Plasma
  17390-6: Orphenadrine [Mass/volume] in Urine
  20411-5: Barbiturates [Mass/volume] in Urine by Confirmatory method
  20412-3: Benzodiazepines [Mass/volume] in Urine by Confirmatory method
  20518-7: Barbital [Mass/volume] in Urine by Confirmatory method
  20522-9: chlordiazePOXIDE [Mass/volume] in Urine by Confirmatory method
  20525-2: Dextroamphetamine [Mass/volume] in Urine by Confirmatory method
  20534-4: Deprecated Hydroxytriazolam [Mass/volume] in Urine by Confirm method
  20535-1: Hydroxytriazolam cutoff [Mass/volume] in Urine for Confirmatory method
  20544-3: Mesoridazine [Mass/volume] in Urine by Confirmatory method
  20550-0: Morphine Free [Mass/volume] in Urine by Confirmatory method
  25971-3: 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine
  26040-6: Norcitalopram [Moles/volume] in Serum or Plasma
  29158-3: Opiates [Mass/mass] in Meconium
  29159-1: Methadone [Mass/mass] in Meconium
  29161-7: Barbiturates [Mass/mass] in Meconium
  3432-2: carBAMazepine [Mass/volume] in Serum or Plasma
  34331-9: Lithium/Creatinine [Molar ratio] in Urine
  34391-3: FDA product label Human prescription drug label
  14183-8: Aprobarbital [Mass/volume] in Urine
  14308-1: Amphetamines [Presence] in Urine by Screen method >1000 ng/mL
  14312-3: Tetrahydrocannabinol [Presence] in Urine by Screen method >50 ng/mL
  14334-7: Lithium [Moles/volume] in Serum or Plasma
  1693-1: 5-Hydroxyindoleacetate [Mass/volume] in Serum or Plasma
  1695-6: 5-Hydroxyindoleacetate [Mass/time] in 24 hour Urine
  25461-5: Lithium [Moles/volume] in Blood
  25520-8: Secobarbital [Moles/volume] in Serum or Plasma
  25724-6: Deprecated Norsertraline [Mass/volume] in Serum or Plasma
  31088-8: Narcotics and opioids [Identifier] in Bile fluid
  31135-7: Cocaethylene [Mass/volume] in Bile fluid
  33946-5: Ziprasidone [Mass/volume] in Serum or Plasma
  59624-7: chlordiazePOXIDE [Mass/mass] in Tissue
  59630-4: cloBAZam [Mass/mass] in Meconium
  59632-0: cloBAZam [Mass/volume] in Serum or Plasma by Confirmatory method
  59633-8: cloBAZam [Mass/mass] in Tissue
  59639-5: clonazePAM [Mass/volume] in Body fluid by Confirmatory method
  59658-5: diazePAM [Mass/mass] in Meconium by Confirmatory method
  59672-6: Estazolam [Mass/volume] in Urine by Confirmatory method
  59683-3: Hydroxyethylflurazepam [Mass/volume] in Blood by Confirmatory method
  59687-4: Hydroxyethylflurazepam [Mass/mass] in Stool by Confirmatory method
  59704-7: LORazepam [Mass/mass] in Tissue
  59708-8: Midazolam [Mass/volume] in Blood by Confirmatory method
  59712-0: Midazolam [Mass/mass] in Tissue
  59730-2: Oxazepam [Mass/volume] in Serum or Plasma by Confirmatory method
  59748-4: Temazepam [Mass/volume] in Body fluid by Confirmatory method
  59880-5: chlordiazePOXIDE [Moles/volume] in Gastric fluid
  19594-1: Deprecated Monoacetylmorphine [Mass/volume] in Urine
  19599-0: Morphine cutoff [Mass/volume] in Urine for Screen method
  19601-4: Morphine Free [Presence] in Urine by Screen method
  19607-1: Nalbuphine cutoff [Mass/volume] in Urine for Screen method
  19610-5: Naltrexone [Mass/volume] in Urine by Confirmatory method
  19613-9: Naltrexone cutoff [Mass/volume] in Urine for Confirmatory method
  19627-9: Nordiazepam cutoff [Mass/volume] in Urine for Confirmatory method
  19632-9: Norpropoxyphene [Presence] in Urine by Screen method
  19640-2: Oxazepam cutoff [Mass/volume] in Urine for Screen method
  19641-0: Oxazepam cutoff [Mass/volume] in Urine for Confirmatory method
  19650-1: oxyMORphone cutoff [Mass/volume] in Urine for Confirmatory method
  19652-7: Para hydroxyamphetamine [Presence] in Urine by Confirmatory method
  19655-0: PENTobarbital [Presence] in Urine by Screen method
  19657-6: PENTobarbital cutoff [Mass/volume] in Urine for Screen method
  19690-7: Psilocybin cutoff [Mass/volume] in Urine for Screen method
  19695-6: Secobarbital [Mass/volume] in Urine
  19696-4: Secobarbital cutoff [Mass/volume] in Urine for Screen method
  19697-2: Secobarbital cutoff [Mass/volume] in Urine for Confirmatory method
  19703-8: Deprecated Tetrahydrocannabinol [Presence] in Urine by Confirm method
  19704-6: Deprecated Tetrahydrocannabinol cutoff [Mass/volume] in Urine for Screen method
  19709-5: Thioridazine cutoff [Mass/volume] in Urine for Confirmatory method
  19713-7: traMADol cutoff [Mass/volume] in Urine for Confirmatory method
  27920-8: Normeperidine [Presence] in Urine
  28072-7: Dihydrocodeine+Hydrocodeinone [Mass/mass] in Stool
  31026-8: Dextromethamphetamine/Amphetamines.total in Urine
  3340-7: Amoxapine [Presence] in Serum or Plasma
  3341-5: Amoxapine [Mass/volume] in Serum or Plasma
  3342-3: Amoxapine [Presence] in Urine
  3349-8: Amphetamines [Presence] in Urine
  33560-4: Benzodiazepines [Mass/volume] in Gastric fluid
  3371-2: Barbital [Mass/volume] in Urine
  13568-1: N-desalkylflurazepam [Presence] in Serum or Plasma
  13569-9: Norchlordiazepoxide [Presence] in Serum or Plasma
  13571-5: Norclozapine [Presence] in Serum or Plasma
  13576-4: oxyCODONE [Presence] in Serum or Plasma
  16114-1: Amitriptyline [Mass/volume] in Urine
  16150-5: Carboxy tetrahydrocannabinol [Mass/volume] in Serum or Plasma
  16190-1: Amobarbital [Presence] in Urine by Confirmatory method
  16199-2: Methadone [Presence] in Urine by Confirmatory method
  16215-6: Mephobarbital [Mass/volume] in Serum or Plasma by Confirmatory method
  16218-0: Nalbuphine [Presence] in Urine by Confirmatory method
  16219-8: Pentazocine [Presence] in Urine by Confirmatory method
  16226-3: Benzoylecgonine [Mass/volume] in Urine by Confirmatory method
  16230-5: N-desalkylflurazepam [Mass/volume] in Urine by Confirmatory method
  16234-7: Amphetamine [Mass/volume] in Urine by Confirmatory method
  16237-0: Butalbital [Mass/volume] in Urine by Confirmatory method
  16241-2: PHENobarbital [Mass/volume] in Urine by Confirmatory method
  16243-8: Cannabinoids [Mass/volume] in Blood by Confirmatory method
  16248-7: 6-monoacetylmorphine free [Mass/volume] in Serum or Plasma by Confirmatory method
  16250-3: Codeine [Mass/volume] in Urine by Confirmatory method
  16251-1: Morphine [Mass/volume] in Urine by Confirmatory method
  16253-7: Meperidine [Mass/volume] in Urine by Confirmatory method
  19059-5: Amphetamines cutoff [Mass/volume] in Urine
  19065-2: Benzoylecgonine cutoff [Mass/volume] in Urine
  12172-3: 5-Hydroxyindoleacetate [Presence] in 24 hour Urine
  18339-2: Nortramadol [Presence] in Serum or Plasma by Confirmatory method
  18356-6: Methylenedioxymethamphetamine [Mass/volume] in Serum or Plasma
  18384-8: Butabarbital [Mass/volume] in Serum or Plasma by Confirmatory method
  18431-7: Amphetamines [Presence] in Stool by Screen method
  18473-9: HYDROmorphone [Presence] in Urine by Confirmatory method
  21386-8: Methamphetamine [Presence] in Urine by SAMHSA confirm method
  21421-3: Norketamine [Mass/volume] in Serum or Plasma
  26816-9: Nordiazepam [Mass/volume] in Vitreous fluid
  26829-2: Phencyclidine [Mass/mass] in Meconium by Screen method
  26837-5: diazePAM [Mass/mass] in Hair
  26838-3: LORazepam [Mass/mass] in Hair
  26839-1: Oxazepam [Mass/mass] in Hair
  26860-7: Morphine [Mass/mass] in Meconium
  26869-8: oxyCODONE [Mass/mass] in Meconium
  26887-0: Alpha hydroxyalprazolam [Mass/mass] in Hair
  26934-0: LORazepam [Mass/mass] in Meconium
  26935-7: diazePAM [Mass/mass] in Meconium
  26936-5: Hydroxyethylflurazepam [Mass/mass] in Meconium
  26945-6: Triazolam [Mass/mass] in Hair
  26979-5: Flurazepam [Mass/mass] in Meconium
  27036-3: Norchlordiazepoxide [Mass/volume] in Urine
  27053-8: Morphine [Mass/volume] in Cerebral spinal fluid
  27054-6: Morphine Free [Mass/volume] in Cerebral spinal fluid
  27063-7: Benzodiazepines [Mass/mass] in Stool
  27080-1: Methylenedioxyethylamphetamine [Mass/mass] in Meconium
  27083-5: Norflunitrazepam [Mass/volume] in Urine
  27085-0: Methylenedioxyethylamphetamine [Mass/volume] in Urine
  27086-8: Cannabinoids [Presence] in Vitreous fluid
  27188-2: Methylenedioxymethamphetamine [Mass/volume] in Vitreous fluid
  27190-8: Propoxyphene [Mass/volume] in Vitreous fluid
  27205-4: Amphetamines [Presence] in Vitreous fluid
  27213-8: Carboxy tetrahydrocannabinol [Mass/volume] in Vitreous fluid
  27226-0: Cocaethylene [Mass/volume] in Serum or Plasma
  27239-3: Nordiazepam [Mass/mass] in Stool
  30107-7: Ecgonine methyl ester [Mass/volume] in Serum or Plasma
  32608-2: cloZAPine [Mass] of Dose
  32642-1: Dextroamphetamine/Levoamphetamine [Mass Ratio] in Serum or Plasma
  32650-4: Norflunitrazepam [Mass/volume] in Serum or Plasma
  3531-1: Desipramine [Mass/volume] in Serum or Plasma
  3533-7: Desipramine [Presence] in Urine
  35603-0: clonazePAM [Mass/volume] in Serum or Plasma by Screen method
  35616-2: LORazepam [Mass/volume] in Serum or Plasma by Screen method
  35619-6: Methaqualone [Mass/volume] in Serum or Plasma by Screen method
  35630-3: PENTobarbital [Mass/volume] in Serum or Plasma by Screen method
  35667-5: Atomoxetine [Mass/volume] in Serum or Plasma
  15108-4: Methadone [Moles/volume] in Serum or Plasma
  15130-8: Methionine+Tryptophan [Presence] in Serum or Plasma
  15366-8: Dextroamphetamine [Mass/volume] in Urine
  18248-5: Nordiazepam [Mass/volume] in Stool
  21045-0: 5-Hydroxytryptophan [Mass/time] in 24 hour Urine
  21047-6: 8-Hydroxyloxapine [Mass/volume] in Urine
  23865-9: FLUoxetine+Norfluoxetine [Presence] in Urine
  26602-3: Tryptophan [Moles/volume] in Cerebral spinal fluid
  26721-1: 6-Monoacetylmorphine (6-MAM) [Mass/mass] in Hair
  26734-4: Methamphetamine [Mass/mass] in Stool
  29348-0: ALPRAZolam [Mass/volume] in Gastric fluid
  3534-5: Desipramine [Mass/volume] in Urine
  3936-2: Phencyclidine [Presence] in Urine
  14623-3: Barbital [Presence] in Serum or Plasma
  14817-1: LORazepam [Moles/volume] in Serum or Plasma
  17384-9: Opiates [Mass/volume] in Urine by Confirmatory method
  17431-8: PENTobarbital [Mass/volume] in Gastric fluid
  17718-8: traMADol [Presence] in Urine by Confirmatory method
  20480-0: Deprecated Benzoylecgonine [Presence] in Meconium by Screen method
  20481-8: Deprecated Opiates [Presence] in Meconium by Screen method
  20516-1: Amitriptyline+Nortriptyline [Mass/volume] in Urine by Confirmatory method
  20521-1: Carboxy tetrahydrocannabinol [Mass/volume] in Urine by Confirmatory method
  20536-9: Hydroxytriazolam cutoff [Mass/volume] in Urine for Screen method
  20545-0: Methylenedioxyamphetamine [Mass/volume] in Urine by Confirmatory method
  20546-8: Methylenedioxyamphetamine cutoff [Mass/volume] in Urine for Confirmatory method
  20560-9: Thioridazine [Mass/volume] in Urine by Confirmatory method
  29160-9: Benzodiazepines [Mass/mass] in Meconium
  3433-0: carBAMazepine free [Mass/volume] in Serum or Plasma
  3435-5: Carboxy tetrahydrocannabinol [Presence] in Urine
  34384-8: Tryptophan [Moles/volume] in Urine
  34415-0: Normirtazapine [Mass/volume] in Serum or Plasma
  3471-0: chlorproMAZINE [Mass/volume] in Serum or Plasma
  3473-6: chlorproMAZINE [Mass/volume] in Urine
  14060-8: Cyclobenzaprine [Presence] in Urine
  14261-2: Codeine [Presence] in Gastric fluid
  16851-8: Ethylmorphine [Units/volume] in Urine
  17002-7: Hydroxytriazolam [Mass/volume] in Serum or Plasma by Confirmatory method
  17033-2: Ketamine [Presence] in Urine by Confirmatory method
  17259-3: Methadone.long acting metabolite [Mass/volume] in Serum or Plasma
  25469-8: Meprobamate [Moles/volume] in Serum or Plasma
  25559-6: Zolpidem [Moles/volume] in Serum or Plasma
  31085-4: Methaqualone [Mass/volume] in Bile fluid
  31086-2: Morphine Free [Mass/volume] in Bile fluid
  31136-5: Carboxy tetrahydrocannabinol [Mass/mass] in Meconium
  3385-2: Benzodiazepines negative [Identifier] in Urine
  3387-8: Benzodiazepines positive [Identifier] in Urine
  3393-6: Benzoylecgonine [Presence] in Urine
  3398-5: Cocaine [Mass/volume] in Urine
  3417-3: Butabarbital [Presence] in Serum or Plasma
  34182-6: Methaqualone metabolite [Presence] in Serum or Plasma by Confirmatory method
  34202-2: Linezolid [Mass/volume] in Serum or Plasma
  3427-2: Cannabinoids [Presence] in Urine
  59638-7: clonazePAM [Mass/volume] in Body fluid
  59648-6: N-desalkylflurazepam [Mass/volume] in Body fluid
  59652-8: N-desalkylflurazepam [Mass/mass] in Tissue
  59653-6: N-desalkylflurazepam [Mass/mass] in Tissue by Confirmatory method
  59657-7: diazePAM [Mass/volume] in Body fluid by Confirmatory method
  59664-3: Estazolam [Mass/volume] in Blood
  59670-0: Estazolam [Mass/mass] in Tissue
  59674-2: Flurazepam [Mass/volume] in Blood
  59675-9: Flurazepam [Mass/volume] in Blood by Confirmatory method
  59686-6: Hydroxyethylflurazepam [Mass/mass] in Meconium by Confirmatory method
  59690-8: Hydroxytriazolam [Mass/volume] in Blood
  59692-4: Hydroxytriazolam [Mass/volume] in Body fluid
  59693-2: Hydroxytriazolam [Mass/volume] in Body fluid by Confirmatory method
  59694-0: Hydroxytriazolam [Mass/mass] in Meconium by Confirmatory method
  59696-5: Hydroxytriazolam [Mass/mass] in Tissue by Confirmatory method
  11343-1: History of Other nonmedical drug use
  18432-5: Tetrahydrocannabinol [Presence] in Stool by Screen method
  18435-8: SUFentanil [Presence] in Urine
  18467-1: Venlafaxine [Mass/volume] in Urine
  26790-6: chlordiazePOXIDE [Mass/mass] in Hair
  26834-2: Temazepam [Mass/mass] in Hair
  26866-4: N-desalkylflurazepam [Mass/mass] in Meconium
  26878-9: ALPRAZolam [Mass/volume] in Vitreous fluid
  26899-5: Midazolam [Mass/volume] in Vitreous fluid
  26901-9: Flurazepam [Mass/volume] in Vitreous fluid
  26914-2: Estazolam [Mass/mass] in Meconium
  26923-3: Butabarbital [Mass/mass] in Hair
  27114-8: Cocaine [Mass/mass] in Hair
  27135-3: Tryptophan [Moles/volume] in Amniotic fluid
  27206-2: Morphine Free [Mass/volume] in Vitreous fluid
  27207-0: Methadone [Mass/volume] in Vitreous fluid
  27208-8: Drugs identified in Stool by Screen method
  27237-7: LORazepam [Mass/mass] in Stool
  27241-9: Mephobarbital [Mass/mass] in Stool
  30110-1: Ecgonine methyl ester [Mass/volume] in Vitreous fluid
  32596-9: Trifluoperazine [Mass] of Dose
  32607-4: Deprecated Clorazepate [Mass] of Dose
  32648-8: Hydroxyethylflurazepam [Mass/volume] in Serum or Plasma
  3546-9: Diamorphine [Presence] in Urine
  3551-9: diazePAM [Mass/volume] in Urine
  3552-7: diazePAM [Mass/volume] in Serum or Plasma --trough
  35598-2: Butalbital [Mass/volume] in Serum or Plasma by Screen method
  35599-0: carBAMazepine [Mass/volume] in Serum or Plasma by Screen method
  35600-6: chlordiazePOXIDE [Mass/volume] in Serum or Plasma by Screen method
  35610-5: FLUoxetine [Mass/volume] in Serum or Plasma by Screen method
  35612-1: fluvoxaMINE [Mass/volume] in Serum or Plasma by Screen method
  3566-7: Dimetamphetamine [Mass/time] in 24 hour Urine
  15109-2: Midazolam [Moles/volume] in Serum or Plasma
  15369-2: Lithium.saliva/Lithium.serum
  18187-5: LORazepam [Presence] in Urine
  26679-1: Secobarbital [Mass/volume] in Vitreous fluid
  26696-5: Morphine Free [Mass/mass] in Stool
  26718-7: HYDROmorphone [Mass/mass] in Hair
  26720-3: Codeine [Mass/mass] in Hair
  26747-6: Cannabinoids/Creatinine [Mass Ratio] in Urine
  29254-0: Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)
  29287-0: Morphine [Presence] in Meconium
  29325-8: Cocaethylene [Mass/volume] in Vitreous fluid
  29405-8: Maprotiline [Mass/volume] in Gastric fluid
  29408-2: Imipramine [Mass/volume] in Gastric fluid
  29599-8: Methylenedioxyethylamphetamine [Mass/volume] in Serum or Plasma by Confirmatory method
  32052-3: Benzodiazepines [Moles/volume] in Serum or Plasma
  32054-9: Butabarbital [Presence] in Specimen
  32056-4: Butalbital [Moles/volume] in Urine
  32066-3: cloZAPine [Presence] in Specimen
  32080-4: HYDROcodone [Presence] in Specimen
  32088-7: Meperidine [Presence] in Specimen
  32091-1: Meprobamate [Moles/volume] in Specimen
  32101-8: oxyCODONE [Presence] in Specimen
  32103-4: PENTobarbital [Moles/volume] in Serum or Plasma
  32108-3: PHENobarbital [Presence] in Specimen
  32112-5: Sertraline [Presence] in Urine
  32121-6: Venlafaxine [Presence] in Specimen
  32128-1: risperiDONE [Presence] in Serum or Plasma
  14845-2: Deprecated Monoacetylmorphine [Presence] in Urine
  63689-4: Drug used in past 30 days [PhenX]
  14597-9: Amitriptyline [Moles/volume] in Serum or Plasma
  14644-9: chlorproMAZINE [Presence] in Gastric fluid
  14655-5: clonazePAM [Moles/volume] in Serum or Plasma
  14690-2: N-desalkylflurazepam [Moles/volume] in Serum or Plasma
  14693-6: Norclobazam [Moles/volume] in Serum or Plasma
  14697-7: diazePAM [Moles/volume] in Serum or Plasma
  14729-8: Flurazepam [Moles/volume] in Serum or Plasma
  14791-8: Imipramine+Desipramine [Presence] in Gastric fluid
  14843-7: 6-Monoacetylmorphine (6-MAM) [Presence] in Gastric fluid
  14851-0: Norclozapine [Moles/volume] in Serum or Plasma
  14856-9: Nortriptyline [Moles/volume] in Serum or Plasma
  14863-5: oxyCODONE [Presence] in Gastric fluid
  14874-2: PHENobarbital [Moles/volume] in Serum or Plasma
  14917-9: Thioridazine [Moles/volume] in Serum or Plasma
  17395-5: oxyMORphone [Mass/volume] in Urine by Confirmatory method
  17505-9: Psilocybin/Psilocin [Mass Ratio] in Serum or Plasma
  20410-7: Amphetamines [Mass/volume] in Urine by Confirmatory method
  20421-4: Barbiturates [Presence] in Serum or Plasma by Screen method
  20501-3: Hydroxytriazolam [Mass/volume] in Urine by Confirmatory method
  20515-3: Amitriptyline [Mass/volume] in Urine by Confirmatory method
  20531-0: Deprecated Hydroxyalprazolam [Mass/volume] in Urine by Confirm method
  20539-3: Deprecated Levomepromazine [Mass/volume] in Urine by Confirm method
  20543-5: Mescaline [Mass/volume] in Urine by Confirmatory method
  20553-4: Norfluoxetine [Mass/volume] in Urine by Confirmatory method
  20561-7: traMADol [Mass/volume] in Urine by Confirmatory method
  20663-1: Tricyclic antidepressants [Mass/volume] in Urine by Screen method
  20664-9: Barbiturates [Mass/volume] in Urine by Screen method
  25994-5: Tryptophan/Creatinine [Molar ratio] in 24 hour Urine
  26042-2: Didesmethylcitalopram [Moles/volume] in Serum or Plasma
  3431-4: carBAMazepine [Presence] in Serum or Plasma
  3437-1: Carisoprodol [Mass/volume] in Serum or Plasma
  34601-5: Drugs identified in Body fluid
  34715-3: Cocaine [Presence] in Hair by Screen method
  14070-7: fluPHENAZine [Presence] in Urine
  14192-9: Triazolam [Presence] in Urine
  1698-0: 8-Hydroxyamoxapine [Mass/volume] in Serum or Plasma
  16998-7: HYDROmorphone [Mass/volume] in Urine by Confirmatory method
  17265-0: Methocarbamol [Units/volume] in Serum or Plasma
  17283-3: Mirtazapine [Mass/volume] in Serum or Plasma
  25357-5: Butabarbital [Moles/volume] in Serum or Plasma
  3390-2: Benzodiazepines [Presence] in Urine
  3395-1: Cocaine [Presence] in Serum or Plasma
  34073-7: FDA package insert Drug interactions section
  3418-1: Butabarbital [Mass/volume] in Serum or Plasma
  59627-0: cloBAZam [Mass/volume] in Blood by Confirmatory method
  59634-6: cloBAZam [Mass/mass] in Tissue by Confirmatory method
  59637-9: clonazePAM [Mass/volume] in Blood by Confirmatory method
  59640-3: clonazePAM [Mass/volume] in Serum or Plasma by Confirmatory method
  59642-9: clonazePAM [Mass/mass] in Tissue by Confirmatory method
  59644-5: Cocaine [Mass/volume] in Serum or Plasma by Confirmatory method
  59649-4: N-desalkylflurazepam [Mass/volume] in Body fluid by Confirmatory method
  59650-2: N-desalkylflurazepam [Mass/mass] in Meconium by Confirmatory method
  59656-9: diazePAM [Mass/volume] in Body fluid
  18282-4: Cannabinoids [Presence] in Urine by Screen method
  18325-1: oxyMORphone [Presence] in Urine by Confirmatory method
  18334-3: Naltrexone [Presence] in Urine by Confirmatory method
  18340-0: Nortramadol [Mass/volume] in Serum or Plasma by Confirmatory method
  18360-8: 8-Hydroxyamoxapine [Mass/volume] in Urine
  18387-1: Diamorphine [Mass/volume] in Serum or Plasma
  18388-9: diazePAM [Presence] in Urine by Confirmatory method
  18470-5: Norclomipramine [Mass/volume] in Urine
  21241-5: diazePAM+Nordiazepam [Mass/volume] in Urine
  26784-9: diazePAM [Mass/volume] in Serum or Plasma by Confirmatory method
  26830-0: Prochlorperazine [Presence] in Serum or Plasma
  26862-3: HYDROmorphone [Mass/mass] in Meconium
  26891-2: Nordiazepam [Mass/mass] in Meconium
  26900-1: chlordiazePOXIDE [Mass/volume] in Vitreous fluid
  26905-0: PHENobarbital [Mass/mass] in Hair
  26906-8: Mephobarbital [Mass/mass] in Hair
  26933-2: Oxazepam [Mass/mass] in Meconium
  26978-7: Protriptyline [Mass/volume] in Urine
  27050-4: Mephobarbital [Mass/volume] in Milk
  27051-2: PHENobarbital [Mass/volume] in Milk
  27061-1: Butabarbital [Mass/mass] in Meconium
  27076-9: Dextromethorphan+Levorphanol [Presence] in Urine
  27105-6: Amphetamines [Mass/volume] in Milk
  27116-3: Methamphetamine [Mass/volume] in Milk
  27194-0: N-desalkylflurazepam [Mass/volume] in Vitreous fluid
  27197-3: Benzodiazepines [Presence] in Vitreous fluid
  27211-2: Norpropoxyphene [Mass/mass] in Hair
  27240-1: PHENobarbital [Mass/mass] in Stool
  27243-5: PENTobarbital [Mass/mass] in Stool
  27247-6: Hydroxyethylflurazepam [Mass/mass] in Stool
  27263-3: Amphetamines [Mass/volume] in Vitreous fluid
  27275-7: diazePAM [Mass/mass] in Stool
  32649-6: Hydroxytriazolam [Mass/volume] in Serum or Plasma
  32852-6: carBAMazepine free/carBAMazepine.total in Serum or Plasma
  3530-3: Tetrahydrocannabinol [Mass/volume] in Urine
  3532-9: Desipramine [Presence] in Serum or Plasma
  35331-8: OXcarbazepine [Mass/volume] in Serum or Plasma
  3537-8: Nordiazepam [Mass/volume] in Serum or Plasma
  3545-1: Propoxyphene [Mass/volume] in Urine
  3547-7: Diamorphine [Mass/volume] in Urine
  3548-5: diazePAM [Mass/volume] in Serum or Plasma
  3549-3: diazePAM [Presence] in Serum or Plasma
  35618-8: Methadone [Mass/volume] in Serum or Plasma by Screen method
  35623-8: Nordoxepin [Mass/volume] in Serum or Plasma by Screen method
  35627-9: Nortriptyline [Mass/volume] in Serum or Plasma by Screen method
  35631-1: PHENobarbital [Mass/volume] in Serum or Plasma by Screen method
  35649-3: Propoxyphene [Mass/volume] in Serum or Plasma by Screen method
  3565-9: Dimetamphetamine [Mass/volume] in Urine
  15107-6: Imipramine [Moles/volume] in Serum or Plasma
  17872-3: Tetrahydrocannabinol [Presence] in Urine by Confirm method >25 ng/mL
  21046-8: 7-Aminoflunitrazepam [Mass/volume] in Serum or Plasma
  21142-5: Carisoprodol [Presence] in Urine
  23864-2: Flunitrazepam [Mass/volume] in Serum or Plasma
  26683-3: Estazolam [Mass/volume] in Vitreous fluid
  26686-6: Triazolam [Mass/volume] in Vitreous fluid
  26722-9: oxyCODONE [Mass/mass] in Hair
  26731-0: Tetrahydrocannabinol [Mass/mass] in Stool
  14695-1: Nordoxepin [Moles/volume] in Serum or Plasma
  27067-8: Propoxyphene [Mass/mass] in Meconium
  4179-8: chlorproMAZINE [Mass] of Dose
  59175-0: QUEtiapine metabolite [Presence] in Urine
  95492-5: Injection drug use Lifetime
  14591-2: ALPRAZolam [Moles/volume] in Serum or Plasma
  14595-3: Amitriptyline+Nortriptyline [Presence] in Serum or Plasma
  14602-7: Deprecated Amoxapine+8-Hydroxyamoxapine [Molecules/volume] in Serum or Plasma
  14639-9: carBAMazepine [Moles/volume] in Serum or Plasma
  14652-2: clomiPRAMINE [Moles/volume] in Serum or Plasma
  14694-4: Norclomipramine [Moles/volume] in Serum or Plasma
  14705-8: Doxepin [Moles/volume] in Serum or Plasma
  14727-2: FLUoxetine [Presence] in Gastric fluid
  14826-2: Meperidine [Presence] in Gastric fluid
  14867-6: PARoxetine [Moles/volume] in Serum or Plasma
  14911-2: Sertraline [Moles/volume] in Serum or Plasma
  14926-0: Triazolam [Moles/volume] in Serum or Plasma
  14931-0: Trimipramine [Moles/volume] in Serum or Plasma
  17504-2: Psilocybin [Presence] in Urine
  20500-5: Hydroxyalprazolam [Mass/volume] in Urine by Confirmatory method
  20517-9: Aprobarbital [Mass/volume] in Urine by Confirmatory method
  20524-5: Deprecated Tetrahydrocannabinol [Mass/volume] in Urine by Confirm method
  20528-6: Flunitrazepam [Mass/volume] in Urine by Confirmatory method
  20529-4: FLUoxetine [Mass/volume] in Urine by Confirmatory method
  20537-7: Ketamine [Mass/volume] in Urine by Confirmatory method
  20551-8: Nalbuphine [Mass/volume] in Urine by Confirmatory method
  25812-9: Trimipramine+Nortrimipramine [Moles/volume] in Serum or Plasma
  26039-8: Norflunitrazepam [Moles/volume] in Serum or Plasma
  3436-3: Carboxy tetrahydrocannabinol [Mass/volume] in Urine
  34386-3: Venlafaxine [Moles/volume] in Serum or Plasma
  34545-4: carBAMazepine free and total panel [Mass/volume] - Serum or Plasma
  34635-3: Citalopram [Mass/volume] in Serum or Plasma
  34666-8: Carisoprodol+Meprobamate [Mass/volume] in Serum or Plasma
  14069-9: Estazolam [Mass/volume] in Serum or Plasma
  14309-9: Amphetamines [Presence] in Urine by Confirm method >200 ng/mL
  17090-2: Loxapine+8-Hydroxyloxapine [Mass/volume] in Serum or Plasma
  17256-9: Mesoridazine [Mass/volume] in Urine
  17275-9: Methylfentanyl [Mass/volume] in Serum or Plasma
  25394-8: Nortrimipramine [Moles/volume] in Serum or Plasma
  25425-0: Gabapentin [Moles/volume] in Serum or Plasma
  25463-1: Lithium [Moles/volume] in Urine
  25475-5: Methaqualone [Moles/volume] in Serum or Plasma
  31081-3: Benzodiazepines [Presence] in Meconium by Screen method
  31084-7: Methadone [Mass/volume] in Bile fluid
  31087-0: Thioridazine [Mass/volume] in Gastric fluid
  31203-3: 5-Hydroxyindoleacetate [Mass/volume] in 24 hour Urine
  3388-6: Deprecated Benzodiazepines positive [Identifier] in Urine
  3392-8: Benzoylecgonine [Mass/volume] in Serum or Plasma
  3394-4: Benzoylecgonine [Mass/volume] in Urine
  3396-9: Cocaine [Mass/volume] in Serum or Plasma
  3397-7: Cocaine [Presence] in Urine
  34074-5: FDA package insert Drug/laboratory test interactions section
  3426-4: Tetrahydrocannabinol [Presence] in Urine
  59655-1: diazePAM [Mass/volume] in Blood by Confirmatory method
  59661-9: diazePAM [Mass/mass] in Tissue by Confirmatory method
  59666-8: Estazolam [Mass/volume] in Body fluid
  59676-7: Flurazepam [Mass/volume] in Body fluid
  59679-1: Flurazepam [Mass/mass] in Tissue by Confirmatory method
  59680-9: Gabapentin [Mass/volume] in Urine
  59688-2: Hydroxyethylflurazepam [Mass/mass] in Tissue
  59691-6: Hydroxytriazolam [Mass/volume] in Blood by Confirmatory method
  59700-5: LORazepam [Mass/volume] in Blood by Confirmatory method
  59703-9: LORazepam [Mass/volume] in Serum or Plasma by Confirmatory method
  59705-4: Methadone [Presence] in Serum or Plasma by Screen method
  59709-6: Midazolam [Mass/volume] in Body fluid
  59716-1: Nordiazepam [Mass/volume] in Blood
  59726-0: Oxazepam [Mass/volume] in Blood by Confirmatory method
  59727-8: Oxazepam [Mass/volume] in Body fluid
  59745-0: Temazepam [Mass/volume] in Blood
  59749-2: Temazepam [Mass/mass] in Meconium by Confirmatory method
  59751-8: Temazepam [Mass/mass] in Stool by Confirmatory method
  59762-5: Triazolam [Mass/volume] in Serum or Plasma by Confirmatory method
  59763-3: Triazolam [Mass/mass] in Tissue
  59764-1: Triazolam [Mass/mass] in Tissue by Confirmatory method
  59879-7: chlordiazePOXIDE [Moles/volume] in Urine
  59890-4: cloZAPine [Moles/volume] in Gastric fluid
  59902-7: FLUoxetine [Moles/volume] in Urine
  59904-3: fluPHENAZine [Moles/volume] in Urine
  59912-6: Imipramine [Moles/volume] in Urine
  59913-4: Imipramine [Moles/volume] in Gastric fluid
  59928-2: Methaqualone [Moles/volume] in Urine
  59939-9: Norclobazam [Moles/volume] in Gastric fluid
  59940-7: Norclomipramine [Moles/volume] in Urine
  59945-6: Nortriptyline [Moles/volume] in Gastric fluid
  59948-0: OXcarbazepine [Moles/volume] in Gastric fluid
  59953-0: Perphenazine [Moles/volume] in Serum or Plasma
  59958-9: Promazine [Moles/volume] in Urine
  60064-3: buPROPion [Mass/volume] in Urine
  60069-2: Dantrolene [Mass/volume] in Blood
  60083-3: Hydroxybupropion [Mass/volume] in Blood
  60084-1: Hydroxybupropion [Mass/volume] in Body fluid
  62849-5: Venlafaxine+O-desmethylvenlafaxine [Mass/volume] in Serum or Plasma
  62886-7: PhenX - injection drug use protocol 161101
  70146-6: Benzoylecgonine [Mass/volume] in Urine by Screen method
  70210-0: Morphine [Moles/volume] in Urine by Confirmatory method
  70212-6: Nordiazepam [Moles/volume] in Serum or Plasma by Screen method
  72800-6: Norketamine/Creatinine [Mass Ratio] in Urine
  72807-1: JWH-073 carboxylated (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine
  72814-7: DULoxetine [Mass/volume] in Urine by Confirmatory method
  72820-4: 5-Hydroxyindoleacetate [Mass/volume] in Urine by Confirmatory method
  72879-0: Deprecated CYP2C19 gene drug metabolism analysis overall interpretation [Interpretation] in Blood, Tissue or Saliva Qualitative by Molecular genetics method
  72928-5: Secobarbital [Moles/volume] in Urine
  72958-2: risperiDONE induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73015-0: Gabapentin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73050-7: carBAMazepine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73109-1: traMADol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73155-4: Sertraline induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73163-8: risperiDONE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  75644-5: Amphetamine+Methamphetamine [Presence] in Blood by Confirmatory method
  75647-8: Meperidine [Presence] in Meconium
  19698-0: Temazepam [Presence] in Urine by Screen method
  19701-2: Temazepam cutoff [Mass/volume] in Urine for Confirmatory method
  19705-3: Deprecated Tetrahydrocannabinol cutoff [Mass/volume] in Urine for Confirm method
  19714-5: Triazolam [Presence] in Urine by Screen method
  19716-0: Triazolam cutoff [Mass/volume] in Urine for Screen method
  25309-6: Amobarbital [Moles/volume] in Serum or Plasma
  27921-6: Alpha hydroxyalprazolam [Mass/volume] in Serum or Plasma
  3070-0: Tryptophan [Mass/volume] in Serum or Plasma
  3073-4: Tryptophan Free [Mass/volume] in Serum or Plasma
  33561-2: Cannabinoids [Mass/volume] in Gastric fluid
  3373-8: Deprecated Barbiturate screen absent [Identifier] in Urine
  3377-9: Barbiturates [Presence] in Urine
  13418-9: Tryptophan [Mass/volume] in Amniotic fluid
  13548-3: chlorproMAZINE [Presence] in Serum or Plasma
  13553-3: Cocaethylene [Presence] in Serum or Plasma
  13566-5: Mesoridazine [Presence] in Serum or Plasma
  13574-9: Norfluoxetine [Presence] in Serum or Plasma
  13579-8: Sertraline [Presence] in Serum or Plasma
  16145-5: Mescaline [Mass/volume] in Serum or Plasma
  16185-1: chlordiazePOXIDE [Mass/volume] in Stool
  16186-9: Hydroxyalprazolam [Mass/volume] in Stool
  16187-7: ALPRAZolam [Mass/volume] in Stool
  16191-9: Butabarbital [Presence] in Urine by Confirmatory method
  16203-2: ALPRAZolam [Presence] in Urine by Confirmatory method
  16212-3: Ethylamphetamine [Presence] in Urine by Confirmatory method
  16232-1: Triazolam [Mass/volume] in Urine by Confirmatory method
  19262-5: Amphetamines tested for in Urine by Screen method Nominal
  19274-0: Barbiturates positive [Identifier] in Urine by Confirmatory method
  19283-1: Benzodiazepines cutoff [Mass/volume] in Urine for Screen method
  19284-9: Benzodiazepines cutoff [Mass/volume] in Urine for Confirmatory method
  19285-6: Benzodiazepines screen method [Identifier] in Urine
  19292-2: Cannabinoids cutoff [Mass/volume] in Urine for Confirmatory method
  19314-4: Tricyclic antidepressants tested for in Urine by Screen method Narrative
  19325-0: Alpha hydroxyalprazolam [Presence] in Urine by Screen method
  19341-7: Amobarbital cutoff [Mass/volume] in Urine for Screen method
  19342-5: Amobarbital cutoff [Mass/volume] in Urine for Confirmatory method
  27302-9: Midazolam [Mass/mass] in Meconium
  27311-0: Codeine Free [Mass/mass] in Stool
  27312-8: HYDROcodone Free [Mass/mass] in Stool
  27439-9: Alpha hydroxyalprazolam [Mass/mass] in Stool
  30249-7: Barbiturates [Mass/volume] in Serum or Plasma by Screen method
  33282-5: Cannabinoids [Mass/mass] in Meconium by Confirmatory method
  33332-8: Linezolid [Susceptibility] by Gradient strip
  3337-3: Amobarbital [Presence] in Serum or Plasma
  3338-1: Amobarbital [Mass/volume] in Serum or Plasma
  58794-9: 5-Hydroxytryptophan [Mass/volume] in 24 hour Urine
  58953-1: Meperidine and Normeperidine panel - Urine
  74769-1: 5-Hydroxyindoleacetate [Moles/volume] in Platelet rich plasma
  74812-9: Mirtazapine [Presence] in Urine
  74920-0: Gamma hydroxybutyrate [Moles/volume] in Blood
  74932-5: Deprecated Citalopram [Mass/volume] in Serum or Plasma --trough
  74934-1: fluPHENAZine [Mass/volume] in Serum or Plasma --trough
  74936-6: QUEtiapine [Mass/volume] in Serum or Plasma --trough
  74946-5: Deprecated Normirtazapine [Mass/volume] in Serum or Plasma --trough
  74948-1: FLUoxetine+Norfluoxetine [Mass/volume] in Serum or Plasma --trough
  59667-6: Estazolam [Mass/volume] in Body fluid by Confirmatory method
  59681-7: Gamma hydroxybutyrate [Presence] in Serum or Plasma by Screen method
  59707-0: Midazolam [Mass/volume] in Blood
  59717-9: Nordiazepam [Mass/volume] in Blood by Confirmatory method
  59719-5: Nordiazepam [Mass/volume] in Body fluid by Confirmatory method
  59720-3: Nordiazepam [Mass/mass] in Meconium by Confirmatory method
  59721-1: Nordiazepam [Mass/volume] in Serum or Plasma by Confirmatory method
  59728-6: Oxazepam [Mass/volume] in Body fluid by Confirmatory method
  59865-6: Amobarbital [Moles/volume] in Urine
  59905-0: fluPHENAZine [Moles/volume] in Gastric fluid
  59926-6: Mesoridazine [Moles/volume] in Gastric fluid
  59938-1: Norclobazam [Moles/volume] in Urine
  59941-5: Norclomipramine [Moles/volume] in Gastric fluid
  59944-9: Normeperidine [Moles/volume] in Serum or Plasma
  59951-4: Pentazocine [Moles/volume] in Urine
  59954-8: Perphenazine [Moles/volume] in Urine
  59955-5: Perphenazine [Moles/volume] in Gastric fluid
  59957-1: Promazine [Moles/volume] in Serum or Plasma
  60061-9: buPROPion [Mass/volume] in Blood
  60062-7: buPROPion [Mass/volume] in Body fluid
  62848-7: Mirtazapine+Normirtazapine [Mass/volume] in Serum or Plasma
  70148-2: Methadone [Presence] in Urine by Screen method >150 ng/mL
  70213-4: Nordiazepam [Moles/volume] in Urine by Confirmatory method
  70215-9: oxyCODONE [Moles/volume] in Urine by Confirmatory method
  72810-5: Gabapentin [Mass/volume] in Urine by Confirmatory method
  72812-1: Norfluoxetine/Creatinine [Mass Ratio] in Urine
  72871-7: FDA product label NDC labeler code request - animal drug
  72932-7: Venlafaxine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  72977-2: PARoxetine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  72978-0: PARoxetine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  72984-8: OLANZapine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73065-5: Amitriptyline induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73084-6: Venlafaxine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73102-6: Triazolam induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73154-7: Sertraline induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73182-8: QUEtiapine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  75763-3: Orphenadrine [Presence] in Serum or Plasma or Urine by Screen method
  78436-3: Primidone and PHENobarbital trough panel - Serum or Plasma
  78437-1: FLUoxetine trough, FLUoxetine+norfluoxetine trough and Norfluoxetine panel - Serum or Plasma
  5935-2: Deprecated Benzoylecgonine [Mass/volume] in Urine
  5938-6: Benzoylecgonine [Presence] in Hair
  5940-2: Deprecated Cocaine [Presence] in Serum or Plasma
  59595-9: 7-Aminoclonazepam [Mass/volume] in Serum or Plasma by Confirmatory method
  59599-1: Alpha hydroxyalprazolam [Mass/volume] in Blood
  59606-4: Alpha hydroxyalprazolam [Mass/mass] in Tissue by Confirmatory method
  59609-8: ALPRAZolam [Mass/volume] in Body fluid by Confirmatory method
  59613-0: ALPRAZolam [Mass/mass] in Tissue
  59617-1: chlordiazePOXIDE [Mass/volume] in Blood
  59621-3: chlordiazePOXIDE [Mass/mass] in Meconium by Confirmatory method
  59622-1: chlordiazePOXIDE [Mass/volume] in Serum or Plasma by Confirmatory method
  64568-9: Does your child use any recreational drugs [PhenX]
  67126-3: Cannabinoids synthetic [Presence] in Urine by Confirmatory method
  19658-4: PENTobarbital cutoff [Mass/volume] in Urine for Confirmatory method
  19659-2: Phencyclidine [Presence] in Urine by Screen method
  19660-0: Phencyclidine cutoff [Mass/volume] in Urine for Screen method
  19661-8: Phencyclidine cutoff [Mass/volume] in Urine for Confirmatory method
  19668-3: PHENobarbital cutoff [Mass/volume] in Urine for Screen method
  19689-9: Deprecated Psilocybin [Mass/volume] in Urine
  19708-7: Thioridazine cutoff [Mass/volume] in Urine for Screen method
  19717-8: Triazolam cutoff [Mass/volume] in Urine for Confirmatory method
  27927-3: Butalbital [Mass/volume] in Vitreous fluid
  28044-6: Gamma hydroxybutyrate [Mass/volume] in Urine
  28059-4: 7-Aminoclonazepam [Mass/volume] in Serum or Plasma
  28157-6: Compromised family coping Family [CCC]
  3068-4: Tryptophan [Mass/volume] in Cerebral spinal fluid
  3374-6: Barbiturate screen present [Identifier] in Urine
  3375-3: Deprecated Barbiturate screen present [Identifier] in Urine
  3376-1: Barbiturates [Presence] in Serum, Plasma or Blood
  13552-5: cloZAPine [Presence] in Serum or Plasma
  13550-9: clonazePAM [Presence] in Serum or Plasma
  13551-7: Clorazepate [Presence] in Serum or Plasma
  13554-1: Cyclobenzaprine [Presence] in Serum or Plasma
  13557-4: Norsertraline [Presence] in Serum or Plasma
  16207-3: Meperidine [Presence] in Urine by Confirmatory method
  16208-1: Buprenorphine [Presence] in Urine by Confirmatory method
  16213-1: Levorphanol [Presence] in Urine by Confirmatory method
  16227-1: diazePAM [Mass/volume] in Urine by Confirmatory method
  16229-7: clonazePAM [Mass/volume] in Urine by Confirmatory method
  16231-3: Flurazepam [Mass/volume] in Urine by Confirmatory method
  16236-2: Butabarbital [Mass/volume] in Urine by Confirmatory method
  16242-0: Propoxyphene [Mass/volume] in Urine by Confirmatory method
  16245-3: Hydroxyethylflurazepam [Mass/volume] in Serum or Plasma by Confirmatory method
  16249-5: oxyCODONE [Mass/volume] in Urine by Confirmatory method
  19279-9: Benzodiazepines tested for in Urine by Screen method Nominal
  19289-8: Cannabinoids [Presence] in Urine by Confirmatory method
  19302-9: Opiates confirm method [Identifier] in Urine
  19323-5: 6-Monoacetylmorphine (6-MAM) cutoff [Mass/volume] in Urine for Screen method
  19329-2: Alpha hydroxyalprazolam cutoff [Mass/volume] in Urine for Screen method
  19334-2: Amitriptyline cutoff [Mass/volume] in Urine for Confirmatory method
  19343-3: Amphetamine [Presence] in Urine by Screen method
  22065-7: Deprecated Propoxyphene [Mass/volume] in Urine
  27283-1: Methadone [Mass/mass] in Stool
  27295-5: Cocaethylene [Mass/mass] in Stool
  27314-4: HYDROmorphone Free [Mass/mass] in Stool
  30250-5: Benzodiazepines [Mass/volume] in Serum or Plasma by Screen method
  33016-7: Methylenedioxyethylamphetamine [Mass/volume] in Serum or Plasma
  33338-5: Zolpidem [Presence] in Urine
  3334-0: Amitriptyline [Presence] in Urine
  59160-2: Cannabinoids [Mass/mass] in Hair
  58925-9: Dextromethamphetamine [Presence] in Urine
  69356-4: oxyCODONE [Presence] in Saliva (oral fluid) by Screen method
  74646-1: Methamphetamine [Presence] in Saliva (oral fluid) by Confirmatory method
  74656-0: Opiates [Presence] in Saliva (oral fluid) by Confirmatory method
  74659-4: oxyMORphone [Presence] in Saliva (oral fluid) by Confirmatory method
  74660-2: Phencyclidine [Presence] in Saliva (oral fluid) by Confirmatory method
  74675-0: Codeine [Presence] in Saliva (oral fluid) by Confirmatory method
  3493-4: clomiPRAMINE+Norclomipramine [Mass/volume] in Serum or Plasma
  35107-2: Norclobazam [Mass/volume] in Serum or Plasma
  61031-1: 7-Aminoclonazepam [Presence] in Specimen
  61032-9: 7-Aminoflunitrazepam [Presence] in Serum or Plasma
  61047-7: Methylenedioxyethylamphetamine [Presence] in Serum or Plasma
  61048-5: Methylenedioxyethylamphetamine [Presence] in Urine
  61050-1: Methylphenidate [Presence] in Specimen
  61054-3: Normeperidine [Presence] in Specimen
  61055-0: Oxazepam [Presence] in Specimen
  61061-8: Temazepam [Presence] in Specimen
  61063-4: Carboxy tetrahydrocannabinol [Presence] in Specimen
  61064-2: Triazolam [Presence] in Serum or Plasma
  61079-0: Flunitrazepam [Presence] in Specimen
  61086-5: Norfentanyl [Presence] in Gastric fluid
  61088-1: Oxazepam [Presence] in Gastric fluid
  63480-8: Pseudomonas aeruginosa.multidrug resistant isolate [Presence] in Specimen by Organism specific culture
  63664-7: How many times in your life have you used this medicine or drug [SSAGA II]
  63673-8: Have you often used this drug, used steadily, more days or in larger amounts than you intended to [SSAGA II]
  63680-3: Did an overdose of this drug that required medical treatment, happen 3 or more times [SSAGA II]
  63682-9: Did you continue to use this drug knowing it caused hepatitis [SSAGA II]
  63684-5: Did you continue to use this drug knowing it caused other serious health problems [SSAGA II]
  63686-0: Did you continue to use drug after you knew it caused any of these emotional or psychological problems [SSAGA II]
  65807-0: Tapentadol [Mass/volume] in Urine
  68314-4: Meperidine and Normeperidine panel - Serum or Plasma
  68541-2: HYDROmorphone [Mass/mass] in Meconium by Confirmatory method
  68544-6: HYDROcodone [Mass/mass] in Meconium by Confirmatory method
  71430-3: oxyCODONE+oxyMORphone [Presence] in Saliva (oral fluid) by Screen method
  73692-6: Escitalopram [Mass/volume] in Urine
  73727-0: Methadone [Presence] in Hair
  73728-8: Norcocaine [Presence] in Meconium
  73730-4: Lysergate diethylamide [Presence] in Meconium
  73919-3: MAM-2201 pentanoate (synthetic cannabinoid metabolite) [Presence] in Blood
  73920-1: JWH-018 4/5-hydroxypentyl (synthetic cannabinoid metabolites) [Presence] in Blood
  73921-9: JWH-073 3-hydroxybutyl (synthetic cannabinoid metabolite) [Presence] in Blood
  73926-8: JWH-073 4-hydroxybutyl (synthetic cannabinoid metabolite) [Presence] in Blood
  73932-6: traMADol [Mass/volume] in Blood
  73934-2: Meperidine [Mass/volume] in Serum, Plasma or Blood
  73972-2: Morphine Free [Mass/volume] in Blood
  76659-2: Antipsychotics drug panel - Urine by Screen method
  79132-7: 4-Hydroxymidazolam [Mass/volume] in Body fluid
  79136-8: Acepromazine [Mass/volume] in Body fluid
  79145-9: Tapentadol [Presence] in Blood by Confirmatory method
  79227-5: Amobarbital [Mass/volume] in Body fluid
  79245-7: Triazolam cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
  79248-1: Methylenedioxyethylamphetamine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
  79252-3: Nordiazepam cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
  79253-1: Oxazepam cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
  79256-4: Carisoprodol+Meprobamate cutoff [Mass/volume] in Urine for Screen method
  60282-1: ALPRAZolam [Moles/volume] in Specimen
  60283-9: Amitriptyline [Moles/volume] in Specimen
  60284-7: Amobarbital [Moles/volume] in Specimen
  60293-8: chlordiazePOXIDE [Moles/volume] in Specimen
  10975-1: 6-Monoacetylmorphine (6-MAM) [Mass/volume] in Urine
  10976-9: 6-Monoacetylmorphine (6-MAM) [Presence] in Urine
  10996-7: Normeperidine [Mass/volume] in Serum or Plasma
  10369-7: Opiates [Mass/mass] in Hair
  10544-5: Normeperidine [Presence] in Serum or Plasma
  3669-9: Haloperidol [Mass/volume] in Serum or Plasma
  3670-7: Haloperidol [Presence] in Urine
  3934-7: Phencyclidine [Mass/volume] in Serum or Plasma
  3949-5: PHENobarbital [Presence] in Urine
  4216-8: Diamorphine [Mass] of Dose
  42227-9: FDA package insert Drug abuse and dependence section
  42252-7: Methaqualone+Metabolite [Presence] in Urine by Screen method
  4229-1: Disulfiram [Mass] of Dose
  42326-9: Drugs identified in Mother's milk by Screen method
  45143-5: Methylenedioxyethylamphetamine [Mass/volume] in Urine by Confirmatory method
  47975-8: tiZANidine [Mass/volume] in Serum or Plasma
  50571-9: FDA product label VFD Type C medicated feed animal drug label
  50592-5: Ecgonine methyl ester [Mass/volume] in Urine by Confirmatory method
  50593-3: 3-Hydroxybenzoylecgonine [Mass/volume] in Serum or Plasma by Confirmatory method
  50805-1: Amitriptyline [Moles/volume] in Gastric fluid
  53497-4: 5-Hydroxytryptophan [Moles/volume] in 24 hour Urine
  3901-6: Para hydroxyamphetamine [Presence] in Urine
  4174-9: Clorazepate [Mass] of Dose
  41859-0: 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Specimen
  4193-9: clomiPRAMINE [Mass] of Dose
  4456-0: Trimipramine [Mass] of Dose
  44909-0: 5-Hydroxyindoleacetate and Creatinine [Interpretation] in Urine
  47404-9: N-desalkylflurazepam [Mass/volume] in Blood by Confirmatory method
  47415-5: Propoxyphene + Norpropoxyphene [Mass/volume] in Serum or Plasma by Confirmatory method
  50150-2: 5-Hydroxytryptophan [Moles/volume] in Serum or Plasma
  50152-8: 5-Hydroxytryptophan/Creatinine [Molar ratio] in Urine
  52949-5: chlordiazePOXIDE [Presence] in Gastric fluid
  52951-1: Phencyclidine [Moles/volume] in Urine
  55520-1: 6-Monoacetylmorphine (6-MAM) [Moles/volume] in Urine
  55530-0: Cocaethylene [Moles/volume] in Serum or Plasma
  55552-4: Methylphenidate [Moles/volume] in Serum or Plasma
  55560-7: Orphenadrine [Moles/volume] in Serum or Plasma
  55566-4: Phenelzine [Moles/volume] in Serum or Plasma
  55587-0: Methamphetamine [Moles/volume] in Urine
  80111-8: 11-Hydroxy delta-9 tetrahydrocannabinol [Mass/volume] in Blood by Confirmatory method
  80115-9: 6-Monoacetylmorphine (6-MAM) [Mass/volume] in Blood by Confirmatory method
  80129-0: Amisulpride [Mass/volume] in Blood
  80134-0: Amphetamine [Mass/mass] in Hair by Confirmatory method
  80196-9: Ecgonine methyl ester [Presence] in Blood by Screen method
  82873-1: Brallobarbital [Mass/volume] in Serum or Plasma
  82967-1: Amphetamine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
  82968-9: Secobarbital [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
  82971-3: Butalbital [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
  90748-5: Atomoxetine [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  90978-8: Vilazodone [Mass/volume] in Serum or Plasma
  90979-6: Vortioxetine [Mass/volume] in Serum or Plasma
  91037-2: Methamphetamine+Methylenedioxymethamphetamine [Presence] in Urine by Screen method
  91041-4: Cannabinoids [Presence] in Body fluid by Screen method
  91042-2: Methamphetamine+Methylenedioxymethamphetamine [Presence] in Body fluid by Screen method
  12788-6: 6-Monoacetylmorphine (6-MAM) [Mass/volume] in Serum or Plasma
  12296-0: Mescaline [Presence] in Urine
  12313-3: Aprobarbital [Presence] in Urine
  12322-4: Triflupromazine [Presence] in Urine
  12351-3: Tetrahydrocannabinol [Presence] in Stool
  12353-9: Methaqualone [Presence] in Stool
  12361-2: Oxazepam [Presence] in Urine
  12382-8: Temazepam [Mass/volume] in Urine
  12385-1: Deprecated Nordoxepin [Mass/volume] in Serum or Plasma
  12386-9: Nordoxepin [Mass/volume] in Urine
  12440-4: Midazolam [Presence] in Stool
  12445-3: Norfluoxetine [Mass/volume] in Urine
  12484-2: PHENobarbital [Presence] in Gastric fluid
  12487-5: Butalbital [Presence] in Gastric fluid
  12493-3: Hexobarbital [Mass/volume] in Serum or Plasma
  12495-8: Barbital [Presence] in Stool
  12496-6: Butabarbital [Presence] in Stool
  12498-2: Metharbital [Presence] in Stool
  12605-2: Flurazepam [Presence] in Stool
  38439-6: Barbiturates [Presence] in Meconium by Confirmatory method
  38441-2: Benzodiazepines [Presence] in Meconium by Confirmatory method
  3872-9: Nortriptyline [Mass/volume] in Serum or Plasma
  3876-0: Nortriptyline [Mass/volume] in Serum or Plasma --trough >12 hours post dose
  4136-8: Barbital [Mass] of Dose
  4155-8: Carisoprodol [Mass] of Dose
  4411-5: Promazine [Mass] of Dose
  44288-9: 5-Hydroxyindoleacetate/Creatinine [Mass Ratio] in 24 hour Urine
  47104-5: Doxepin [Moles/volume] in Gastric fluid
  47119-3: Meprobamate [Moles/volume] in Gastric fluid
  49691-9: Nortrimipramine [Presence] in Serum or Plasma
  49749-5: 6-monoacetylmorphine free [Mass/volume] in Serum or Plasma
  49753-7: Norbuprenorphine [Mass/volume] in Urine
  49876-6: Alpha hydroxytriazolam [Mass/volume] in Urine by Confirmatory method
  50005-8: Methaqualone [Presence] in Body fluid by Screen method
  55428-7: Drug test kit name [Identifier] in Urine
  57861-7: HYDROcodone [Moles/volume] in Specimen
  57864-1: Meperidine [Moles/volume] in Specimen
  57869-0: Phencyclidine [Moles/volume] in Specimen
  57873-2: Thiothixene [Moles/volume] in Specimen
  57945-8: Cocaethylene [Presence] in Meconium
  57981-3: HYDROcodone [Presence] in Meconium
  58013-4: Norclomipramine [Presence] in Urine
  58030-8: Tranylcypromine [Presence] in Urine
  58042-3: Phencyclidine [Presence] in Blood by Confirmatory method
  58047-2: Tetrahydrocannabinol [Presence] in Blood by Confirmatory method
  3787-9: Methaqualone [Mass/volume] in Urine
  3807-5: Methylphenidate [Mass/volume] in Serum or Plasma
  3821-6: Midazolam [Mass/volume] in Serum or Plasma
  3827-3: Morphine [Mass/volume] in Serum or Plasma
  3828-1: Morphine Free [Presence] in Urine
  3830-7: Morphine [Presence] in Urine
  40799-9: Amphetamines [Presence] in Saliva (oral fluid) by Screen method
  40803-9: Methamphetamine [Presence] in Hair by Screen method
  40807-0: Phencyclidine [Presence] in Hair by Screen method
  4370-3: oxyCODONE [Mass] of Dose
  43828-3: Benzodiazepines [Presence] in Specimen
  4383-6: Pentazocine [Mass] of Dose
  4385-1: PENTobarbital [Mass] of Dose
  43975-2: Aprobarbital [Presence] in Specimen
  28608-8: Tryptophan/Creatinine [Ratio] in Urine
  31137-3: Cocaine [Mass/volume] in Bile fluid
  3386-0: Deprecated Benzodiazepines negative [Identifier] in Urine
  3389-4: Benzodiazepines [Presence] in Serum or Plasma
  3391-0: Benzoylecgonine [Presence] in Serum or Plasma
  3414-0: Buprenorphine [Presence] in Urine
  3416-5: Buprenorphine [Mass/time] in 24 hour Urine
  34176-8: Tricyclic antidepressants [Presence] in Specimen
  34177-6: Opiates [Presence] in Specimen
  3419-9: Butabarbital [Presence] in Urine
  3425-6: Cannabinoids [Presence] in Serum or Plasma
  59625-4: chlordiazePOXIDE [Mass/mass] in Tissue by Confirmatory method
  59626-2: cloBAZam [Mass/volume] in Blood
  59629-6: cloBAZam [Mass/volume] in Body fluid by Confirmatory method
  59635-3: cloBAZam [Mass/volume] in Urine by Confirmatory method
  59636-1: clonazePAM [Mass/volume] in Blood
  59641-1: clonazePAM [Mass/mass] in Tissue
  59647-8: N-desalkylflurazepam [Mass/volume] in Blood
  59654-4: diazePAM [Mass/volume] in Blood
  59659-3: diazePAM [Mass/mass] in Stool by Confirmatory method
  59660-1: diazePAM [Mass/mass] in Tissue
  59669-2: Estazolam [Mass/mass] in Stool by Confirmatory method
  59677-5: Flurazepam [Mass/volume] in Body fluid by Confirmatory method
  59682-5: Hydroxyethylflurazepam [Mass/volume] in Blood
  59710-4: Midazolam [Mass/volume] in Body fluid by Confirmatory method
  59729-4: Oxazepam [Mass/mass] in Meconium by Confirmatory method
  59731-0: Oxazepam [Mass/mass] in Stool by Confirmatory method
  59734-4: Propoxyphene [Presence] in Serum or Plasma by Screen method
  59759-1: Triazolam [Mass/volume] in Blood by Confirmatory method
  59761-7: Triazolam [Mass/volume] in Body fluid by Confirmatory method
  59866-4: Amobarbital [Moles/volume] in Gastric fluid
  59876-3: carBAMazepine [Presence] in Gastric fluid
  59906-8: fluvoxaMINE [Moles/volume] in Urine
  59929-0: Methaqualone [Moles/volume] in Gastric fluid
  59943-1: Nordoxepin [Moles/volume] in Gastric fluid
  59946-4: OLANZapine [Moles/volume] in Gastric fluid
  59949-8: PARoxetine [Moles/volume] in Urine
  59961-3: Propoxyphene [Moles/volume] in Gastric fluid
  59975-3: traZODone [Moles/volume] in Urine
  59976-1: traZODone [Moles/volume] in Gastric fluid
  60063-5: buPROPion [Mass/mass] in Tissue
  67669-2: Alcohol - drug use NEMSIS
  70150-8: Opiates [Mass/volume] in Urine by Screen method
  70178-9: 11-Hydroxy delta-9 tetrahydrocannabinol [Presence] in Blood
  70206-8: Codeine [Moles/volume] in Urine by Confirmatory method
  72799-0: Norketamine [Mass/volume] in Urine by Confirmatory method
  72802-2: JWH-250 5-carboxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method
  72805-5: JWH-210 5-carboxypentyl (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine
  72808-9: JWH-018 carboxylated (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method
  72813-9: FLUoxetine/Creatinine [Mass Ratio] in Urine
  72815-4: DULoxetine/Creatinine [Mass Ratio] in Urine
  72818-8: AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine
  72875-8: JWH-073 butanol (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method
  72880-8: Deprecated CYP2D6 gene drug metabolism analysis overall interpretation [Interpretation] in Blood, Tissue or Saliva Qualitative by Molecular genetics method
  13560-8: fluvoxaMINE [Presence] in Serum or Plasma
  13570-7: Norclomipramine [Presence] in Serum or Plasma
  13573-1: Nordoxepin [Presence] in Serum or Plasma
  13575-6: Normaprotiline [Presence] in Serum or Plasma
  16144-8: Droperidol [Presence] in Serum or Plasma
  16181-0: Tricyclic antidepressants [Mass/volume] in Urine by Confirmatory method
  16184-4: Temazepam [Mass/volume] in Stool
  16193-5: PENTobarbital [Presence] in Urine by Confirmatory method
  16196-8: Morphine [Presence] in Urine by Confirmatory method
  16200-8: Propoxyphene [Presence] in Urine by Confirmatory method
  16204-0: clonazePAM [Presence] in Urine by Confirmatory method
  16206-5: Temazepam [Presence] in Urine by Confirmatory method
  16224-8: Triazolam [Presence] in Urine by Confirmatory method
  16233-9: Midazolam [Mass/volume] in Urine by Confirmatory method
  16254-5: Phencyclidine [Mass/volume] in Urine by Confirmatory method
  16281-8: traZODone [Units/volume] in Urine
  16334-5: Alfentanil [Mass/volume] in Urine
  16348-5: Alpha hydroxyalprazolam [Mass/volume] in Urine by Confirmatory method
  19055-3: Carboxy tetrahydrocannabinol/Creatinine [Mass Ratio] in Urine
  19138-7: Opiates cutoff [Mass/volume] in Urine
  19261-7: Amphetamines [Presence] in Urine by Screen method
  19267-4: Amphetamines cutoff [Mass/volume] in Urine for Confirmatory method
  19269-0: Amphetamines confirm method [Identifier] in Urine
  19270-8: Barbiturates [Presence] in Urine by Screen method
  19278-1: Barbiturates confirm method [Identifier] in Urine
  19282-3: Benzodiazepines positive [Identifier] in Urine by Confirmatory method
  19288-0: Cannabinoids tested for in Urine by Screen method Narrative
  19290-6: Cannabinoids positive [Identifier] in Urine by Confirmatory method
  19299-7: Opiates cutoff [Mass/volume] in Urine for Screen method
  19301-1: Opiates screen method [Identifier] in Urine
  19317-7: Tricyclic antidepressants cutoff [Mass/volume] in Urine for Screen method
  19318-5: Tricyclic antidepressants cutoff [Mass/volume] in Urine for Confirmatory method
  19336-7: Amitriptyline+Nortriptyline [Presence] in Urine by Confirmatory method
  19337-5: Amitriptyline+Nortriptyline cutoff [Mass/volume] in Urine for Screen method
  19339-1: Amobarbital [Presence] in Urine by Screen method
  27281-5: Propoxyphene [Mass/mass] in Stool
  27321-9: Opiates [Mass/volume] in Milk
  27324-3: Amobarbital [Mass/mass] in Meconium
  33280-9: Amphetamine+Methamphetamine [Mass/volume] in Urine by Screen method
  3333-2: Amitriptyline [Mass/volume] in Serum or Plasma
  59002-6: Deprecated Paliperidone [Mass/volume] in Serum or Plasma
  6691-0: Loxapine+8-Hydroxyamoxapine [Mass/volume] in Serum or Plasma
  6953-4: Zolpidem [Mass/volume] in Serum or Plasma
  74644-6: HYDROcodone [Presence] in Saliva (oral fluid) by Confirmatory method
  74645-3: HYDROmorphone [Presence] in Saliva (oral fluid) by Confirmatory method
  74648-7: Methylenedioxyamphetamine [Presence] in Saliva (oral fluid) by Confirmatory method
  74653-7: Methylenedioxymethamphetamine [Presence] in Saliva (oral fluid) by Confirmatory method
  74662-8: Sertraline [Mass/volume] in Urine
  74664-4: Zolpidem [Mass/volume] in Blood
  74670-1: Cocaine+Metabolites [Presence] in Saliva (oral fluid) by Confirmatory method
  74672-7: Carisoprodol+Meprobamate [Mass/volume] in Urine
  74681-8: Amphetamines [Presence] in Saliva (oral fluid) by Confirmatory method
  74760-0: HYDROcodone and metabolites panel - Urine by Confirmatory method
  72956-6: Sertraline induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  72967-3: QUEtiapine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  72973-1: PHENobarbital induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  72974-9: PHENobarbital induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73066-3: Amitriptyline induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  75766-6: fluPHENAZine [Presence] in Blood or Urine by Screen method
  75770-8: Thioridazine [Presence] in Blood or Urine by Screen method
  78363-9: Norhydrocodone [Presence] in Saliva (oral fluid) by Confirmatory method
  78438-9: Sertraline trough and Norsertraline panel - Serum or Plasma
  59352-5: Tapentadol [Mass/volume] in Blood
  59353-3: Tapentadol [Mass/volume] in Body fluid
  59354-1: Tapentadol [Mass/volume] in Serum or Plasma
  59594-2: 7-Aminoclonazepam [Mass/volume] in Body fluid by Confirmatory method
  59596-7: 7-Aminoclonazepam [Mass/mass] in Tissue
  59619-7: chlordiazePOXIDE [Mass/volume] in Body fluid
  64569-7: Which recreational drugs does your child use [PhenX]
  67033-1: How many times in the last year have you used marijuana [Denver Youth Survey]
  69797-9: 1-Hydroxymidazolam [Mass/volume] in Serum or Plasma
  70139-1: Barbiturates [Presence] in Urine by Screen method >300 ng/mL
  70144-1: Cannabinoids [Presence] in Urine by Screen method >20 ng/mL
  72380-9: LORazepam [Mass/volume] in Saliva (oral fluid)
  72386-6: 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Saliva (oral fluid) by Confirmatory method
  72407-0: Benzoylecgonine [Presence] in Blood by Screen method
  72451-8: Barbiturates [Presence] in Saliva (oral fluid) by Confirmatory method
  72455-9: Amobarbital [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  72456-7: Benzodiazepines [Presence] in Saliva (oral fluid) by Confirmatory method
  72461-7: JWH-018 pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
  72466-6: JWH-250 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
  72468-2: RCS-4 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
  72470-8: MAM-2201 pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
  72479-9: Drugs of abuse panel - Blood by Screen method
  72614-1: Oxazepam [Presence] in Saliva (oral fluid)
  72621-6: Propoxyphene [Mass/volume] in Saliva (oral fluid)
  72622-4: Propoxyphene [Presence] in Saliva (oral fluid)
  72656-2: risperiDONE [Mass/volume] in Serum or Plasma --trough
  72737-0: Cocaine [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  72743-8: Normeperidine [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  72747-9: N-nortramadol [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  72755-2: clonazePAM [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  72759-4: Codeine [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  72770-1: Zolpidem [Mass/volume] in Urine by Confirmatory method
  72772-7: O-desmethylvenlafaxine [Mass/volume] in Urine by Confirmatory method
  72792-5: Methylphenidate/Creatinine [Mass Ratio] in Urine
  74958-0: clomiPRAMINE [Mass/volume] in Serum or Plasma --trough
  74962-2: Maprotiline [Mass/volume] in Serum or Plasma --trough
  74965-5: Haloperidol [Mass/volume] in Serum or Plasma --trough
  75379-8: Norbuprenorphine [Mass/mass] in Meconium by Confirmatory method
  77731-8: oxyCODONE+oxyMORphone [Interpretation] in Serum, Plasma or Blood Qualitative by Confirmatory method
  77764-9: Buprenorphine cutoff [Mass/volume] in Urine for Confirmatory method
  29286-2: Methamphetamine [Presence] in Meconium
  29288-8: Orphenadrine [Presence] in Urine
  29326-6: Carboxy tetrahydrocannabinol [Mass/volume] in Gastric fluid
  29344-9: LORazepam [Mass/volume] in Gastric fluid
  29387-8: Norpropoxyphene [Mass/volume] in Gastric fluid
  29409-0: Desipramine [Mass/volume] in Gastric fluid
  29530-3: Amphetamines [Presence] in Specimen
  29598-0: Methylenedioxyamphetamine [Mass/volume] in Serum or Plasma by Confirmatory method
  29654-1: Temazepam [Moles/volume] in Serum or Plasma
  32051-5: Barbital [Presence] in Specimen
  32057-2: Butalbital [Presence] in Specimen
  32093-7: Methadone [Presence] in Specimen
  32107-5: Phencyclidine [Presence] in Specimen
  3491-8: clomiPRAMINE [Mass/volume] in Serum or Plasma
  3508-9: Codeine [Mass/volume] in Urine
  3509-7: Prochlorperazine [Mass/volume] in Serum or Plasma
  35121-3: E-10-Hydroxynortriptyline [Mass/volume] in Serum or Plasma
  35237-7: carBAMazepine [Mass or Moles/volume] in Serum or Plasma
  61029-5: 7-Aminoclonazepam [Presence] in Serum or Plasma
  61052-7: Norfentanyl [Presence] in Serum or Plasma
  61074-1: diazePAM [Presence] in Specimen
  61080-8: Flurazepam [Presence] in Specimen
  61081-6: Ketamine [Presence] in Gastric fluid
  61083-2: Methylenedioxymethamphetamine [Presence] in Gastric fluid
  61103-8: Prochlorperazine [Moles/volume] in Urine
  63644-9: Have you ever used any of these medicines or drugs [SSAGA II]
  63647-2: Did you ever use marijuana at least 21 times in a single year [SSAGA II]
  63649-8: Problem, related to marijuana use, that occurred for more than 24 hours to the point that it interfered with functioning or relationships [SSAGA II]
  63667-0: Have you ever tried to stop or cut down on this drug but found that you couldn't [SSAGA II]
  63669-6: Did you ever need larger amounts of this drug to get an effect or find that you could no longer get high on the amount you used to use [SSAGA II]
  63674-6: Problem when you stopped, cut down, or went without drugs after using drugs steadily [SSAGA II]
  63675-3: When you stopped, cut down, or went without drugs after using drugs steadily, did you ever experience this problem [SSAGA II]
  63678-7: Did you have to use this drug to make problems go away 3 or more times [SSAGA II]
  63681-1: Did using this drug cause you to have any other problems, like hepatitis [SSAGA II]
  65912-8: Agoraphobias [CIDI-SF]
  68441-5: Gamma hydroxybutyrate [Moles/volume] in Gastric fluid
  68525-5: In the past year, have you used drugs other than those required for medical reasons [SAMHSA]
  68526-3: Do you abuse more than one drug at a time [SAMHSA]
  68543-8: oxyCODONE [Mass/mass] in Meconium by Confirmatory method
  73662-9: Benzodiazepines panel - Saliva (oral fluid) by Screen method
  73663-7: Barbiturates panel - Saliva (oral fluid) by Confirmatory method
  73726-2: Lysergate diethylamide [Presence] in Hair
  73823-7: Cocaine+Benzoylecgonine [Presence] in Serum, Plasma or Blood by Screen method
  73927-6: JWH-073 butanoate (synthetic cannabinoid metabolite) [Presence] in Blood
  73929-2: JWH-250 5-carboxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood
  73936-7: fentaNYL [Presence] in Blood by Screen method
  73938-3: fentaNYL [Mass/volume] in Blood by Confirmatory method
  73941-7: 6-monoacetylmorphine free [Mass/volume] in Blood
  73947-4: JWH-398 (synthetic cannabinoid) [Presence] in Blood
  76492-8: Amphetamine+Methamphetamine [Presence] in Urine by Screen method
  79161-6: Nortriptyline and E-10-hydroxynortriptyline and Z-10-hydroxynortriptyline panel - Serum or Plasma
  3735-8: Maprotiline [Mass/volume] in Serum or Plasma
  3750-7: Mephobarbital [Mass/volume] in Serum or Plasma
  3753-1: Meprobamate [Mass/volume] in Serum or Plasma
  3772-1: Methadone [Mass/volume] in Serum or Plasma
  40381-6: Methamphetamine [Presence] in Specimen
  40421-0: Amphetamine+Methamphetamine [Presence] in Serum or Plasma
  40531-6: Methylenedioxyamphetamine [Presence] in Gastric fluid
  4062-6: Tranylcypromine [Mass/volume] in Urine
  40629-8: Doxepin [Presence] in Specimen
  4064-2: traZODone [Mass/volume] in Serum or Plasma
  4309-1: Mephobarbital [Mass] of Dose
  43122-1: Doxepin and Nordoxepin panel - Serum or Plasma
  4313-3: Mesoridazine [Mass] of Dose
  4323-2: Methocarbamol [Mass] of Dose
  4342-2: Nalbuphine [Mass] of Dose
  45948-7: Resident assessment protocol 17--Psychotropic drug - triggered [Minimum Data Set]
  45949-5: Resident assessment protocol 17--Psychotropic drug - proceed with care [Minimum Data Set]
  46227-5: DULoxetine [Mass/volume] in Serum or Plasma
  48937-7: Alpha hydroxyalprazolam [Mass/volume] in Specimen
  48942-7: Cannabinoids [Mass/volume] in Specimen
  48946-8: Cocaethylene [Mass/volume] in Specimen
  48950-0: Flurazepam [Mass/volume] in Specimen
  48954-2: Hydroxytriazolam [Mass/volume] in Specimen
  48955-9: LORazepam [Mass/volume] in Specimen
  48956-7: Methadone [Mass/volume] in Specimen by Confirmatory method
  49072-2: Cocaethylene [Presence] in Hair
  51738-3: HYDROcodone Free [Mass/volume] in Urine
  51765-6: Dihydrocodeine+Hydrocodol [Mass/volume] in Serum or Plasma
  51777-1: 7-Aminoflunitrazepam [Mass/volume] in Urine by Confirmatory method
  3710-1: Levorphanol [Mass/volume] in Serum or Plasma
  3719-2: Lithium [Mass/volume] in Serum or Plasma
  3722-6: Lithium renal clearance in 24 hour Urine and Serum or Plasma
  39795-0: Trifluoperazine [Moles/volume] in Serum or Plasma
  39799-2: risperiDONE [Moles/volume] in Serum or Plasma
  39800-8: risperiDONE+9-Hydroxyrisperidone [Moles/volume] in Serum or Plasma
  3999-0: Protriptyline [Mass/volume] in Serum or Plasma
  4000-6: Protriptyline [Presence] in Serum or Plasma
  40358-4: Desipramine [Presence] in Gastric fluid
  42586-8: Benzodiazepines [Mass/volume] in Blood by Confirmatory method
  42618-9: Naloxone [Presence] in Urine by Screen method
  42773-2: Multiple drug resistant organism identified in Urine
  42775-7: Multiple drug resistant organism identified in Sputum
  42860-7: Cannabinoids [Mass/volume] in Urine
  4298-6: Levorphanol [Mass] of Dose
  4303-4: Loxapine [Mass] of Dose
  48354-5: ARIPiprazole [Moles/volume] in Serum or Plasma
  53743-1: Cocaine metabolites.other [Mass/volume] in Urine
  53745-6: Benzodiazepines panel - Urine
  80970-7: Lithium free [Moles/volume] in Serum or Plasma
  81203-2: FDA product label Bulk ingredient - animal drug
  81273-5: fentaNYL and Norfentanyl panel - Specimen
  81276-8: Doxepin and Nordoxepin panel - Urine
  81279-2: Meperidine and Normeperidine panel - Specimen
  86607-9: Cocaine/Creatinine [Mass Ratio] in Urine by Confirmatory method
  89042-6: Eszopiclone [Mass/volume] in Urine
  89300-8: Tapentadol glucuronide [Presence] in Urine by Screen method
  89303-2: Noroxycodone [Presence] in Urine by Screen method
  10998-3: oxyCODONE [Presence] in Urine
  11073-4: Despropionylfentanyl [Mass/volume] in Urine
  11234-2: Propoxyphene [Mass/mass] in Hair
  10363-0: Barbiturates [Presence] in Specimen
  10529-6: Amoxapine metabolite [Mass/volume] in Serum or Plasma
  3636-8: fentaNYL [Mass/volume] in Serum or Plasma
  3651-7: fluPHENAZine [Mass/volume] in Urine
  3652-5: Flurazepam [Presence] in Serum or Plasma
  3653-3: Flurazepam [Mass/volume] in Serum or Plasma
  3935-4: Phencyclidine [Presence] in Serum or Plasma
  3947-9: PHENobarbital [Presence] in Serum or Plasma
  3948-7: PHENobarbital [Mass/volume] in Serum or Plasma
  4230-9: Doxepin [Mass] of Dose
  42523-1: Molindone [Mass/volume] in Urine
  45146-8: Triflupromazine [Presence] in Serum or Plasma
  47980-8: Mirtazapine [Presence] in Serum or Plasma
  50574-3: FDA product label OTC Type B medicated feed animal drug label
  50575-0: FDA product label VFD Type A medicated article animal drug label
  50577-6: FDA product label OTC animal drug label
  50620-4: Opiates cutoff [Mass/mass] in Meconium for Confirmatory method
  3581-6: Doxepin [Mass/volume] in Urine
  3903-2: Para hydroxyamphetamine [Mass/time] in 24 hour Urine
  3925-5: PENTobarbital [Presence] in Urine
  3926-3: PENTobarbital [Mass/volume] in Urine
  4175-6: chlordiazePOXIDE [Mass] of Dose
  4452-9: Triazolam [Mass] of Dose
  50148-6: Gamma hydroxybutyrate [Moles/volume] in Amniotic fluid
  50406-8: Cannabinoids [Presence] in Meconium by Confirmatory method
  52830-7: State, district or territory federal abbreviation Facility
  52953-7: Cocaine [Moles/volume] in Urine
  52957-8: Amphetamine [Moles/volume] in Urine
  52958-6: Methadone [Moles/volume] in Urine
  55527-6: buPROPion [Moles/volume] in Serum or Plasma
  55549-0: Methocarbamol [Moles/volume] in Serum or Plasma
  55564-9: Pentazocine [Moles/volume] in Serum or Plasma
  80117-5: 7-Aminoflunitrazepam [Mass/volume] in Body fluid by Confirmatory method
  80135-7: Amphetamine [Mass/volume] in Body fluid by Confirmatory method
  80144-9: Ecgonine methyl ester [Presence] in Urine by Screen method
  80238-9: Drug given for spasm stress test [Identifier]
  82664-4: Drug Abuse Screening Test [DAST]
  82723-8: Cocaine+Benzoylecgonine+Cocaethylene [Presence] in Urine by Confirmatory method
  82880-6: Escitalopram+norescitalopram [Mass/volume] in Serum or Plasma
  82973-9: Amobarbital [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
  90894-7: Noroxymorphone [Mass/volume] in Urine by Confirmatory method
  91029-9: Cocaine+Benzoylecgonine [Presence] in Meconium by Screen method
  91032-3: oxyCODONE+oxyMORphone [Presence] in Meconium by Screen method
  91035-6: Phencyclidine [Presence] in Tissue by Screen method
  91040-6: Phencyclidine [Presence] in Body fluid by Screen method
  91046-3: Methadone+Metabolite [Presence] in Hair by Screen method
  91050-5: Methadone+Metabolite [Presence] in Tissue by Screen method
  91052-1: Opiates [Presence] in Tissue by Screen method
  9325-2: Tryptophan [Moles/volume] in 24 hour Urine
  93346-5: Genetic variant effect on drug sensitivity in Blood or Tissue Narrative
  93461-2: 4-Methoxybutyrylfentanyl [Mass/volume] in Urine by Confirmatory method
  93469-5: 4-Fluorobutyrylfentanyl [Mass/volume] in Urine by Confirmatory method
  93472-9: 4-Methylphenethylacetylfentanyl [Mass/volume] in Urine by Confirmatory method
  28041-2: Gamma hydroxybutyrate [Mass/volume] in Serum or Plasma
  28065-1: Deprecated Gamma hydroxybutyrate [Mass/volume] in Urine
  3072-6: Tryptophan [Mass/volume] in Urine
  3339-9: Amobarbital [Presence] in Urine
  3372-0: Barbiturate screen absent [Identifier] in Urine
  13498-1: Dextromethamphetamine/Levomethamphetamine [Mass Ratio] in Urine
  13545-9: ALPRAZolam [Presence] in Serum or Plasma
  13549-1: clomiPRAMINE [Presence] in Serum or Plasma
  13565-7: LORazepam [Presence] in Serum or Plasma
  13572-3: Nordiazepam [Presence] in Serum or Plasma
  13577-2: PARoxetine [Presence] in Serum or Plasma
  13578-0: Promazine [Presence] in Serum or Plasma
  16115-8: Doxepin [Mass/mass] in Tissue
  16197-6: Codeine [Presence] in Urine by Confirmatory method
  16202-4: Nordiazepam [Presence] in Urine by Confirmatory method
  16205-7: LORazepam [Presence] in Urine by Confirmatory method
  16214-9: Lysergate diethylamide [Presence] in Urine by Confirmatory method
  16225-5: Amitriptyline [Presence] in Urine by Confirmatory method
  16228-9: Nordiazepam [Mass/volume] in Urine by Confirmatory method
  16239-6: Amobarbital [Mass/volume] in Urine by Confirmatory method
  16240-4: PENTobarbital [Mass/volume] in Urine by Confirmatory method
  19141-1: Propoxyphene [Presence] in Urine
  19144-5: Reason for drug test [Interpretation]
  19247-6: Doxepin+Metabolites [Mass/volume] in Urine
  19266-6: Amphetamines cutoff [Mass/volume] in Urine for Screen method
  19286-4: Benzodiazepines confirm method [Identifier] in Urine
  19287-2: Cannabinoids tested for in Urine by Screen method Nominal
  19291-4: Cannabinoids cutoff [Mass/volume] in Urine for Screen method
  19293-0: Cannabinoids screen method [Identifier] in Urine
  19294-8: Cannabinoids confirm method [Identifier] in Urine
  19296-3: Opiates tested for in Urine by Screen method Nominal
  19315-1: Tricyclic antidepressants [Presence] in Urine by Confirmatory method
  19316-9: Tricyclic antidepressants positive [Identifier] in Urine by Confirmatory method
  19319-3: Tricyclic antidepressants screen method [Identifier] in Urine
  19322-7: 6-Monoacetylmorphine (6-MAM) [Presence] in Urine by Confirmatory method
  19331-8: Amitriptyline [Presence] in Urine by Screen method
  19338-3: Amitriptyline+Nortriptyline cutoff [Mass/volume] in Urine for Confirmatory method
  21888-3: Summary stage abbreviated at Dx Cancer
  24349-3: Drugs of abuse 5 panel - Urine
  27285-6: Estazolam [Mass/mass] in Stool
  27286-4: Triazolam [Mass/mass] in Stool
  27287-2: Flurazepam [Mass/mass] in Stool
  27288-0: Midazolam [Mass/mass] in Stool
  27289-8: Methamphetamine [Mass/mass] in Meconium
  27293-0: oxyCODONE Free [Mass/mass] in Stool
  27308-6: PENTobarbital [Mass/mass] in Meconium
  27334-2: Tryptophan [Units/volume] in Serum or Plasma
  27357-3: HYDROcodone Free [Mass/volume] in Vitreous fluid
  3307-6: Alfentanil [Mass/volume] in Serum or Plasma
  3313-4: ALPRAZolam [Mass/volume] in Urine
  33301-3: Norchlordiazepoxide [Presence] in Urine by Screen method
  3335-7: Amitriptyline+Nortriptyline [Mass/volume] in Serum or Plasma
  6930-2: Psilocybin [Mass/volume] in Urine
  6946-8: Imipramine [Mass/volume] in Specimen
  74649-5: Methylenedioxyethylamphetamine [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  74652-9: Methylenedioxymethamphetamine [Mass/volume] in Serum, Plasma or Blood
  59884-7: chlorproMAZINE [Moles/volume] in Urine
  59885-4: chlorproMAZINE [Moles/volume] in Gastric fluid
  59886-2: Citalopram [Moles/volume] in Urine
  59887-0: Citalopram [Moles/volume] in Gastric fluid
  59889-6: clomiPRAMINE [Moles/volume] in Gastric fluid
  59952-2: Pentazocine [Moles/volume] in Gastric fluid
  59960-5: Propoxyphene [Moles/volume] in Urine
  59963-9: QUEtiapine [Moles/volume] in Urine
  59977-9: Venlafaxine [Moles/volume] in Urine
  60086-6: Hydroxybupropion [Mass/volume] in Urine
  70149-0: Methadone [Presence] in Urine by Screen method >300 ng/mL
  70197-9: 6-Monoacetylmorphine (6-MAM) [Moles/volume] in Urine by Confirmatory method
  70214-2: Oxazepam [Moles/volume] in Urine by Confirmatory method
  72801-4: Ketamine/Creatinine [Mass Ratio] in Urine
  72804-8: JWH-210 5-carboxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method
  72811-3: Gabapentin/Creatinine [Mass Ratio] in Urine
  72817-0: AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method
  72874-1: JWH-073 butanol (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine
  72908-7: Drug induced platelet Ab panel - Serum or Plasma
  73051-5: buPROPion induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73162-0: risperiDONE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73183-6: QUEtiapine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  75648-6: Methylenedioxymethamphetamine+Methylenedioxyamphetamine [Presence] in Blood
  75768-2: Prochlorperazine [Presence] in Blood or Urine by Screen method
  78364-7: Amphetamine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
  78434-8: carBAMazepine free and total trough and 10,11-Epoxide panel - Serum or Plasma
  78440-5: risperiDONE trough and 9-Hydroxyrisperidone panel - Serum or Plasma
  59171-9: Norclozapine [Presence] in Urine
  59174-3: QUEtiapine [Presence] in Urine
  59209-7: Gamma hydroxybutyrate [Moles/volume] in Serum or Plasma
  59311-1: Milnacipran [Mass/volume] in Serum or Plasma
  59312-9: Milnacipran [Mass/volume] in Urine
  59588-4: 1-Hydroxymidazolam [Mass/mass] in Meconium
  59597-5: 7-Aminoclonazepam [Mass/mass] in Tissue by Confirmatory method
  59600-7: Alpha hydroxyalprazolam [Mass/volume] in Blood by Confirmatory method
  59616-3: Benzoylecgonine [Mass/volume] in Serum or Plasma by Confirmatory method
  6696-9: Thiothixene [Mass/volume] in Serum or Plasma
  69798-7: 2,5-dimethoxy-4-bromoamphetamine [Presence] in Urine
  72378-3: Oxazepam [Mass/volume] in Saliva (oral fluid)
  72388-2: Methadone [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  72398-1: Butalbital [Mass/volume] in Blood by Confirmatory method
  72399-9: Amobarbital [Mass/volume] in Blood by Confirmatory method
  72459-1: JWH-018 4/5-hydroxypentyl (synthetic cannabinoid metabolites) [Presence] in Urine by Confirmatory method
  72462-5: JWH-200 4-hydroxyindole (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
  72467-4: JWH-250 5-carboxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
  72471-6: UR-144 4/5-hydroxypentyl (synthetic cannabinoid metabolites) [Presence] in Urine by Confirmatory method
  72485-6: Tapentadol [Presence] in Urine by Screen method
  72609-1: Nonsteroidal antiinflammatory drugs [Presence] in Serum or Plasma by Screen method
  72613-3: Oxazepam [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  72615-8: Nordiazepam [Presence] in Saliva (oral fluid)
  72616-6: Benzodiazepines [Presence] in Saliva (oral fluid)
  29278-9: Codeine [Presence] in Meconium
  29323-3: Cocaine [Mass/volume] in Gastric fluid
  29345-6: 6-Monoacetylmorphine (6-MAM) [Mass/mass] in Meconium
  29372-0: Codeine [Mass/volume] in Gastric fluid
  29385-2: Nordiazepam [Mass/volume] in Gastric fluid
  29386-0: chlorproMAZINE [Mass/volume] in Gastric fluid
  29407-4: Nortriptyline [Mass/volume] in Gastric fluid
  29655-8: Oxazepam [Moles/volume] in Serum or Plasma
  32072-1: FLUoxetine [Presence] in Specimen
  32073-9: fluvoxaMINE [Moles/volume] in Serum or Plasma
  32074-7: fluvoxaMINE [Presence] in Urine
  32075-4: fluvoxaMINE [Presence] in Specimen
  32081-2: HYDROmorphone [Presence] in Specimen
  32087-9: Loxapine [Moles/volume] in Serum or Plasma
  32089-5: Mephobarbital [Moles/volume] in Serum or Plasma
  32105-9: Perphenazine [Presence] in Urine
  32129-9: risperiDONE [Presence] in Urine
  32130-7: risperiDONE [Presence] in Specimen
  3505-5: Codeine [Presence] in Serum or Plasma
  3506-3: Codeine [Mass/volume] in Serum or Plasma
  3507-1: Codeine [Presence] in Urine
  35108-0: Normaprotiline [Mass/volume] in Serum or Plasma
  60677-2: Alpha hydroxytriazolam [Mass/volume] in Urine
  61034-5: 7-Aminoflunitrazepam [Presence] in Specimen
  61036-0: Alpha hydroxyalprazolam [Presence] in Urine
  61040-2: N-desalkylflurazepam [Presence] in Urine
  61046-9: Methylenedioxyamphetamine [Presence] in Specimen
  61073-3: ALPRAZolam [Presence] in Gastric fluid
  61084-0: Methylphenidate [Presence] in Gastric fluid
  61091-5: Temazepam [Presence] in Gastric fluid
  61093-1: Triazolam [Presence] in Specimen
  61105-3: Prochlorperazine [Moles/volume] in Gastric fluid
  63643-1: Drug type used in your lifetime
  63656-3: Did you ever need larger amounts of marijuana to get an effect, or did you ever find that you could no longer get high on the amount you used to use [SSAGA II]
  63657-1: When you stopped, cut down, or went without marijuana, did you ever experience any of these problems for most of the day for 2 days or longer [SSAGA II]
  63659-7: Did using marijuana, to keep from having any of these problems, happen 3 or more times [SSAGA II]
  63668-8: Were you unable to stop or cut down 3 or more times on this drug [SSAGA II]
  63683-7: Did using this drug cause you to have any other serious health problems [SSAGA II]
  63687-8: Which specific drug of this type did you use [SSAGA II]
  68439-9: Gabapentin [Presence] in Urine
  73564-7: Alpha hydroxytriazolam [Mass/mass] in Meconium by Confirmatory method
  73660-3: Propoxyphene panel - Saliva (oral fluid)
  73661-1: Methadone panel - Saliva (oral fluid) by Screen method
  73753-6: oxyCODONE [Presence] in Hair
  73826-0: Flurazepam+N-desalkylflurazepam [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
  73828-6: Flunitrazepam [Mass/volume] in Serum, Plasma or Blood
  73928-4: JWH-250 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood
  73933-4: Normeperidine [Mass/volume] in Serum, Plasma or Blood
  73944-1: MAM-2201 (synthetic cannabinoid) [Presence] in Blood
  73946-6: JWH-200 (synthetic cannabinoid) [Presence] in Blood
  73949-0: JWH-018 (synthetic cannabinoid) [Presence] in Blood
  73950-8: JWH-250 (synthetic cannabinoid) [Presence] in Blood
  73951-6: RCS-4 (synthetic cannabinoid) [Presence] in Blood
  73952-4: AM-2201 (synthetic cannabinoid) [Presence] in Blood
  10915-7: Phencyclidine [Mass/volume] in Specimen
  11092-4: Barbiturates [Mass/mass] in Hair
  11243-3: Methadone [Mass/mass] in Hair
  11244-1: Morphine Free [Mass/volume] in Serum or Plasma
  11247-4: oxyMORphone [Presence] in Urine
  10530-4: Aprobarbital [Mass/volume] in Serum or Plasma
  3640-0: Flunitrazepam [Mass/volume] in Blood
  3643-4: FLUoxetine [Presence] in Serum or Plasma
  3928-9: Perphenazine [Mass/volume] in Urine
  3937-0: Phencyclidine [Mass/volume] in Urine
  39487-4: PHENobarbital [Moles/volume] in Urine
  4213-5: Nordiazepam [Mass] of Dose
  45129-4: FDA product label Human prescription drug label with highlights
  45185-6: 2-Oxo-3-Hydroxy-Lysergate diethylamide [Mass/volume] in Urine
  45320-9: Ecgonine methyl ester [Presence] in Serum or Plasma by Confirmatory method
  50572-7: FDA product label VFD Type B medicated feed animal drug label
  50844-0: cloZAPine [Moles/volume] in Urine
  50849-9: diazePAM+Nordiazepam [Moles/volume] in Serum or Plasma
  50891-1: OLANZapine [Moles/volume] in Urine
  3579-0: Doxepin [Mass/volume] in Serum or Plasma
  3583-2: Doxepin+Metabolites [Mass/volume] in Serum or Plasma
  3915-6: Pentazocine [Presence] in Serum or Plasma
  3919-8: Pentazocine [Mass/time] in 24 hour Urine
  3924-8: PENTobarbital [Mass/volume] in Serum or Plasma
  3927-1: Perphenazine [Mass/volume] in Serum or Plasma
  4449-5: Tranylcypromine [Mass] of Dose
  4450-3: traZODone [Mass] of Dose
  4453-7: Trimeperidine [Mass] of Dose
  44907-4: 5-Hydroxyindoleacetate panel - 24 hour Urine
  47411-4: Methadone [Presence] in Serum or Plasma by Confirmatory method
  47414-8: Pregabalin [Mass/volume] in Serum or Plasma
  47542-6: Gamma hydroxybutyrate/Creatinine [Molar ratio] in Urine
  47545-9: 5-Hydroxyindoleacetate/Creatinine [Molar ratio] in 24 hour Urine
  50338-3: Cannabinoids [Mass/volume] in Dialysis fluid
  52946-1: diazePAM [Presence] in Gastric fluid
  52950-3: Barbital [Presence] in Gastric fluid
  52952-9: Opiates [Moles/volume] in Urine
  52955-2: Benzodiazepines [Moles/volume] in Urine
  52956-0: Barbiturates [Moles/volume] in Urine
  52965-1: clonazePAM [Presence] in Gastric fluid
  55559-9: Norpropoxyphene [Moles/volume] in Serum or Plasma
  80114-2: 2-Oxo-3-Hydroxy-Lysergate diethylamide [Mass/volume] in Blood by Confirmatory method
  80128-2: Amisulpride [Mass/mass] in Hair
  80149-8: Tricyclic antidepressants [Presence] in Urine by Screen method >1000 ng/mL
  80193-6: Ecgonine methyl ester [Mass/volume] in Blood by Confirmatory method
  82965-5: Methylenedioxyethylamphetamine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
  82972-1: Butabarbital [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
  82974-7: O-nortramadol [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
  90750-1: O-nortramadol [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  90890-5: Benzodiazepines panel - Urine by Confirmatory method
  91047-1: Barbiturates [Presence] in Hair by Screen method
  91051-3: Methamphetamine+Methylenedioxymethamphetamine [Presence] in Tissue by Screen method
  91054-7: Drugs of abuse panel - Body fluid
  93719-3: traMADol [Presence] in Meconium by Screen method
  93722-7: N-nortramadol [Mass/mass] in Meconium by Confirmatory method
  9625-5: Amoxapine+8-Hydroxyamoxapine [Mass/volume] in Serum or Plasma
  59699-9: LORazepam [Mass/volume] in Blood
  59722-9: Nordiazepam [Mass/mass] in Stool by Confirmatory method
  59723-7: Nordiazepam [Mass/mass] in Tissue
  59732-8: Oxazepam [Mass/mass] in Tissue
  59746-8: Temazepam [Mass/volume] in Blood by Confirmatory method
  59750-0: Temazepam [Mass/volume] in Serum or Plasma by Confirmatory method
  59752-6: Temazepam [Mass/mass] in Tissue
  59757-5: tiZANidine [Mass/volume] in Blood
  59758-3: Triazolam [Mass/volume] in Blood
  59837-5: Methylenedioxyamphetamine [Mass/volume] in Serum or Plasma
  59868-0: Amoxapine [Moles/volume] in Gastric fluid
  59888-8: cloBAZam [Moles/volume] in Urine
  59950-6: PARoxetine [Moles/volume] in Gastric fluid
  59956-3: Phencyclidine [Moles/volume] in Serum or Plasma
  59959-7: Promazine [Moles/volume] in Gastric fluid
  59964-7: QUEtiapine [Moles/volume] in Gastric fluid
  60043-7: Acepromazine [Mass/volume] in Blood
  60044-5: Acepromazine [Mass/volume] in Urine
  60071-8: 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/volume] in Serum or Plasma
  60085-8: Hydroxybupropion [Mass/mass] in Tissue
  70155-7: Barbiturates [Presence] in Urine by Screen method >200 ng/mL
  70205-0: clonazePAM [Moles/volume] in Serum or Plasma by Screen method
  72957-4: risperiDONE induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  72968-1: QUEtiapine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  72993-9: Methylphenidate induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73025-9: Escitalopram induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73026-7: Escitalopram induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73049-9: carBAMazepine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73052-3: buPROPion induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73075-4: Drug induced neutrophil Ab [Interpretation] in Serum or Plasma by Flow cytometry (FC) Narrative
  75760-9: Haloperidol [Presence] in Blood or Urine by Screen method
  75771-6: Trifluoperazine [Presence] in Blood or Urine by Screen method
  75815-1: Antipsychotics drug panel - Blood or Urine by Screen method
  78435-5: Mirtazapine trough and Normirtazapine panel - Serum or Plasma
  59169-3: buPROPion [Presence] in Urine
  59289-9: Iloperidone [Mass/volume] in Blood
  59290-7: Iloperidone [Mass/volume] in Serum or Plasma
  59309-5: Metaxalone [Mass/volume] in Urine
  5937-8: Deprecated Cocaine [Mass/volume] in Urine
  5941-0: Deprecated Cocaine [Mass/volume] in Serum or Plasma
  59573-6: Cannabinoids [Presence] in Gastric fluid
  59604-9: Alpha hydroxyalprazolam [Mass/volume] in Serum or Plasma by Confirmatory method
  59611-4: ALPRAZolam [Mass/volume] in Serum or Plasma by Confirmatory method
  59615-5: ALPRAZolam [Mass/volume] in Urine by Confirmatory method
  59618-9: chlordiazePOXIDE [Mass/volume] in Blood by Confirmatory method
  64576-2: Has your child ever taken Ritalin, methylphenidate, for behavioral problems [PhenX]
  64590-3: How often does your child use recreational drugs [PhenX]
  66981-2: How many times in the last year have you sold hard drugs such as heroin, cocaine, and LSD [Denver Youth Survey]
  6706-6: buPROPion [Mass/volume] in Serum or Plasma
  69739-1: Drugs of abuse panel - Urine by Screen method
  70140-9: Benzodiazepines [Mass/volume] in Urine by Screen method
  70142-5: Benzodiazepines [Presence] in Urine by Screen method >300 ng/mL
  3728-3: Loxapine [Mass/volume] in Serum or Plasma
  3731-7: Lysergate diethylamide [Mass/volume] in Serum or Plasma
  3733-3: Deprecated Lysergate diethylamide [Mass/volume] in Urine
  3745-7: Meperidine [Mass/volume] in Serum or Plasma
  3747-3: Meperidine [Mass/volume] in Urine
  3760-6: Mesoridazine [Mass/volume] in Serum or Plasma
  3771-3: Methadone [Presence] in Serum or Plasma
  3773-9: Methadone [Presence] in Urine
  3774-7: Methadone [Mass/volume] in Urine
  3775-4: Methadone [Mass/time] in 24 hour Urine
  3778-8: Methamphetamine [Mass/volume] in Serum or Plasma
  40382-4: Methaqualone [Presence] in Gastric fluid
  40402-0: traZODone [Presence] in Gastric fluid
  40464-0: Drugs identified in Urine by Confirmatory method
  4051-9: Deprecated Thioridazine [Mass/volume] in Serum or Plasma
  4052-7: Thioridazine [Mass/volume] in Serum or Plasma
  40529-0: Amphetamines [Presence] in Hair
  40634-8: HYDROcodone [Presence] in Gastric fluid
  4318-2: Methadone [Mass] of Dose
  43194-0: Gamma hydroxybutyrate [Mass/volume] in Serum or Plasma by Confirmatory method
  43197-3: Gamma hydroxybutyrate [Presence] in Urine by Screen method
  43219-5: traMADol [Presence] in Urine
  43230-2: Benzoylecgonine [Mass/volume] in Specimen
  46256-4: oxyCODONE Free [Presence] in Serum or Plasma by Screen method
  46258-0: oxyMORphone Free [Presence] in Serum or Plasma by Screen method
  48944-3: Carboxy tetrahydrocannabinol [Mass/volume] in Specimen
  48947-6: Cocaine [Presence] in Specimen by Confirmatory method
  48957-5: Methadone [Mass/volume] in Specimen
  48958-3: Midazolam [Mass/volume] in Specimen
  49046-6: Drugs of abuse panel - Meconium
  51690-6: Amphetamines [Presence] in Blood by Screen method
  51736-7: oxyMORphone Free [Mass/volume] in Urine
  51740-9: 6-monoacetylmorphine free [Mass/volume] in Urine
  56993-9: Tryptophan/Creatinine [Ratio] in 24 hour Urine
  5706-7: Opiates [Identifier] in Urine
  57255-2: Drug regimen review identified potential medication issues [CMS Assessment]
  57301-4: Benzoylecgonine [Mass/volume] in Saliva (oral fluid)
  3680-6: HYDROcodone [Mass/volume] in Serum or Plasma
  3690-5: Imipramine [Mass/volume] in Serum or Plasma
  3692-1: Imipramine [Mass/volume] in Urine
  3709-3: Deprecated Levomepromazine [Mass/volume] in Urine
  3724-2: LORazepam [Mass/volume] in Serum or Plasma
  4263-0: fluPHENAZine [Mass] of Dose
  42630-4: Cannabinoids [Presence] in Blood
  4272-1: Haloperidol [Mass] of Dose
  4297-8: Deprecated Levomepromazine [Mass] of Dose
  48349-5: Pregabalin [Moles/volume] in Serum or Plasma
  48350-3: Venlafaxine+O-desmethylvenlafaxine [Moles/volume] in Serum or Plasma
  48355-2: traMADol [Moles/volume] in Serum or Plasma
  53787-8: Zolpidem [Presence] in Urine by Confirmatory method
  53796-9: Interferon drug given [Identifier]
  53881-9: Norbuprenorphine [Mass/volume] in Serum or Plasma
  56704-0: Droperidol IgE Ab [Units/volume] in Serum
  5679-6: Lysergate diethylamide [Mass/volume] in Urine
  81204-0: FDA product label NDC labeler code inactivation - animal drug
  81208-1: Amitriptyline and Nortriptyline panel - Urine
  81278-4: Meperidine and Normeperidine panel - Gastric fluid
  59695-7: Hydroxytriazolam [Mass/mass] in Tissue
  59701-3: LORazepam [Mass/volume] in Body fluid
  59702-1: LORazepam [Mass/volume] in Body fluid by Confirmatory method
  59711-2: Midazolam [Mass/volume] in Serum or Plasma by Confirmatory method
  59713-8: Midazolam [Mass/mass] in Tissue by Confirmatory method
  59718-7: Nordiazepam [Mass/volume] in Body fluid
  59725-2: Oxazepam [Mass/volume] in Blood
  59747-6: Temazepam [Mass/volume] in Body fluid
  59760-9: Triazolam [Mass/volume] in Body fluid
  59767-4: Ziprasidone [Mass/volume] in Blood
  59844-1: Methylenedioxyethylamphetamine [Presence] in Urine by Screen method
  59867-2: Amoxapine [Moles/volume] in Urine
  59893-8: Desipramine [Moles/volume] in Gastric fluid
  59903-5: FLUoxetine [Moles/volume] in Gastric fluid
  59907-6: fluvoxaMINE [Moles/volume] in Gastric fluid
  59924-1: Meperidine [Moles/volume] in Serum or Plasma
  59925-8: Mesoridazine [Moles/volume] in Urine
  59942-3: Nordoxepin [Moles/volume] in Urine
  59947-2: OXcarbazepine [Moles/volume] in Urine
  59978-7: Venlafaxine [Moles/volume] in Gastric fluid
  62885-9: Deprecated PhenX measure - injection drug use
  67682-5: Family history of Drug - alcohol problem [PhenX]
  70147-4: Methadone [Mass/volume] in Urine by Screen method
  70151-6: Opiates [Presence] in Urine by Screen method >300 ng/mL
  72803-0: JWH-250 5-carboxypentyl (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine
  72806-3: JWH-073 carboxylated (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method
  72809-7: JWH-018 carboxylated (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine
  72825-3: Phencyclidine [Mass/volume] in Urine by Screen method
  72877-4: Deprecated CYP2B6 gene drug metabolism analysis overall interpretation [Interpretation] in Blood, Tissue or Saliva Qualitative by Molecular genetics method
  72909-5: Drug induced neutrophil Ab panel - Serum or Plasma
  72931-9: Venlafaxine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  72955-8: Sertraline induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  72983-0: OLANZapine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  72994-7: Methylphenidate induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73016-8: Gabapentin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73035-8: Citalopram induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73036-6: Citalopram induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73085-3: Venlafaxine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73103-4: Triazolam induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73108-3: traMADol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73188-5: Propoxyphene+Acetaminophen induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  75645-2: Butabarbital [Mass/volume] in Blood by Confirmatory method
  75767-4: Mesoridazine [Presence] in Blood or Urine by Screen method
  75769-0: Promazine [Presence] in Blood or Urine by Screen method
  78362-1: Imipramine+Desipramine [Mass/volume] in Serum or Plasma --trough
  78365-4: Imipramine trough, Imipramine+desimipramine trough and Desipramine panell - Serum or Plasma
  59170-1: Citalopram [Presence] in Urine
  59307-9: Metaxalone [Mass/volume] in Blood
  59308-7: Metaxalone [Mass/volume] in Serum or Plasma
  59310-3: Milnacipran [Mass/volume] in Blood
  59355-8: Tapentadol [Mass/mass] in Tissue
  13478-3: Tetrahydrocannabinol/Creatinine [Mass Ratio] in Urine
  13479-1: Benzoylecgonine/Creatinine [Mass Ratio] in Urine
  13497-3: Dextroamphetamine/Levoamphetamine [Mass Ratio] in Urine
  13580-6: Temazepam [Presence] in Serum or Plasma
  16171-1: Cocaethylene [Mass/mass] in Hair
  16192-7: PHENobarbital [Presence] in Urine by Confirmatory method
  16194-3: Secobarbital [Presence] in Urine by Confirmatory method
  16195-0: Benzodiazepines [Presence] in Urine by Confirmatory method
  16198-4: Diamorphine [Presence] in Urine by Confirmatory method
  16201-6: Oxazepam [Mass/volume] in Urine by Confirmatory method
  16211-5: Dihydrocodeine [Presence] in Urine by Confirmatory method
  16235-4: Methamphetamine [Mass/volume] in Urine by Confirmatory method
  16238-8: Secobarbital [Mass/volume] in Urine by Confirmatory method
  16244-6: Methaqualone [Mass/volume] in Urine by Confirmatory method
  16246-1: Methadone [Mass/volume] in Urine by Confirmatory method
  16252-9: HYDROcodone [Mass/volume] in Urine by Confirmatory method
  19064-5: Benzodiazepines cutoff [Mass/volume] in Urine
  19073-6: Cannabinoids cutoff [Mass/volume] in Urine
  19245-0: clonazePAM [Presence] in Urine
  19268-2: Amphetamines screen method [Identifier] in Urine
  19271-6: Barbiturates tested for in Urine by Screen method Nominal
  19272-4: Barbiturates tested for in Urine by Screen method Narrative
  19275-7: Barbiturates cutoff [Mass/volume] in Urine for Screen method
  19295-5: Opiates [Presence] in Urine by Screen method
  19313-6: Tricyclic antidepressants tested for in Urine by Screen method Nominal
  19320-1: Tricyclic antidepressants confirm method [Identifier] in Urine
  19321-9: 6-Monoacetylmorphine (6-MAM) [Presence] in Urine by Screen method
  19326-8: Alpha hydroxyalprazolam [Presence] in Urine by Confirmatory method
  19328-4: Alpha hydroxyalprazolam [Mass/volume] in Urine
  19333-4: Amitriptyline cutoff [Mass/volume] in Urine for Screen method
  27347-4: Methaqualone [Mass/volume] in Vitreous fluid
  27356-5: Phencyclidine [Mass/volume] in Vitreous fluid
  27358-1: Benzoylecgonine [Mass/volume] in Vitreous fluid
  27436-5: N-desalkylflurazepam [Mass/mass] in Stool
  3312-6: ALPRAZolam [Mass/volume] in Serum or Plasma
  3332-4: Amitriptyline [Presence] in Serum or Plasma
  33339-3: Zolpidem [Mass/volume] in Urine
  58738-6: Drugs of abuse [Interpretation] in Meconium
  74545-5: Tryptophan-related indole profiling panel - Platelet rich plasma
  74647-9: Methylenedioxyamphetamine [Mass/volume] in Serum, Plasma or Blood
  74651-1: Methylenedioxymethamphetamine [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  74654-5: Morphine [Presence] in Saliva (oral fluid) by Confirmatory method
  74671-9: Cocaine [Presence] in Saliva (oral fluid) by Confirmatory method
  74677-6: 6-Monoacetylmorphine (6-MAM) [Presence] in Saliva (oral fluid) by Confirmatory method
  74679-2: Benzoylecgonine [Presence] in Saliva (oral fluid) by Confirmatory method
  74767-5: Tryptophan [Moles/volume] in Platelet rich plasma
  74768-3: 5-Hydroxytryptophan [Moles/volume] in Platelet rich plasma
  74921-8: Deprecated Norclobazam [Mass/volume] in Serum or Plasma --trough
  74931-7: ARIPiprazole [Mass/volume] in Serum or Plasma --trough
  77320-0: Benzoylecgonine [Moles/volume] in Specimen
  77323-4: diazePAM [Moles/volume] in Specimen
  77328-3: Methadone [Moles/volume] in Specimen
  77364-8: Tryptophan, kynurenin and 3-hydroxykynurenin panel - Serum or Plasma
  58359-1: Buprenorphine+Norbuprenorphine [Presence] in Urine by Screen method
  29356-3: fentaNYL [Presence] in Serum or Plasma
  29371-2: cloZAPine [Mass/volume] in Serum or Plasma --peak
  29376-1: Narcotics and opioids [Identifier] in Blood
  29380-3: chlordiazePOXIDE [Mass/volume] in Gastric fluid
  29388-6: Methaqualone [Mass/volume] in Gastric fluid
  29399-3: clonazePAM [Mass/volume] in Gastric fluid
  29406-6: Amitriptyline [Mass/volume] in Gastric fluid
  29619-4: Methylenedioxymethamphetamine [Mass/volume] in Serum or Plasma by Confirmatory method
  32050-7: Barbital [Moles/volume] in Serum or Plasma
  32055-6: Butalbital [Moles/volume] in Serum or Plasma
  32058-0: carBAMazepine free [Moles/volume] in Serum or Plasma
  32061-4: chlorproMAZINE [Presence] in Specimen
  32096-0: Methaqualone [Presence] in Specimen
  32099-4: 6-Monoacetylmorphine (6-MAM) [Presence] in Specimen
  32100-0: Morphine [Presence] in Specimen
  32106-7: Perphenazine [Presence] in Specimen
  32113-3: Sertraline [Presence] in Specimen
  32120-8: Venlafaxine [Presence] in Urine
  3510-5: Prochlorperazine [Presence] in Urine
  61030-3: 7-Aminoclonazepam [Presence] in Urine
  61039-4: clonazePAM [Presence] in Specimen
  61041-0: N-desalkylflurazepam [Presence] in Specimen
  61042-8: fentaNYL [Presence] in Specimen
  61045-1: Methylenedioxyamphetamine [Presence] in Serum or Plasma
  61049-3: Methylenedioxyethylamphetamine [Presence] in Specimen
  61051-9: Nordiazepam [Presence] in Specimen
  61070-9: 7-Aminoclonazepam [Presence] in Gastric fluid
  61072-5: Alpha hydroxyalprazolam [Presence] in Gastric fluid
  61077-4: fentaNYL [Presence] in Gastric fluid
  61087-3: Normeperidine [Presence] in Gastric fluid
  61094-9: Lysergate diethylamide [Presence] in Gastric fluid
  61098-0: N-desalkylflurazepam [Presence] in Gastric fluid
  63660-5: Did these problems, related to using marijuana, ever occur together [SSAGA II]
  63662-1: Medicine or drug used to feel good or high, or to feel more active or alert [SSAGA II]
  63672-0: Did giving up or greatly reducing important activities while using this drug, happen 3 or more times or more or for a month or more [SSAGA II]
  63677-9: Have you ever used this drug to keep from having any of these problems or make them go away [SSAGA II]
  63679-5: Did using this drug cause you to have any other problems, like an overdose that required medical treatment [SSAGA II]
  63691-0: Problem when you stopped, cut down or went without marijuana for 2 days or longer [SSAGA II]
  65808-8: Nortapentadol [Mass/volume] in Urine
  68534-7: Have you had medical problems as a result of your drug use [SAMHSA]
  73567-0: Propoxyphene [Presence] in Meconium by Screen method
  73914-4: JWH-018 (synthetic cannabinoid) [Presence] in Urine by Confirmatory method
  73917-7: JWH-250 4/5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
  73930-0: RCS-4 5-carboxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood
  73937-5: Norfentanyl [Mass/volume] in Blood by Confirmatory method
  73942-5: Buprenorphine [Presence] in Saliva (oral fluid) by Screen method
  73948-2: JWH-122 (synthetic cannabinoid) [Presence] in Blood
  73954-0: JWH-398 5 hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood
  73955-7: UR-144 4/5-hydroxypentyl (synthetic cannabinoid metabolites) [Presence] in Blood
  79131-9: 1-Hydroxymidazolam [Mass/volume] in Body fluid
  79140-0: Carisoprodol+Meprobamate [Presence] in Blood by Screen method
  79142-6: Gamma hydroxybutyrate [Mass/volume] in Body fluid
  79147-5: traMADol [Presence] in Blood by Confirmatory method
  19263-3: Amphetamines tested for in Urine by Screen method Narrative
  19265-8: Amphetamines [Identifier] in Urine by Confirmatory method
  19276-5: Barbiturates cutoff [Mass/volume] in Urine for Confirmatory method
  19277-3: Barbiturates screen method [Identifier] in Urine
  19280-7: Benzodiazepines tested for in Urine by Screen method Narrative
  19297-1: Opiates tested for in Urine by Screen method Narrative
  19298-9: Opiates positive [Identifier] in Urine by Confirmatory method
  19300-3: Opiates cutoff [Mass/volume] in Urine for Confirmatory method
  19312-8: Tricyclic antidepressants [Presence] in Urine by Screen method
  19324-3: 6-Monoacetylmorphine (6-MAM) cutoff [Mass/volume] in Urine for Confirmatory method
  19330-0: Alpha hydroxyalprazolam cutoff [Mass/volume] in Urine for Confirmatory method
  19335-9: Amitriptyline+Nortriptyline [Presence] in Urine by Screen method
  24457-4: Deprecated Tryptophan [Molecules/volume] in Serum or Plasma
  27299-7: Methylenedioxyethylamphetamine [Mass/volume] in Vitreous fluid
  27418-3: chlordiazePOXIDE [Mass/mass] in Stool
  3296-1: Acepromazine [Mass/volume] in Serum or Plasma
  33060-5: chlordiazePOXIDE+Metabolites [Mass/volume] in Serum or Plasma
  33340-1: Zolpidem [Moles/volume] in Urine
  33350-0: Lysergate diethylamide [Mass/volume] in Urine by Screen method
  3336-5: Amitriptyline [Mass/volume] in Serum or Plasma --trough >12 hours post dose
  72090-4: FDA product label Identification of CBER-regulated generic drug facility
  74650-3: Methylenedioxyethylamphetamine [Presence] in Saliva (oral fluid) by Confirmatory method
  74657-8: oxyCODONE [Presence] in Saliva (oral fluid) by Confirmatory method
  74663-6: Zaleplon [Mass/volume] in Urine
  74680-0: Amphetamine [Presence] in Saliva (oral fluid) by Confirmatory method
  74697-4: Acamprosate [Mass/volume] in Serum or Plasma
  74806-1: Lithium [Moles/volume] in Serum or Plasma --trough
  74811-1: Dihydrocodeine [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  74818-6: Desomorphine [Presence] in Urine by Screen method
  74913-5: Deprecated Escitalopram [Mass/volume] in Serum or Plasma --trough
  77336-6: Oxazepam [Moles/volume] in Specimen
  77648-4: FDA product label Indexing - biologic or drug substance
  58358-3: Methamphetamine/Creatinine [Mass Ratio] in Urine
  58365-8: 7-Aminoclonazepam [Presence] in Urine by Confirmatory method
  58367-4: Nordiazepam/Creatinine [Mass Ratio] in Urine
  58368-2: Oxazepam/Creatinine [Mass Ratio] in Urine
  58370-8: Carisoprodol+Meprobamate [Presence] in Urine by Screen method
  58373-2: Meprobamate [Presence] in Urine by Confirmatory method
  58387-2: Normeperidine/Creatinine [Mass Ratio] in Urine
  58402-9: Tapentadol [Mass/volume] in Urine by Confirmatory method
  58404-5: traMADol/Creatinine [Mass Ratio] in Urine
  58411-0: Clinical research drug XXX [Mass/volume] in Plasma
  61415-6: Doxepin [Presence] in Urine by Confirmatory method
  64136-5: Pregabalin/Creatinine [Mass Ratio] in Urine
  66378-1: Do you take cortisone, prednisone, other steroids, or anticancer drugs, or have you had radiation treatments [PhenX]
  66467-2: Have you ever, even once, used a needle to inject a drug not prescribed by a doctor [PhenX]
  66468-0: Which of the following drugs have you injected using a needle [PhenX]
  66473-0: Think about the period of your life when you injected drugs the most often. How often did you inject then [PhenX]
  69007-3: Carboxy tetrahydrocannabinol [Mass/mass] in Meconium by Confirmatory method
  69009-9: Cocaine [Mass/mass] in Meconium by Confirmatory method
  69012-3: 3-Hydroxybenzoylecgonine [Mass/mass] in Meconium by Confirmatory method
  29410-8: Doxepin [Mass/volume] in Gastric fluid
  29411-6: Nordoxepin [Mass/volume] in Gastric fluid
  29520-4: 5-Hydroxyindoleacetate/Creatinine [Molar ratio] in Urine
  32048-1: Amitriptyline+Nortriptyline [Presence] in Specimen
  32064-8: Clorazepate [Moles/volume] in Serum or Plasma
  32104-2: PENTobarbital [Presence] in Specimen
  32111-7: Secobarbital [Presence] in Specimen
  32275-0: Tryptophan [Moles/volume] in Body fluid
  3487-6: cloBAZam [Mass/volume] in Serum or Plasma
  3494-2: clonazePAM [Mass/volume] in Serum or Plasma
  61033-7: 7-Aminoflunitrazepam [Presence] in Urine
  61038-6: ALPRAZolam [Presence] in Specimen
  61043-6: Ketamine [Presence] in Specimen
  61044-4: LORazepam [Presence] in Specimen
  61053-5: Norfentanyl [Presence] in Specimen
  61062-6: Carboxy tetrahydrocannabinol [Presence] in Gastric fluid
  61067-5: Barbiturates [Presence] in Specimen by Screen method
  61071-7: 7-Aminoflunitrazepam [Presence] in Gastric fluid
  61076-6: 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Gastric fluid
  61078-2: Flunitrazepam [Presence] in Gastric fluid
  61082-4: Methylenedioxyethylamphetamine [Presence] in Gastric fluid
  61104-6: Prochlorperazine [Moles/volume] in Specimen
  63646-4: During the past 30 days, on how many days did you use drugs [PhenX]
  63652-2: Have you often wanted to stop or cut down on marijuana [SSAGA II]
  63653-0: Have you ever tried to stop or cut down on marijuana but found you couldn't [SSAGA II]
  63661-3: Did giving up, or greatly reducing important activities while using marijuana happen 3 or more times or last for a month or longer [SSAGA II]
  63663-9: Have you ever used any of these medicines or drugs to feel good or high, or to feel more active or alert - or did you use any prescription drugs when they were not prescribed, or more than prescribed [PhenX]
  63666-2: Have you often wanted to stop or cut down on this drug [SSAGA II]
  63685-2: Has use of this drug ever caused you emotional or psychological problems for more than 24 hours to the point that it interfered with your functioning or relationships [SSAGA II]
  63688-6: Emotional or psychological problem related to drug use [SSAGA II]
  65687-6: Other drugs or medications occurring with insomnia [PhenX]
  65750-2: Drugs of abuse 5 panel - Urine by Screen method
  68440-7: Gamma hydroxybutyrate [Moles/volume] in Urine
  68527-1: Are you always able to stop using drugs when you want to [SAMHSA]
  68530-5: Does your spouse or parent ever complain about your involvement with drugs [SAMHSA]
  68532-1: Have you engaged in illegal activities in order to obtain drugs [SAMHSA]
  68542-0: Codeine [Mass/mass] in Meconium by Confirmatory method
  73563-9: 7-Aminoclonazepam [Mass/mass] in Meconium by Confirmatory method
  73584-5: Norcitalopram [Mass/volume] in Urine
  73827-8: Gamma hydroxybutyrate [Mass/volume] in Serum, Plasma or Blood
  73829-4: 7-Aminoflunitrazepam [Mass/volume] in Serum, Plasma or Blood
  73918-5: JWH-073 (synthetic cannabinoid) [Presence] in Urine by Confirmatory method
  73923-5: JWH-018 pentanoate (synthetic cannabinoid metabolite) [Presence] in Blood
  73925-0: AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood
  73935-9: Tetrahydrocannabinol [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
  73939-1: HYDROcodone Free [Mass/volume] in Blood
  73940-9: HYDROmorphone Free [Mass/volume] in Blood
  73943-3: Cannabinoids synthetic [Presence] in Blood
  76349-0: clonazePAM [Mass/mass] in Meconium by Confirmatory method
  79133-5: 9-Hydroxyrisperidone [Mass/volume] in Body fluid
  79222-6: Benzodiazepines [Presence] in Body fluid by Screen method
  10978-5: Amitriptyline+Nortriptyline [Mass/volume] in Urine
  10979-3: Carisoprodol [Mass/volume] in Urine
  11024-7: Benzodiazepines [Mass/volume] in Serum or Plasma
  11025-4: Methadone [Mass/volume] in Meconium
  11026-2: Methaqualone [Mass/volume] in Meconium
  11071-8: Butalbital [Mass/volume] in Urine
  10370-5: Phencyclidine [Mass/mass] in Hair
  10542-9: Metharbital [Mass/volume] in Serum or Plasma
  10547-8: Primidone+PHENobarbital [Mass/volume] in Serum or Plasma
  10550-2: Deprecated Temazepam [Mass/volume] in Serum or Plasma
  10552-8: Tricyclic antidepressants [Mass/volume] in Serum or Plasma
  3641-8: Flunitrazepam [Mass/volume] in Urine
  3644-2: FLUoxetine [Mass/volume] in Serum or Plasma
  3650-9: fluPHENAZine [Mass/volume] in Serum or Plasma
  3654-1: Flurazepam [Presence] in Urine
  3655-8: Flurazepam [Mass/volume] in Urine
  39477-5: fluPHENAZine [Moles/volume] in Serum or Plasma
  39591-3: PARoxetine [Mass/volume] in Urine
  42251-9: Methadone+Metabolite [Presence] in Urine by Screen method
  4238-2: Estazolam [Mass] of Dose
  45246-6: Degree of adherence to anti-retroviral drug regimen
  48168-9: 5-Hydroxyindoleacetate [Presence] in Urine
  50576-8: FDA product label OTC Type A medicated article animal drug label
  50890-3: Norclozapine [Moles/volume] in Urine
  56120-9: Amphetamine+Methamphetamine [Mass/volume] in Urine
  3578-2: Doxepin [Presence] in Serum or Plasma
  3598-0: Estazolam [Mass/volume] in Urine
  38893-4: ARIPiprazole [Mass/volume] in Serum or Plasma
  38899-1: fluPHENAZine [Presence] in Serum or Plasma
  3916-4: Pentazocine [Mass/volume] in Serum or Plasma
  3918-0: Pentazocine [Mass/volume] in Urine
  41858-2: 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Urine
  4210-1: Nordoxepin [Mass] of Dose
  47546-7: 5-Hydroxytryptophan [Moles/volume] in Cerebral spinal fluid
  52945-3: LORazepam [Presence] in Gastric fluid
  52948-7: cloBAZam [Presence] in Gastric fluid
  52963-6: Flurazepam [Presence] in Gastric fluid
  53110-3: 5-Hydroxytryptophan/Creatinine [Molar ratio] in 24 hour Urine
  55525-0: Benzoylecgonine [Moles/volume] in Serum or Plasma
  55537-5: fentaNYL [Moles/volume] in Serum or Plasma
  55554-0: Mirtazapine [Moles/volume] in Serum or Plasma
  55576-3: QUEtiapine [Moles/volume] in Serum or Plasma
  80113-4: 11-Hydroxy delta-9 tetrahydrocannabinol [Mass/volume] in Urine by Confirmatory method
  80131-6: Amisulpride [Mass/volume] in Urine
  80198-5: Nonsteroidal antiinflammatory drugs [Presence] in Blood by Screen method
  82666-9: Drug Abuse Screening Test-10 [DAST-10]
  82934-1: clonazePAM [Mass/volume] in Serum or Plasma --trough
  82966-3: Methamphetamine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
  82970-5: PHENobarbital [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
  91033-1: Methadone+Metabolite [Presence] in Serum, Plasma or Blood by Screen method
  91039-8: Methadone+Metabolite [Presence] in Body fluid by Screen method
  91053-9: oxyCODONE+oxyMORphone [Presence] in Tissue by Screen method
  91056-2: Drugs of abuse panel - Hair
  93465-3: 3-Methylfentanyl [Mass/volume] in Urine by Confirmatory method
  93466-1: Valerylfentanyl [Mass/volume] in Urine by Confirmatory method
  93471-1: Acetyl norfentanyl [Mass/volume] in Urine by Confirmatory method
  3727-5: Loxapine [Presence] in Serum or Plasma
  3729-1: Loxapine [Presence] in Urine
  3730-9: Lysergate diethylamide [Presence] in Serum or Plasma
  3736-6: Deprecated Maprotiline [Mass/volume] in Serum or Plasma
  3737-4: Maprotiline [Presence] in Urine
  3744-0: Meperidine [Presence] in Serum or Plasma
  3748-1: Meperidine [Mass/time] in 24 hour Urine
  3780-4: Methamphetamine [Mass/volume] in Urine
  4027-9: Secobarbital [Presence] in Serum or Plasma
  4029-5: Secobarbital [Presence] in Urine
  40380-8: Meprobamate [Presence] in Gastric fluid
  40413-7: Barbiturates [Presence] in Hair
  40420-2: Amphetamine+Methamphetamine [Presence] in Specimen
  40481-4: Methylenedioxymethamphetamine [Presence] in Specimen
  40528-2: Opiates [Presence] in Hair
  4063-4: traZODone [Presence] in Serum or Plasma
  4310-9: Meprobamate [Mass] of Dose
  43117-1: FLUoxetine and Norfluoxetine panel [Mass/volume] - Serum or Plasma
  43127-0: clomiPRAMINE and Norclomipramine panel - Serum or Plasma
  43184-1: 6-Monoacetylmorphine (6-MAM) [Presence] in Serum or Plasma by Confirmatory method
  4334-9: Midazolam [Mass] of Dose
  4337-2: Morphine [Mass] of Dose
  46257-2: Dihydrocodeine+Hydrocodol [Presence] in Serum or Plasma by Screen method
  46263-0: 6-monoacetylmorphine free [Presence] in Serum or Plasma
  48934-4: 11-Hydroxy delta-9 tetrahydrocannabinol [Mass/volume] in Specimen
  48941-9: Benzodiazepines [Mass/volume] in Specimen
  48960-9: Norpropoxyphene [Mass/volume] in Specimen
  48961-7: Opiates [Mass/volume] in Specimen
  48962-5: Oxazepam [Mass/volume] in Specimen
  51691-4: Opiates [Presence] in Blood by Screen method
  51692-2: Phencyclidine [Presence] in Blood by Screen method
  51737-5: HYDROmorphone Free [Mass/volume] in Urine
  51739-1: Codeine Free [Mass/volume] in Urine
  51776-3: 7-Aminoclonazepam [Mass/volume] in Urine by Confirmatory method
  54247-2: Drug screen comment [Interpretation] in Urine
  54402-3: 4-Hydroxymidazolam [Mass/volume] in Serum or Plasma
  57302-2: Temazepam [Mass/volume] in Saliva (oral fluid)
  3679-8: HYDROcodone [Presence] in Serum or Plasma
  3691-3: Imipramine [Presence] in Urine
  3711-9: Levorphanol [Presence] in Urine
  3720-0: Lithium [Presence] in Serum or Plasma
  4001-4: Protriptyline [Presence] in Urine
  4264-8: Flurazepam [Mass] of Dose
  42774-0: Multiple drug resistant organism identified in Wound
  42922-5: Ketamine [Presence] in Serum or Plasma
  4304-2: Maprotiline [Mass] of Dose
  48403-0: Methadone+Metabolite [Mass/volume] in Serum or Plasma
  53736-5: Benzodiazepines.other [Mass/volume] in Urine
  53821-5: Chloroamphetamine [Mass/volume] in Serum
  53880-1: Norbuprenorphine [Mass/volume] in Serum or Plasma by Confirmatory method
  53882-7: O-desmethylvenlafaxine [Mass/volume] in Urine
  56525-9: 5-Hydroxytryptophan [Mass/volume] in Urine
  81275-0: fentaNYL and Norfentanyl panel - Serum or Plasma
  81277-6: fentaNYL and Norfentanyl panel - Gastric fluid
  86610-3: SUFentanil/Creatinine [Mass Ratio] in Urine by Confirmatory method
  89308-1: Morphine-6-Glucuronide [Presence] in Urine by Screen method
  91606-4: clomiPRAMINE+Norclomipramine [Mass/volume] in Urine
  94297-9: Norfluvoxamine [Mass/volume] in Serum or Plasma by Confirmatory method
  10339-0: FLUoxetine+Norfluoxetine [Mass/volume] in Serum or Plasma
  10340-8: Molindone [Mass/volume] in Serum or Plasma
  12289-5: Drugs identified in Vitreous fluid by Screen method
  12308-3: HYDROcodone [Presence] in Urine
  12315-8: Mephobarbital [Presence] in Urine
  12319-0: Thioridazine [Presence] in Urine
  12352-1: Benzoylecgonine [Presence] in Stool
  12381-0: Oxazepam [Presence] in Stool
  12383-6: Hydroxytriazolam [Presence] in Stool
  12407-3: Deprecated 6-Beta naltrexone [Mass/volume] in Serum or Plasma
  12411-5: Promazine [Mass/volume] in Serum or Plasma
  12422-2: Triflupromazine [Mass/volume] in Serum or Plasma
  12477-6: Dextromethamphetamine [Mass/volume] in Urine
  12488-3: PENTobarbital [Presence] in Gastric fluid
  12500-5: Secobarbital [Presence] in Stool
  12501-3: PHENobarbital [Presence] in Stool
  12502-1: Allobarbital [Presence] in Stool
  12602-9: Hydroxyethylflurazepam [Mass/volume] in Urine
  38364-6: Haloperidol reduced [Mass/volume] in Serum or Plasma
  38384-4: Cocaine [Presence] in Gastric fluid
  3840-6: Nalbuphine [Mass/volume] in Urine
  3871-1: Norpropoxyphene [Presence] in Urine
  3875-2: Nortriptyline [Mass/volume] in Urine
  4109-5: Alfentanil [Mass] of Dose
  4152-5: carBAMazepine [Mass] of Dose
  46973-4: oxyCODONE Free [Mass/volume] in Urine by Confirmatory method
  46977-5: Benzodiazepines [Mass/volume] in Serum or Plasma by Confirmatory method
  47114-4: LORazepam [Moles/volume] in Gastric fluid
  55155-6: Flunitrazepam and 7-Aminoflunitrazepam panel [Mass/volume] - Urine
  55157-2: risperiDONE and 9-Hydroxyrisperidone panel - Serum or Plasma
  55419-6: Home drug screening panel - Urine
  57865-8: oxyCODONE [Moles/volume] in Specimen
  57868-2: Perphenazine [Moles/volume] in Specimen
  57898-9: Cocaine [Moles/volume] in Specimen
  3784-6: Methaqualone [Presence] in Serum or Plasma
  3785-3: Methaqualone [Mass/volume] in Serum or Plasma
  3806-7: Methylphenidate [Presence] in Serum or Plasma
  3832-3: Morphine [Mass/time] in 24 hour Urine
  40684-3: Acinetobacter sp multidrug resistant identified in Specimen by Organism specific culture
  4070-9: Triazolam [Mass/volume] in Urine
  4075-8: Trimeperidine [Presence] in Urine
  40798-1: Amphetamines [Presence] in Hair by Screen method
  40801-3: Cannabinoids [Presence] in Saliva (oral fluid) by Screen method
  4354-7: Deprecated Nordiazepam [Mass] of Dose
  4375-2: Para hydroxyamphetamine [Mass] of Dose
  43834-1: Tetrahydrocannabinol [Presence] in Specimen
  46703-5: Dihydrocodeine Free+Hydrocodol Free [Presence] in Serum or Plasma by Screen method
  46704-3: Dihydrocodeine Free+Hydrocodol Free [Mass/volume] in Serum or Plasma by Screen method
  51961-1: Genetic variation's effect on drug efficacy
  52047-8: Immunosuppressive drug attachment
  8183-6: Benzoylecgonine [Presence] in Gastric fluid
  8191-9: Cocaine [Presence] in Serum or Plasma by Screen method
  81922-7: Tryptophan intake 24 hour Estimated
  8210-7: Opiates [Presence] in Gastric fluid
  87486-7: PB-22 3-carboxyindole (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
  87489-1: AKB48 N-pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
  87491-7: ADBICA N-4-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
  79148-3: traMADol [Presence] in Blood by Screen method
  79153-3: Alfentanil [Mass/volume] in Body fluid
  79163-2: Z-10-Hydroxynortriptyline [Mass/volume] in Serum or Plasma
  79225-9: Barbital [Mass/volume] in Body fluid
  79250-7: 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
  79262-2: Methamphetamine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
  79348-9: Body weight --used for drug calculation
  79408-1: cloBAZam and norclobazam panel - Serum or Plasma
  60107-0: OLANZapine [Mass/mass] in Tissue
  60137-7: PARoxetine [Mass/volume] in Body fluid
  60153-4: PENTobarbital [Mass/mass] in Tissue
  60291-2: carBAMazepine [Presence] in Specimen
  60297-9: clomiPRAMINE [Moles/volume] in Specimen
  60306-8: fluvoxaMINE [Moles/volume] in Specimen
  60325-8: OLANZapine [Moles/volume] in Specimen
  60329-0: Promazine [Moles/volume] in Specimen
  60514-7: 6-Acetylcodeine [Mass/volume] in Urine by Confirmatory method
  65500-1: Did you take medication or use drugs or alcohol more than once for these problems [CIDI-SF]
  6799-1: Tricyclic antidepressants [Presence] in Urine by Immunoassay
  73223-0: oxyCODONE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73257-8: Morphine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73261-0: Mirtazapine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73268-5: Midazolam induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73284-2: Methocarbamol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73341-0: HYDROmorphone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73349-3: HYDROcodone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73367-5: Gabapentin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73382-4: fentaNYL induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73442-6: Citalopram induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73443-4: Citalopram induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73492-1: Butalbital+Acetylsalicylate+Caffeine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73552-2: Drug induced platelet Ab [Interpretation] in Serum or Plasma Narrative
  73562-1: 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/mass] in Meconium by Confirmatory method
  78760-6: 6-Monoacetylmorphine (6-MAM) [Presence] in Body fluid by Screen method
  78766-3: fentaNYL [Mass/volume] in Urine -- adjusted for lean body mass+urine creatinine
  78768-9: Morphine [Mass/volume] in Urine -- adjusted for lean body mass+urine creatinine
  78776-2: Acepromazine [Mass/mass] in Hair
  78822-4: Doxepin cutoff [Mass/volume] in Urine for Confirmatory method
  78830-7: HYDROcodone [Z-score] in Urine
  78832-3: Hydroxybupropion cutoff [Mass/volume] in Urine for Confirmatory method
  78842-2: JWH-122 5-hydroxypentyl (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method
  78843-0: JWH-200 4-hydroxyindole (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method
  78860-4: Mirtazapine cutoff [Mass/volume] in Urine for Confirmatory method
  78867-9: Norfentanyl cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
  78875-2: PARoxetine cutoff [Mass/volume] in Urine for Confirmatory method
  78883-6: Triazolam [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  78885-1: traZODone cutoff [Mass/volume] in Urine for Confirmatory method
  78886-9: Venlafaxine cutoff [Mass/volume] in Urine for Confirmatory method
  78889-3: Tricyclic antidepressants [Presence] in Urine by Screen method >300 ng/mL
  10988-4: fluvoxaMINE [Mass/volume] in Serum or Plasma
  10994-2: Naltrexone [Mass/volume] in Serum or Plasma
  11004-9: Tricyclic antidepressants [Presence] in Urine
  11023-9: Benzodiazepines [Mass/volume] in Meconium
  11027-0: Propoxyphene [Mass/volume] in Meconium
  11052-8: Ketamine [Mass/volume] in Urine
  11075-9: Norfentanyl [Mass/volume] in Urine
  11145-0: 5-Hydroxyindoleacetate/Creatinine [Mass Ratio] in Urine
  11235-9: fentaNYL [Presence] in Urine
  11246-6: oxyCODONE [Mass/volume] in Urine
  10533-8: Propoxyphene+Acetaminophen [Mass/volume] in Serum or Plasma
  10538-7: Deprecated Fluoxetine+Norfluoxetine [Mass/volume] in Serum or Plasma
  3645-9: FLUoxetine [Presence] in Urine
  3671-5: Haloperidol [Mass/volume] in Urine
  39455-1: 9-Hydroxyrisperidone [Moles/volume] in Serum or Plasma
  39470-0: Prochlorperazine [Moles/volume] in Serum or Plasma
  3950-3: PHENobarbital [Mass/volume] in Urine
  4217-6: diazePAM [Mass] of Dose
  4223-4: HYDROmorphone [Mass] of Dose
  42253-5: Methylenedioxyamphetamine [Presence] in Urine
  4247-3: Ethylmorphine [Mass] of Dose
  42491-1: Cannabinoids [Presence] in Blood by Screen method
  45144-3: clomiPRAMINE [Presence] in Urine
  47979-0: Tranylcypromine [Presence] in Serum or Plasma
  48072-3: Synthetic glucocorticoid drug [Mass/volume] in Unknown substance
  50542-0: 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/volume] in Urine
  50543-8: Tricyclic antidepressants [Mass/volume] in Urine
  50578-4: FDA product label Prescription animal drug label
  50594-1: 3-Hydroxybenzoylecgonine [Mass/volume] in Urine by Confirmatory method
  50804-4: Amitriptyline [Moles/volume] in Urine
  50872-1: Lithium [Moles/mass] in Hair
  3577-4: Disulfiram [Mass/volume] in Serum or Plasma
  3582-4: Doxepin+Nordoxepin [Mass/volume] in Serum or Plasma
  3584-0: Doxepin [Mass/volume] in Serum or Plasma --trough
  3618-6: Ethylmorphine [Presence] in Urine
  3886-9: Oxazepam [Mass/volume] in Serum or Plasma
  3893-5: oxyCODONE [Mass/volume] in Serum or Plasma
  3902-4: Para hydroxyamphetamine [Mass/volume] in Urine
  39245-6: Drug or alcohol abuse counselled CPHS
  41860-8: 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Serum or Plasma
  4190-5: cloBAZam [Mass] of Dose
  4194-7: clonazePAM [Mass] of Dose
  4199-6: Codeine [Mass] of Dose
  44939-7: History of Adverse drug reaction Narrative
  50021-5: oxyCODONE [Mass/volume] in Serum, Plasma or Blood by Screen method
  50149-4: 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
  50337-5: carBAMazepine free and total and 10,11-Epoxide panel [Mass/volume] - Serum or Plasma
  52964-4: cloBAZam [Moles/volume] in Gastric fluid
  53040-2: Genetic variation's effect on drug metabolism
  53159-0: Tryptophan [Moles/volume] in DBS
  55542-5: Hydroxybupropion [Moles/volume] in Serum or Plasma
  55574-8: Propoxyphene + Norpropoxyphene [Moles/volume] in Serum or Plasma
  55583-9: Tranylcypromine [Moles/volume] in Serum or Plasma
  80112-6: 11-Hydroxy delta-9 tetrahydrocannabinol [Mass/volume] in Body fluid by Confirmatory method
  80122-5: Alfentanil [Mass/volume] in Blood by Confirmatory method
  80146-4: Tricyclic antidepressants [Presence] in Blood by Screen method
  80147-2: Tricyclic antidepressants [Presence] in Body fluid by Screen method
  78443-9: Deprecated carBAMazepine 10,11-Epoxide [Mass/volume] in Serum or Plasma --trough
  5939-4: Deprecated Benzoylecgonine [Presence] in Urine
  59602-3: Alpha hydroxyalprazolam [Mass/volume] in Body fluid by Confirmatory method
  59607-2: ALPRAZolam [Mass/volume] in Blood by Confirmatory method
  59608-0: ALPRAZolam [Mass/volume] in Body fluid
  59610-6: ALPRAZolam [Mass/mass] in Meconium by Confirmatory method
  59612-2: ALPRAZolam [Mass/mass] in Stool by Confirmatory method
  59614-8: ALPRAZolam [Mass/mass] in Tissue by Confirmatory method
  59620-5: chlordiazePOXIDE [Mass/volume] in Body fluid by Confirmatory method
  66980-4: How many times in the last year have you sold marijuana or hashish, pot, grass, hash [Denver Youth Survey]
  67034-9: How many times in the last year have you used a harder drug, such as heroin, cocaine or LSD [Denver Youth Survey]
  69757-3: Indications of drug or alcohol use by the patient NEMSIS
  70138-3: Amphetamines [Mass/volume] in Urine by Screen method
  70141-7: Benzodiazepines [Presence] in Urine by Screen method >200 ng/mL
  72381-7: ALPRAZolam [Mass/volume] in Saliva (oral fluid)
  72400-5: Methadone [Presence] in Blood by Screen method
  72463-3: AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
  72480-7: Barbiturates panel - Blood by Confirmatory method
  72620-8: Norpropoxyphene [Presence] in Saliva (oral fluid)
  72628-1: PHENobarbital [Presence] in Saliva (oral fluid) by Confirmatory method
  72630-7: PENTobarbital [Presence] in Saliva (oral fluid) by Confirmatory method
  72631-5: Amobarbital [Presence] in Saliva (oral fluid) by Confirmatory method
  72640-6: I took drugs in last week [BSL-SUPP]
  72659-6: OXcarbazepine [Mass/volume] in Serum or Plasma --trough
  72678-6: Venlafaxine+O-desmethylvenlafaxine [Mass/volume] in Serum or Plasma --trough
  72736-2: Methylenedioxyamphetamine [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  72744-6: Norhydrocodone [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  72746-1: Norbuprenorphine [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  72753-7: HYDROcodone [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  72771-9: Zolpidem/Creatinine [Mass Ratio] in Urine
  72774-3: Venlafaxine [Mass/volume] in Urine by Confirmatory method
  72779-2: JWH-073 butanoate (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine
  72780-0: JWH-018 pentanol (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method
  72781-8: JWH-018 pentanol (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine
  72788-3: Deprecated 6-Beta naltrexone/Creatinine [Mass Ratio] in Urine
  74972-1: Deprecated 9-Hydroxyrisperidone [Mass/volume] in Serum or Plasma --trough
  74974-7: carBAMazepine free [Mass/volume] in Serum or Plasma --trough
  74985-3: ALPRAZolam [Mass/volume] in Serum or Plasma --trough
  75031-5: FDA product label Human compounded drug label
  77754-0: 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) cutoff [Mass/volume] in Urine for Confirmatory method
  77757-3: 7-Hydroxyquetiapine [Mass/volume] in Urine by Confirmatory method
  77763-1: ALPRAZolam cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
  77765-6: Citalopram+Escitalopram [Mass/volume] in Urine by Confirmatory method
  77772-2: Methylenedioxyethylamphetamine cutoff [Mass/volume] in Urine for Confirmatory method
  77776-3: Norhydrocodone cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
  77777-1: Normeperidine cutoff [Mass/volume] in Urine for Confirmatory method
  77780-5: oxyMORphone cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
  77787-0: Buprenorphine cutoff [Mass/volume] in Urine for Screen method
  77876-1: Phencyclidine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
  26742-7: Methylenedioxyamphetamine [Mass/volume] in Milk
  26760-9: Cannabinoids [Units/volume] in Urine
  29212-8: carBAMazepine [Mass/volume] in Body fluid
  29228-4: Tricyclic antidepressants [Mass/volume] in Body fluid
  29324-1: Cocaethylene [Mass/volume] in Gastric fluid
  29337-3: Morphine Free [Mass/volume] in Gastric fluid
  29370-4: cloZAPine [Mass/volume] in Serum or Plasma --trough
  29377-9: Narcotics and opioids [Identifier] in Gastric fluid
  29381-1: Meprobamate [Mass/volume] in Gastric fluid
  29400-9: Meperidine [Mass/volume] in Gastric fluid
  29402-5: Trimipramine [Mass/volume] in Gastric fluid
  29404-1: Thiothixene [Mass/volume] in Gastric fluid
  29532-9: Methadone [Units/volume] in Specimen
  29592-3: Amphetamine [Mass/volume] in Serum or Plasma by Confirmatory method
  32049-9: Amobarbital [Presence] in Specimen
  32059-8: chlordiazePOXIDE [Moles/volume] in Serum or Plasma
  32065-5: cloZAPine [Presence] in Urine
  32083-8: Imipramine+Desipramine [Presence] in Specimen
  32092-9: Meprobamate [Presence] in Specimen
  32102-6: PARoxetine [Presence] in Specimen
  32125-7: Propoxyphene [Moles/volume] in Serum or Plasma
  32136-4: Antidepressants [Presence] in Urine
  3492-6: clomiPRAMINE [Mass/volume] in Urine
  3498-3: Clorazepate [Mass/volume] in Serum or Plasma
  35106-4: Norcitalopram [Mass/volume] in Serum or Plasma
  61035-2: Alpha hydroxyalprazolam [Presence] in Serum or Plasma
  61037-8: Alpha hydroxyalprazolam [Presence] in Specimen
  61060-0: Temazepam [Presence] in Urine
  61065-9: Lysergate diethylamide [Presence] in Specimen
  61085-7: Nordiazepam [Presence] in Gastric fluid
  61092-3: Triazolam [Presence] in Gastric fluid
  61096-4: Barbiturates [Presence] in Gastric fluid by Screen method
  63645-6: How old were you when you first used this drug [AUDADIS-IV]
  63651-4: Did you continue to use marijuana after you knew it caused this problem [SSAGA II]
  63654-8: Were you unable to stop or cut down on marijuana 3 or more times [SSAGA II]
  63655-5: Have you often used marijuana more frequently or in larger amounts than you intended to [SSAGA II]
  63658-9: Have you ever used marijuana to keep from having any of these problems or to make them go away [SSAGA II]
  63671-2: Drug type used steadily, for a month or more [SSAGA II]
  68524-8: How many times in the past year have you used an illegal drug or used a prescription medication for non-medical reasons
  68528-9: Have you had blackouts or flashbacks as a result for drug use [SAMHSA]
  68529-7: Do you ever feel bad or guilty about your drug use [SAMHSA]
  68531-3: Have you neglected your family because of your use of drugs [SAMHSA]
  73729-6: Meperidine [Presence] in Hair
  73922-7: RCS-4 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood
  73924-3: JWH-200 4-hydroxyindole (synthetic cannabinoid metabolite) [Presence] in Blood
  73945-8: UR-144 (synthetic cannabinoid) [Presence] in Blood
  73953-2: JWH-073 (synthetic cannabinoid) [Presence] in Blood
  73957-3: UR-144 pentanoate (synthetic cannabinoid metabolite) [Presence] in Blood
  79138-4: Buprenorphine [Presence] in Blood by Confirmatory method
  79162-4: chlordiazePOXIDE and Norchlordiazepoxide panel - Serum or Plasma
  79226-7: ARIPiprazole [Mass/volume] in Body fluid
  79229-1: Amitriptyline [Mass/volume] in Body fluid
  79247-3: Methylenedioxymethamphetamine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
  10341-6: Norpropoxyphene [Mass/volume] in Serum or Plasma
  12314-1: Clorazepate [Presence] in Urine
  12320-8: Thiothixene [Presence] in Urine
  12342-2: oxyMORphone [Presence] in Serum or Plasma
  12357-0: Propoxyphene [Presence] in Stool
  12378-6: diazePAM [Presence] in Stool
  12389-3: OLANZapine [Mass/volume] in Serum or Plasma
  12425-5: Chlorzoxazone [Mass/volume] in Serum or Plasma
  12478-4: Levomethamphetamine [Mass/volume] in Urine
  12489-1: Secobarbital [Presence] in Gastric fluid
  12490-9: Allyl-sec-butyl-barbiturate [Mass/volume] in Serum or Plasma
  12494-1: Amobarbital [Presence] in Stool
  12551-8: Isocarboxazid [Mass/volume] in Serum or Plasma
  12603-7: N-desalkylflurazepam [Presence] in Stool
  38373-7: Buprenorphine+Norbuprenorphine [Presence] in Urine
  3851-3: Nicomorphine [Mass/volume] in Urine
  3862-0: Nordoxepin [Mass/volume] in Serum or Plasma
  3874-5: Nortriptyline [Presence] in Urine
  3878-6: Opiates [Presence] in Serum or Plasma
  3879-4: Opiates [Presence] in Urine
  3880-2: Orphenadrine [Mass/volume] in Serum or Plasma
  4121-0: Amobarbital [Mass] of Dose
  4122-8: Amoxapine [Mass] of Dose
  41270-0: Drugs identified in Urine
  4149-1: Butalbital [Mass] of Dose
  4438-8: Tetrahydrocannabinol [Mass] of Dose
  47117-7: Maprotiline [Moles/volume] in Gastric fluid
  47126-8: Protriptyline [Moles/volume] in Gastric fluid
  47127-6: Protriptyline [Moles/volume] in Urine
  47134-2: Trimipramine [Moles/volume] in Urine
  52570-9: Deprecated Drug list is complete
  55346-1: cloBAZam+Norclobazam [Moles/volume] in Serum or Plasma
  57982-1: HYDROmorphone [Presence] in Meconium
  58014-2: Nordoxepin [Presence] in Urine
  3789-5: Methocarbamol [Presence] in Serum or Plasma
  3790-3: Methocarbamol [Mass/volume] in Serum or Plasma
  3791-1: Methocarbamol [Presence] in Urine
  3809-1: Methylphenidate [Mass/volume] in Urine
  38194-7: Antidepressants [Identifier] in Gastric fluid
  3826-5: Morphine [Presence] in Serum or Plasma
  3831-5: Morphine [Mass/volume] in Urine
  4074-1: Trifluoperazine [Mass/volume] in Serum or Plasma
  4076-6: Trimeperidine [Mass/volume] in Urine
  40800-5: Cannabinoids [Presence] in Hair by Screen method
  40808-8: Phencyclidine [Presence] in Saliva (oral fluid) by Screen method
  40839-3: fentaNYL [Presence] in Urine by Confirmatory method
  40901-1: 3-Hydroxybenzoylecgonine [Mass/mass] in Meconium
  41037-3: Cocaine [Presence] in Meconium by Confirmatory method
  4104-6: Acepromazine [Mass] of Dose
  43595-8: Methadone [Presence] in Meconium
  4389-3: Phencyclidine [Mass] of Dose
  43934-9: Amphetamines [Mass/mass] in Meconium by Confirmatory method
  43983-6: Amphetamines [Presence] in Urine by Screen method >500 ng/mL
  43985-1: Benzoylecgonine [Presence] in Urine by Screen method >300 ng/mL
  51955-3: Dihydrocodeine Free+Hydrocodol Free [Mass/volume] in Urine
  57727-0: Norolanzapine [Mass/volume] in Serum or Plasma
  8184-4: Benzoylecgonine [Presence] in Gastric fluid by Confirmatory method
  8188-5: Benzoylecgonine [Presence] in Meconium by Confirmatory method
  8190-1: Cocaine [Presence] in Serum or Plasma by Confirmatory method
  10338-2: Barbiturates [Mass/volume] in Serum or Plasma
  12785-2: Dihydrocodeine Free [Mass/volume] in Serum or Plasma
  12789-4: oxyCODONE Free [Mass/volume] in Serum or Plasma
  12327-3: Ketamine [Presence] in Urine
  12362-0: Oxazepam [Presence] in Serum or Plasma
  12364-6: Benzodiazepines [Presence] in Gastric fluid
  12380-2: LORazepam [Presence] in Stool
  12384-4: Triazolam [Presence] in Stool
  12394-3: Butorphanol [Mass/volume] in Serum or Plasma
  12395-0: Butorphanol [Mass/volume] in Urine
  12398-4: Diphenoxylate [Mass/volume] in Serum or Plasma
  12410-7: Pimozide [Mass/volume] in Serum or Plasma
  12439-6: FLUoxetine [Mass/volume] in Urine
  12485-9: Amobarbital [Presence] in Gastric fluid
  12486-7: Butabarbital [Presence] in Gastric fluid
  12497-4: Butalbital [Presence] in Stool
  12554-2: Narcotics and opioids [Identifier] in Urine
  12604-5: Hydroxyethylflurazepam [Presence] in Stool
  4140-0: Benzoylecgonine [Mass] of Dose
  41464-9: Amphetamines/Creatinine [Mass Ratio] in Urine
  41465-6: Opiates/Creatinine [Mass Ratio] in Urine
  41472-2: carBAMazepine [Mass/volume] in DBS
  44035-4: Analgesics Non-narcotic [Presence] in Serum or Plasma
  4416-4: Protriptyline [Mass] of Dose
  44390-3: Imipramine [Presence] in Specimen
  44414-1: Tryptophan/Creatinine [Mass Ratio] in 24 hour Urine
  46975-9: oxyMORphone Free [Mass/volume] in Urine by Confirmatory method
  46979-1: Flurazepam [Mass/volume] in Serum or Plasma by Confirmatory method
  47004-7: 6-monoacetylmorphine free [Mass/volume] in Urine by Confirmatory method
  47120-1: Meprobamate [Moles/volume] in Urine
  49690-1: Mirtazapine [Mass/volume] in Urine
  49829-5: Norcodeine [Mass/volume] in Urine
  57856-7: Carisoprodol [Moles/volume] in Specimen
  57858-3: Normaprotiline [Moles/volume] in Specimen
  57863-3: HYDROmorphone [Moles/volume] in Specimen
  3808-3: Methylphenidate [Presence] in Urine
  4065-9: traZODone [Presence] in Urine
  4069-1: Triazolam [Mass/volume] in Serum or Plasma
  4077-4: Trimeperidine [Mass/time] in 24 hour Urine
  4096-4: Volatile drugs negative [Identifier] in Urine by Screen method
  4363-8: Orphenadrine [Mass] of Dose
  4386-9: Perphenazine [Mass] of Dose
  4393-5: PHENobarbital [Mass] of Dose
  43984-4: Benzoylecgonine [Presence] in Urine by Screen method >150 ng/mL
  8195-0: Cocaine [Presence] in Unknown substance
  8197-6: Cocaine [Presence] in Unknown substance by Screen method
  8209-9: Opiates [Mass/volume] in Gastric fluid
  8212-3: Opiates [Presence] in Gastric fluid by Screen method
  85090-9: Citalopram and norcitalopram and didesmethylcitalopram panel - Serum or Plasma
  87485-9: ADBICA N-pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
  87495-8: AB-CHMINACA butanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
  87496-6: Gabapentin [Presence] in Serum, Plasma or Blood by Screen method
  89981-5: QUEtiapine [Presence] in Serum or Plasma by Screen method
  89986-4: Vortioxetine [Mass/volume] in Urine by Confirmatory method
  92637-8: traZODone [Mass/volume] in Urine by Confirmatory method
  92645-1: Citalopram [Presence] in Urine by Confirmatory method
  92649-3: Naloxone [Presence] in Urine by Confirmatory method
  3734-1: Maprotiline [Presence] in Serum or Plasma
  3738-2: Maprotiline [Mass/volume] in Urine
  3751-5: Deprecated Mephobarbital [Mass/volume] in Serum or Plasma
  3755-6: Meprobamate [Mass/volume] in Urine
  3776-2: Methamphetamine [Mass/volume] in Blood
  4028-7: Secobarbital [Mass/volume] in Serum or Plasma
  40393-1: Pentazocine [Presence] in Gastric fluid
  40414-5: Benzodiazepines [Presence] in Meconium
  40415-2: Benzodiazepines [Presence] in Hair
  4053-5: Thioridazine [Mass/volume] in Urine
  40585-2: Drugs identified in Specimen by Confirmatory method
  40609-0: Benzoylecgonine [Presence] in Specimen
  43106-4: Amitriptyline and Nortriptyline panel - Serum or Plasma
  43176-7: Lithium [Moles/volume] in Saliva (oral fluid)
  4329-9: Methylphenidate [Mass] of Dose
  4348-9: Nicomorphine [Mass] of Dose
  46085-7: Gamma hydroxybutyrate [Presence] in Serum or Plasma
  46259-8: Morphine Free [Presence] in Serum or Plasma by Screen method
  46260-6: HYDROmorphone Free [Presence] in Serum or Plasma by Screen method
  46261-4: HYDROcodone Free [Presence] in Serum or Plasma
  48938-5: ALPRAZolam [Mass/volume] in Specimen
  48945-0: chlordiazePOXIDE [Mass/volume] in Specimen
  48948-4: diazePAM [Mass/volume] in Specimen
  48949-2: Estazolam [Mass/volume] in Specimen
  48959-1: Nordiazepam [Mass/volume] in Specimen
  48964-1: Propoxyphene [Mass/volume] in Specimen
  57282-6: Patient/caregiver drug education intervention [OASIS-C]
  3681-4: HYDROcodone [Mass/volume] in Urine
  3689-7: Imipramine [Presence] in Serum or Plasma
  3693-9: Imipramine [Mass/volume] in Serum or Plasma --trough
  3718-4: Lithium [Mass/mass] in Hair
  3987-5: Promazine [Mass/volume] in Urine
  42576-9: Amphetamine [Mass/volume] in Blood by Confirmatory method
  4277-0: Deprecated HYDROmorphone [Mass] of Dose
  42901-9: Dihydrocodeine [Mass/volume] in Serum or Plasma
  48362-8: O-desmethylvenlafaxine [Moles/volume] in Serum or Plasma
  48363-6: Morphine-6-Glucuronide [Moles/volume] in Serum or Plasma
  50966-1: Flunitrazepam [Presence] in Serum, Plasma or Blood
  53735-7: Barbiturates.other [Mass/volume] in Urine
  53781-1: Acetaminophen and Propoxyphene panel [Mass/volume] - Urine
  53816-5: Alpha hydroxytriazolam [Mass/volume] in Serum
  81207-3: Amitriptyline and Nortriptyline panel - Gastric fluid
  81210-7: clomiPRAMINE and Norclomipramine panel - Gastric fluid
  81211-5: Amitriptyline and Nortriptyline panel - Specimen
  86606-1: Cocaethylene/Creatinine [Mass Ratio] in Urine by Confirmatory method
  86608-7: Norcodeine/Creatinine [Mass Ratio] in Urine by Confirmatory method
  89065-7: Type of nonsteroidal anti-inflammatory drugs (NSAIDs) used several times a week
  94296-1: Norfluvoxamine [Presence] in Serum or Plasma by Screen method
  94305-0: OxyMORphone and Noroxymorphone panel - Urine by Confirmatory method
  9699-0: PARoxetine [Mass/volume] in Serum or Plasma
  9835-0: HYDROmorphone [Mass/volume] in Urine
  83318-6: Sexual activity with known intravenous drug user in the past year
  88714-1: Dehydroaripiprazole [Mass/volume] in Serum or Plasma by Confirmatory method
  88870-1: Drug regimen review identified potential medication issues in the last 3 days [CMS Assessment]
  91393-9: Opioid risk tool panel
  91568-6: Shot up or injected any non-prescription drugs Lifetime
  10344-0: Tranylcypromine [Mass/volume] in Serum or Plasma
  12784-5: Codeine Free [Mass/volume] in Serum or Plasma
  12787-8: HYDROmorphone Free [Mass/volume] in Serum or Plasma
  13063-3: Drug induced platelet Ab [Units/volume] in Serum
  12287-9: Drugs identified in Gastric fluid by Screen method
  12326-5: Diamorphine [Presence] in Unknown substance
  12350-5: Amphetamines [Presence] in Stool
  12354-7: Opiates [Presence] in Stool
  12360-4: Barbital [Presence] in Urine
  12363-8: carBAMazepine [Presence] in Urine
  12367-9: Mesoridazine [Presence] in Urine
  12374-5: cloBAZam [Mass/volume] in Urine
  12437-0: traMADol [Mass/volume] in Serum or Plasma
  12438-8: Nortramadol [Mass/volume] in Serum or Plasma
  12444-6: Nortrimipramine [Mass/volume] in Urine
  12499-0: PENTobarbital [Presence] in Stool
  12544-3: Nefazodone [Mass/volume] in Serum or Plasma
  3841-4: Nalbuphine [Mass/time] in 24 hour Urine
  3861-2: Nordiazepam [Presence] in Urine
  3869-5: Normeperidine [Mass/volume] in Urine
  41466-4: Methadone/Creatinine [Mass Ratio] in Urine
  41474-8: Diethylcarbamazepine [Mass/volume] in DBS
  41500-0: Linezolid [Susceptibility] by Method for Slow-growing mycobacteria
  4424-8: Secobarbital [Mass] of Dose
  4442-0: Thioridazine [Mass] of Dose
  44424-0: Methylenedioxymethamphetamine/Creatinine [Mass Ratio] in Urine
  46971-8: HYDROmorphone Free [Mass/volume] in Urine by Confirmatory method
  46976-7: Benzodiazepines [Presence] in Serum or Plasma by Screen method
  49746-1: Carboxy tetrahydrocannabinol [Presence] in Serum or Plasma by Screen method
  49831-1: Normorphine [Mass/volume] in Urine
  49871-7: Codeine IgE Ab [Units/volume] in Serum
  52571-7: Known allergies or adverse drug reactions [CARE]
  54986-5: Antidepressant received in last 7 days or since admission/reentry if less than 7 days [MDSv3]
  57924-3: Carboxy tetrahydrocannabinol [Presence] in Meconium
  58109-0: Multidrug-resistant organism (MDRO) in last 7 days [MDSv3]
  58187-6: Psychotropic drug use - care area triggered [MDSv3]
  40652-0: Methamphetamine [Presence] in Hair
  4073-3: Tricyclic antidepressants [Presence] in Serum or Plasma
  40802-1: Cocaine [Presence] in Saliva (oral fluid) by Screen method
  40804-7: Methamphetamine [Presence] in Saliva (oral fluid) by Screen method
  40805-4: Opiates [Presence] in Hair by Screen method
  4082-4: Trimipramine [Presence] in Serum or Plasma
  40864-1: 11-Hydroxy delta-9 tetrahydrocannabinol [Mass/volume] in Serum or Plasma
  4355-4: Deprecated Nordoxepin [Mass] of Dose
  4361-2: Nortriptyline [Mass] of Dose
  4367-9: Oxazepam [Mass] of Dose
  43811-9: Propoxyphene [Presence] in Specimen
  43827-5: Barbiturates [Mass/volume] in Specimen
  43897-8: Baclofen [Presence] in Serum or Plasma
  51954-6: oxyCODONE Free [Mass/volume] in Urine
  51964-5: Drug efficacy analysis overall interpretation
  57866-6: PENTobarbital [Moles/volume] in Specimen
  57767-6: Trimipramine and Nortrimipramine panel - Serum or Plasma
  8178-6: Cannabinoids [Presence] in Unknown substance by Confirmatory method
  8189-3: Benzoylecgonine [Presence] in Meconium by Screen method
  8193-5: Benzoylecgonine [Presence] in Urine by SAMHSA screen method
  85088-3: Maprotiline and normaprotiline panel - Serum or Plasma
  3746-5: Meperidine [Presence] in Urine
  3754-9: Meprobamate [Presence] in Urine
  3779-6: Methamphetamine [Presence] in Urine
  40370-9: Imipramine [Presence] in Gastric fluid
  40390-7: OLANZapine [Presence] in Urine
  40394-9: Phencyclidine [Presence] in Hair
  40419-4: Amphetamine+Methamphetamine [Presence] in Urine
  40493-9: Methylenedioxymethamphetamine [Presence] in Serum or Plasma
  40527-4: Cocaine [Presence] in Meconium
  40626-4: Codeine [Presence] in Specimen
  4307-5: Meperidine [Mass] of Dose
  4319-0: Methamphetamine [Mass] of Dose
  43198-1: Gamma hydroxybutyrate [Mass/volume] in Urine by Confirmatory method
  4321-6: Methaqualone [Mass] of Dose
  45914-9: Psychotropic drug use trigger [Minimum Data Set]
  48940-1: Benzodiazepines [Mass/volume] in Specimen by Confirmatory method
  48953-4: Hydroxyethylflurazepam [Mass/volume] in Specimen
  49044-1: diazePAM and Nordiazepam panel - Serum or Plasma
  5707-5: Deprecated Opiates [Identifier] in Urine
  57300-6: 6-Monoacetylmorphine (6-MAM) [Mass/volume] in Saliva (oral fluid)
  57304-8: Codeine [Mass/volume] in Saliva (oral fluid)
  3682-2: HYDROmorphone [Presence] in Serum or Plasma
  3683-0: HYDROmorphone [Mass/volume] in Serum or Plasma
  3701-0: Ketamine [Mass/volume] in Serum or Plasma
  3712-7: Levorphanol [Mass/volume] in Urine
  3713-5: Levorphanol [Mass/time] in 24 hour Urine
  3723-4: Lithium [Mass/volume] in Serum or Plasma --trough
  4002-2: Protriptyline [Mass/volume] in Serum or Plasma --trough
  4258-0: Flunitrazepam [Mass] of Dose
  42582-7: Barbiturates [Mass/volume] in Blood by Confirmatory method
  4276-2: HYDROcodone [Mass] of Dose
  42831-8: Drug abuse [CCC]
  4283-8: Imipramine [Mass] of Dose
  42856-5: Benzoylecgonine [Mass/volume] in Blood by Confirmatory method
  4301-8: LORazepam [Mass] of Dose
  45838-0: Number of days antidepressant medication received [Minimum Data Set]
  48364-4: Morphine-3-Glucuronide [Moles/volume] in Serum or Plasma
  48365-1: Methadone.R [Moles/volume] in Serum or Plasma
  53747-2: Cocaine panel - Urine
  53975-9: Drug crystals [Presence] in Urine sediment by Light microscopy
  56663-8: 5-Hydroxytryptophan [Moles/time] in 24 hour Urine
  86453-8: O-nortramadol [Presence] in Urine
  86604-6: Alfentanil/Creatinine [Mass Ratio] in Urine by Confirmatory method
  86605-3: Alpha hydroxytriazolam/Creatinine [Mass Ratio] in Urine by Confirmatory method
  89301-6: oxymorphone-3-glucuronide [Presence] in Urine by Screen method
  89302-4: Noroxymorphone [Presence] in Urine by Screen method
  89307-3: Naloxone-3-glucuronide [Presence] in Urine by Screen method
  89310-7: Codeine-6-glucuronide [Presence] in Urine by Screen method
  89424-6: Long-term opioid therapy for pain consent Document
  94291-2: Hydroxybupropion [Presence] in Serum or Plasma by Screen method
  94300-1: Vilazodone [Mass/volume] in Serum or Plasma by Confirmatory method
  94302-7: Vortioxetine [Mass/volume] in Serum or Plasma by Confirmatory method
  94304-3: OxyCODONE and metabolites panel - Urine by Confirmatory method
  9739-4: Deprecated Morphine [Presence] in Gastric fluid
  9776-6: Norchlordiazepoxide [Mass/volume] in Serum or Plasma
  80557-2: 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/mass] in Hair
  80560-6: Citalopram [Mass/volume] in DBS
  73956-5: JWH-122 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood
  73971-4: Methylenedioxymethamphetamine(MDMA)+Methylenedioxyethylamphetamine (MDEA)+Methylenedioxyamphetamine(MDA) [Interpretation] in Urine Qualitative
  73973-0: O-nortramadol [Mass/volume] in Blood
  73996-1: oxyCODONE [Presence] in Meconium by Screen method
  79139-2: Buprenorphine [Presence] in Blood by Screen method
  79146-7: Tapentadol [Presence] in Blood by Screen method
  79224-2: Baclofen [Mass/volume] in Body fluid
  79231-7: Amoxapine [Mass/volume] in Body fluid
  79240-8: Tapentadol cutoff [Mass/volume] in Urine for Screen method
  79255-6: oxyCODONE cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
  79257-2: Methylenedioxyamphetamine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
  60099-9: Loxapine [Mass/volume] in Blood
  60100-5: Loxapine [Mass/volume] in Urine
  60103-9: O-desmethylvenlafaxine [Mass/volume] in Body fluid
  60151-8: PENTobarbital [Mass/volume] in Blood
  60152-6: PENTobarbital [Mass/volume] in Body fluid
  60298-7: cloZAPine [Moles/volume] in Specimen
  60316-7: Methaqualone [Moles/volume] in Specimen
  60321-7: Norclobazam [Moles/volume] in Specimen
  60322-5: Norclomipramine [Moles/volume] in Specimen
  60330-8: Propoxyphene [Moles/volume] in Specimen
  60468-6: PHENobarbital [Mass/volume] in Serum or Plasma by Confirmatory method
  73209-9: PHENobarbital induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73211-5: Perphenazine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73256-0: Morphine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73260-2: Mirtazapine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73269-3: Midazolam induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73278-4: Methylphenidate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73366-7: Gabapentin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73374-1: FLUoxetine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73393-1: Escitalopram induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73425-1: Amphetamine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73435-0: clonazePAM induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73455-8: chlorproMAZINE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73496-2: buPROPion induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  75891-2: Abbreviated Injury Scale severity score AAAM
  76066-0: Abbreviated Injury Scale version code AAAM
  78752-3: 11-Hydroxy delta-9 tetrahydrocannabinol [Presence] in Body fluid by Screen method
  78758-0: 4-Hydroxymidazolam [Mass/volume] in Urine
  78770-5: Methadone [Mass/volume] in Urine -- adjusted for lean body mass+urine creatinine
  78778-8: Alfentanil [Presence] in Blood by Screen method
  78789-5: Amoxapine [Mass/mass] in Hair
  78793-7: ARIPiprazole [Mass/mass] in Hair
  78812-5: buPROPion cutoff [Mass/volume] in Urine for Confirmatory method
  78819-0: clomiPRAMINE cutoff [Mass/volume] in Urine for Confirmatory method
  78828-1: fentaNYL [Z-score] in Urine
  78831-5: Hydroxybupropion [Presence] in Urine by Confirmatory method
  78833-1: Hydroxylurasidone [Mass/volume] in Urine by Confirmatory method
  78838-0: JWH-073 4-hydroxybutyl (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method
  78846-3: JWH-200 6-Hydroxyindole (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method
  10977-7: ALPRAZolam [Mass/volume] in Blood
  10992-6: Norclozapine [Mass/volume] in Serum or Plasma
  11022-1: Barbiturates [Mass/volume] in Meconium
  11072-6: Despropionylfentanyl [Mass/volume] in Serum or Plasma
  11074-2: Norfentanyl [Mass/volume] in Serum or Plasma
  11230-0: Amobarbital [Mass/volume] in Urine
  11238-3: Hydroxyalprazolam [Mass/volume] in Urine
  11245-8: Deprecated Orphenadrine
  10537-9: Deprecated Doxepin+Nordoxepin [Mass/volume] in Serum or Plasma
  3637-6: fentaNYL [Mass/volume] in Urine
  39484-1: OLANZapine [Moles/volume] in Serum or Plasma
  3951-1: PHENobarbital Free [Mass/volume] in Serum or Plasma
  4212-7: Desipramine [Mass] of Dose
  42235-2: Benzodiazepine metabolites [Presence] in Urine by Screen method
  42241-0: Cocaine+Benzoylecgonine [Presence] in Urine by Screen method
  42492-9: Carboxy tetrahydrocannabinol [Presence] in Blood
  4255-6: fentaNYL [Mass] of Dose
  45022-1: Methadone+Metabolite [Presence] in Serum or Plasma by Confirmatory method
  45301-9: Nortriptyline [Moles/volume] in Urine
  50573-5: FDA product label OTC Type C medicated feed animal drug label
  50843-2: clonazePAM [Moles/volume] in Urine
  56032-6: Lithium [Moles/volume] in Gastric fluid
  3580-8: Doxepin [Presence] in Urine
  3619-4: Ethylmorphine [Mass/volume] in Urine
  3887-7: Oxazepam [Mass/volume] in Urine
  3917-2: Pentazocine [Presence] in Urine
  3923-0: PENTobarbital [Presence] in Serum or Plasma
  39244-9: Patient drug or alcohol use CPHS
  4200-2: Prochlorperazine [Mass] of Dose
  4209-3: Deprecated clomiPRAMINE [Mass] of Dose
  47386-8: Carboxy tetrahydrocannabinol [Mass/volume] in Serum or Plasma by Confirmatory method
  47400-7: Cocaine+Benzoylecgonine [Presence] in Urine by Confirmatory method
  47544-2: 5-Hydroxyindoleacetate [Moles/volume] in Cerebral spinal fluid
  50151-0: 5-Hydroxytryptophan [Moles/volume] in Urine
  52954-5: Cannabinoids [Moles/volume] in Urine
  52959-4: cloBAZam [Presence] in Urine
  55531-8: Cyclobenzaprine [Moles/volume] in Serum or Plasma
  55551-6: Methylenedioxyamphetamine [Moles/volume] in Serum or Plasma
  55588-8: OXcarbazepine + 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
  80116-7: 6-Monoacetylmorphine (6-MAM) [Mass/volume] in Body fluid by Confirmatory method
  80130-8: Amisulpride [Mass/volume] in Body fluid
  80148-0: Tricyclic antidepressants [Presence] in Serum or Plasma by Screen method
  80194-4: Ecgonine methyl ester [Mass/volume] in Body fluid by Confirmatory method
  80195-1: Ecgonine methyl ester [Mass/volume] in Serum or Plasma by Confirmatory method
  82935-8: Oxazepam [Mass/volume] in Serum or Plasma --trough
  90749-3: 4-Hydroxyatomoxetine [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  91031-5: Methamphetamine+Methylenedioxymethamphetamine [Presence] in Meconium by Screen method
  91034-9: Methamphetamine+Methylenedioxymethamphetamine [Presence] in Serum, Plasma or Blood by Screen method
  91036-4: Benzodiazepines [Presence] in Tissue by Screen method
  91038-0: Cocaine+Benzoylecgonine [Presence] in Body fluid by Screen method
  91045-5: Methamphetamine+Methylenedioxymethamphetamine [Presence] in Hair by Screen method
  91048-9: Cannabinoids [Presence] in Tissue by Screen method
  93345-7: Genetic variant effect on drug resistance in Blood or Tissue Narrative
  93437-2: Lurasidone [Mass/volume] in Serum or Plasma
  93467-9: Butyrylfentanyl [Mass/volume] in Urine by Confirmatory method
  3725-9: LORazepam [Mass/volume] in Urine
  3732-5: Lysergate diethylamide [Presence] in Urine
  3752-3: Meprobamate [Presence] in Serum or Plasma
  3777-0: Methamphetamine [Presence] in Serum or Plasma
  40412-9: Barbiturates [Presence] in Meconium
  40369-1: HYDROmorphone [Presence] in Gastric fluid
  40384-0: Morphine [Presence] in Hair
  40389-9: Nortriptyline [Presence] in Gastric fluid
  40403-8: Trimipramine [Presence] in Gastric fluid
  40411-1: Amitriptyline [Presence] in Gastric fluid
  43123-9: Imipramine and Desipramine panel - Serum or Plasma
  43199-9: Norfentanyl [Presence] in Urine
  43200-5: Norfentanyl [Presence] in Urine by Confirmatory method
  46262-2: Codeine Free [Presence] in Serum or Plasma by Screen method
  48935-1: 11-Hydroxy delta-9 tetrahydrocannabinol [Presence] in Specimen
  48939-3: Amphetamines [Mass/volume] in Specimen
  48943-5: Cannabinoids [Presence] in Specimen by Confirmatory method
  48963-3: Propoxyphene [Mass/volume] in Specimen by Confirmatory method
  48965-8: Temazepam [Mass/volume] in Specimen
  48966-6: Triazolam [Mass/volume] in Specimen
  51448-9: Dihydrocodeine+Hydrocodol [Mass/volume] in Urine
  51782-1: Drugs of abuse 7 and Alcohol and Tricyclics panel - Urine by Screen method
  51791-2: Tetrahydrocannabinol [Presence] in Serum or Plasma by Confirmatory method
  57195-0: Patient/caregiver drug education intervention [CMS Assessment]
  57257-8: Patient/caregiver received high risk drug education [CMS Assessment]
  3721-8: Lithium [Mass/volume] in Urine
  4260-6: FLUoxetine [Mass] of Dose
  42662-7: Benzodiazepines [Presence] in Blood
  4292-9: Ketamine [Mass] of Dose
  4300-0: Lithium [Mass] of Dose
  45753-1: Alcohol or drug treatment program
  50965-3: Gamma hydroxybutyrate cutoff [Mass/volume] in Serum or Plasma
  53746-4: Barbiturates panel - Urine
  53846-2: Buprenorphine [Mass/volume] in Serum or Plasma by Confirmatory method
  5678-8: Lysergate diethylamide [Mass/volume] in Serum or Plasma by Radioimmunoassay (RIA)
  81209-9: clomiPRAMINE and Norclomipramine panel - Urine
  81212-3: clomiPRAMINE and Norclomipramine panel - Specimen
  81274-3: Doxepin and Nordoxepin panel - Gastric fluid
  89304-0: Norhydrocodone [Presence] in Urine by Screen method
  89305-7: Norbuprenorphine-3-glucuronide [Presence] in Urine by Screen method
  89309-9: Hydromorphone-3-glucuronide [Presence] in Urine by Screen method
  89321-4: Buprenorphine-3-glucuronide [Mass/volume] in Serum or Plasma by Confirmatory method
  89322-2: Norbuprenorphine-3-glucuronide [Mass/volume] in Serum or Plasma by Confirmatory method
  94301-9: Vortioxetine [Presence] in Serum or Plasma by Screen method
  9738-6: Gabapentin [Mass/volume] in Serum, Plasma or Blood
  80555-6: Diamorphine [Mass/mass] in Hair
  80614-1: Baclofen [Moles/volume] in Specimen
  86225-0: clonazePAM/Creatinine [Mass Ratio] in Urine by Confirmatory method
  86227-6: Dihydrocodeine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
  91370-7: Body height --used for drug calculation
  91385-5: Age when first used cocaine or crack
  91569-4: Frequency of medicine or drug injection with needle during time period with highest use 12 months
  9383-1: 9-Hydroxyrisperidone [Mass/volume] in Serum or Plasma
  9391-4: Quazepam [Mass/volume] in Serum or Plasma
  9395-5: SUFentanil [Mass/volume] in Serum or Plasma
  79249-9: Methadone cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
  79260-6: fentaNYL cutoff [Mass/volume] in Urine for Screen method
  60104-7: O-desmethylvenlafaxine [Mass/mass] in Tissue
  60106-2: OLANZapine [Mass/volume] in Body fluid
  60115-3: 9-Hydroxyrisperidone [Mass/volume] in Blood
  60208-6: Venlafaxine [Mass/volume] in Blood
  60276-3: oxyCODONE+oxyMORphone cutoff [Mass/volume] in Urine for Screen method
  60305-0: fluPHENAZine [Moles/volume] in Specimen
  60324-1: Nortriptyline [Moles/volume] in Specimen
  60327-4: PARoxetine [Moles/volume] in Specimen
  60335-7: traZODone [Moles/volume] in Specimen
  60467-8: oxyMORphone [Mass/volume] in Serum or Plasma
  65632-2: cloZAPine and Norclozapine panel - Serum or Plasma
  73214-9: PARoxetine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73221-4: oxyCODONE+Acetylsalicylate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73234-7: OLANZapine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73235-4: OLANZapine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73285-9: Methocarbamol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73344-4: HYDROcodone+Chlorpheniramine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73422-8: diazePAM induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73423-6: diazePAM induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73434-3: clonazePAM induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73483-0: Carisoprodol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  78744-0: FDA product label Drug for further processing label
  78753-1: 11-Hydroxy delta-9 tetrahydrocannabinol [Presence] in Serum or Plasma by Screen method
  78756-4: 2-Oxo-3-Hydroxy-Lysergate diethylamide [Presence] in Blood by Screen method
  78761-4: 7-Aminoclonazepam [Mass/mass] in Hair
  78765-5: oxyMORphone [Mass/volume] in Urine -- adjusted for lean body mass+urine creatinine
  78777-0: Alfentanil [Mass/mass] in Hair
  78790-3: Amphetamine [Presence] in Body fluid by Screen method
  78811-7: Buprenorphine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
  78815-8: Carisoprodol [Mass/volume] in Blood by Confirmatory method
  78816-6: Carisoprodol+Meprobamate [Presence] in Blood by Confirmatory method
  78818-2: Citalopram cutoff [Mass/volume] in Urine for Confirmatory method
  78836-4: JWH-018 5-hydroxypentyl (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method
  78837-2: JWH-018 pentanoate (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method
  78844-8: JWH-200 4-hydroxyindole (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method
  78850-5: JWH-250 5-hydroxypentyl (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method
  78861-2: Morphine [Z-score] in Urine
  78869-5: O-desmethylvenlafaxine cutoff [Mass/volume] in Urine for Confirmatory method
  78874-5: oxyMORphone [Z-score] in Urine
  78877-8: QUEtiapine [Mass/volume] in Urine by Confirmatory method
  78879-4: RCS-4 5-carboxypentyl (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method
  78881-0: RCS-4 5-hydroxypentyl (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method
  78891-9: Tricyclic antidepressants [Presence] in Hair
  78918-0: 7-Hydroxyquetiapine [Z-score] in Urine
  97183-8: Mephobarbital and PHENobarbital panel - Serum or Plasma
  97270-3: Meprobamate [Presence] in Cord tissue by Screen method
  97245-5: 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Cord tissue by Confirmatory method
  74819-4: Promazine [Presence] in Urine by Screen method
  74911-9: Sertraline [Mass/volume] in Serum or Plasma --trough
  74923-4: Deprecated Temazepam [Mass/volume] in Serum or Plasma --trough
  74926-7: PHENobarbital [Mass/volume] in Serum or Plasma --trough
  74949-9: Perphenazine [Mass/volume] in Serum or Plasma --trough
  77322-6: Amitriptyline+Nortriptyline [Moles/volume] in Specimen
  77326-7: LORazepam [Moles/volume] in Specimen
  77331-7: Nortrimipramine [Moles/volume] in Specimen
  77335-8: Propoxyphene + Norpropoxyphene [Moles/volume] in Specimen
  77374-7: clomiPRAMINE trough, clomiPRAMINE+Norclomipramine trough and Norclomipramine panel - Serum or Plasma
  58363-3: Alpha hydroxyalprazolam/Creatinine [Mass Ratio] in Urine
  58379-9: fentaNYL+Norfentanyl [Presence] in Urine by Screen method
  58385-6: Meperidine+Normeperidine [Presence] in Urine by Screen method
  58392-2: Morphine/Creatinine [Mass Ratio] in Urine
  58426-8: Carisoprodol [Presence] in Urine by Confirmatory method
  61409-9: Cyclobenzaprine [Presence] in Urine by Confirmatory method
  61410-7: Cyclobenzaprine [Mass/volume] in Urine by Confirmatory method
  61411-5: Desipramine/Creatinine [Mass Ratio] in Urine
  61419-8: Imipramine [Mass/volume] in Urine by Confirmatory method
  61420-6: Norhydrocodone/Creatinine [Mass Ratio] in Urine
  61421-4: Norhydrocodone [Presence] in Urine by Confirmatory method
  61424-8: Noroxycodone [Presence] in Urine by Confirmatory method
  61426-3: Nortriptyline/Creatinine [Mass Ratio] in Urine
  66128-0: chlordiazePOXIDE/Creatinine [Mass Ratio] in Urine
  66238-7: Is your doctor currently prescribing drugs, for example, water pills, for your blood pressure or heart condition [Revised PARQ]
  66388-0: Has the child take cortisone, prednisone, other steroids, or anticancer drugs or had x-ray treatments in the past 3 months [PhenX]
  66470-6: How long ago has it been since you last used a needle to inject a drug not prescribed by a doctor [PhenX]
  68970-3: Gamma hydroxybutyrate [Moles/volume] in Specimen
  69008-1: Cocaine panel - Meconium by Confirmatory method
  69021-4: Amphetamines panel - Meconium by Confirmatory method
  69023-0: Methylenedioxyamphetamine [Mass/mass] in Meconium by Confirmatory method
  69028-9: oxyMORphone [Mass/mass] in Meconium by Confirmatory method
  74136-3: fentaNYL [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
  74379-9: Morphine [Mass/volume] in Unknown substance
  74383-1: fentaNYL [Mass/volume] in Unknown substance
  74386-4: Normirtazapine [Mass/mass] in Specimen
  74387-2: Normirtazapine [Mass/volume] in Urine
  74391-4: Baclofen [Mass/volume] in Blood
  77204-6: Buprenorphine [Presence] in Saliva (oral fluid) by Confirmatory method
  97229-9: chlordiazePOXIDE [Presence] in Cord tissue by Confirmatory method
  97239-8: N-desalkylflurazepam [Presence] in Cord tissue by Confirmatory method
  96843-8: How often have you used illegal or recreational drugs in past 12 months
  97285-1: Norfentanyl [Presence] in Cord tissue by Confirmatory method
  97234-9: Cocaine [Presence] in Cord tissue by Screen method
  96864-4: Have you tried and failed to control, cut down or stop using an opiate pain reliever in past 3 months [TAPS]
  97267-9: Methylenedioxymethamphetamine [Presence] in Cord tissue by Confirmatory method
  97305-7: Temazepam [Presence] in Cord tissue by Confirmatory method
  97218-2: ALPRAZolam [Presence] in Cord tissue by Screen method
  97268-7: Meperidine [Presence] in Cord tissue by Screen method
  97221-6: Amphetamine [Presence] in Cord tissue by Confirmatory method
  96859-4: Has anyone expressed concern about your use of cocaine, crack, or methamphetamine (crystal meth) in past 3 months [TAPS]
  79258-0: Meprobamate cutoff [Mass/volume] in Urine for Confirmatory method
  79259-8: fentaNYL cutoff [Mass/volume] in Urine for Confirmatory method
  79261-4: HYDROcodone cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
  60102-1: O-desmethylvenlafaxine [Mass/volume] in Blood
  60116-1: 9-Hydroxyrisperidone [Mass/volume] in Urine
  60138-5: PARoxetine [Mass/mass] in Tissue
  60149-2: Pentazocine [Mass/volume] in Blood
  60160-9: Perphenazine [Mass/volume] in Blood
  60210-2: Venlafaxine [Mass/mass] in Tissue
  60295-3: Citalopram [Moles/volume] in Specimen
  60300-1: Desipramine [Moles/volume] in Specimen
  60302-7: Doxepin [Moles/volume] in Specimen
  60304-3: FLUoxetine [Moles/volume] in Specimen
  60313-4: Maprotiline [Moles/volume] in Specimen
  60315-9: Mesoridazine [Moles/volume] in Specimen
  60328-2: Pentazocine [Moles/volume] in Specimen
  60336-5: Trimipramine [Moles/volume] in Specimen
  67822-7: fentaNYL and Norfentanyl panel - Urine
  6797-5: Cyclobenzaprine [Mass/volume] in Serum or Plasma
  73191-9: Propoxyphene induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73208-1: PHENobarbital induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73215-6: PARoxetine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73279-2: Methylphenidate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73294-1: LORazepam induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73295-8: LORazepam induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73303-0: Linezolid induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73346-9: HYDROcodone+Acetaminophen induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73392-3: Escitalopram induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73413-7: Diphenoxylate and Atropine (Lomatil) induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73454-1: chlorproMAZINE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73456-6: chlordiazePOXIDE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73514-2: Atomoxetine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  75890-4: Abbreviated Injury Scale predot code AAAM
  76067-8: Abbreviated Injury Scale panel AAAM
  78754-9: 11-Hydroxy delta-9 tetrahydrocannabinol [Presence] in Urine by Screen method
  78755-6: 1-Hydroxymidazolam [Mass/volume] in Blood
  78759-8: 6-Monoacetylmorphine (6-MAM) [Presence] in Blood by Screen method
  78764-8: 7-Hydroxyquetiapine [Mass/volume] in Urine -- adjusted for lean body mass+urine creatinine
  78767-1: oxyCODONE [Mass/volume] in Urine -- adjusted for lean body mass+urine creatinine
  78769-7: HYDROcodone [Mass/volume] in Urine -- adjusted for lean body mass+urine creatinine
  78802-6: Baclofen [Mass/mass] in Hair
  78804-2: Barbital [Mass/volume] in Blood
  78824-0: DULoxetine cutoff [Mass/volume] in Urine for Confirmatory method
  78835-6: Imipramine cutoff [Mass/volume] in Urine for Confirmatory method
  78839-8: JWH-073 butanoate (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method
  78840-6: JWH-081 5-hydroxypentyl (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method
  78864-6: Naloxone cutoff [Mass/volume] in Urine for Confirmatory method
  78878-6: RCS-4 5-carboxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method
  97248-9: fentaNYL [Presence] in Cord tissue by Screen method
  97278-6: Midazolam [Presence] in Cord tissue by Screen method
  5936-0: Benzoylecgonine [Mass/mass] in Hair
  59589-2: 1-Hydroxymidazolam [Mass/volume] in Urine
  59590-0: 1-Hydroxymidazolam [Mass/volume] in Urine by Confirmatory method
  59591-8: 7-Aminoclonazepam [Mass/volume] in Blood
  59592-6: 7-Aminoclonazepam [Mass/volume] in Blood by Confirmatory method
  59593-4: 7-Aminoclonazepam [Mass/volume] in Body fluid
  59601-5: Alpha hydroxyalprazolam [Mass/volume] in Body fluid
  59603-1: Alpha hydroxyalprazolam [Mass/mass] in Meconium by Confirmatory method
  59605-6: Alpha hydroxyalprazolam [Mass/mass] in Tissue
  64718-0: During this pregnancy, did you receive help with an alcohol or drug problem [PhenX]
  67083-6: Someone in your family has an alcohol or drug problem [PhenX]
  72385-8: 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  72396-5: PHENobarbital [Mass/volume] in Blood by Confirmatory method
  72397-3: Secobarbital [Mass/volume] in Blood by Confirmatory method
  72405-4: Cocaine [Mass/volume] in Blood by Confirmatory method
  72406-2: Norchlordiazepoxide [Mass/volume] in Blood by Confirmatory method
  72464-1: JWH-073 4-hydroxybutyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
  72474-0: JWH-122 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
  72478-1: Synthetic cannabinoids panel - Urine by Confirmatory method
  72627-3: Barbiturates [Presence] in Saliva (oral fluid) by Screen method
  72635-6: PENTobarbital [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  72668-7: Mirtazapine [Mass/volume] in Serum or Plasma --trough
  72672-9: traZODone [Mass/volume] in Serum or Plasma --trough
  72733-9: HYDROmorphone [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  72741-2: Nortramadol [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  72742-0: Noroxycodone [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  72748-7: Meprobamate [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  72752-9: Morphine [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  72758-6: Amphetamine [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  72764-4: Carboxy tetrahydrocannabinol [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  72775-0: Venlafaxine/Creatinine [Mass Ratio] in Urine
  72782-6: JWH-018 pentanoate (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method
  72785-9: PARoxetine/Creatinine [Mass Ratio] in Urine
  72789-1: Naltrexone/Creatinine [Mass Ratio] in Urine
  74959-8: Deprecated fluvoxaMINE [Mass/volume] in Serum or Plasma --trough
  74973-9: carBAMazepine [Mass/volume] in Serum or Plasma --trough
  74980-4: LORazepam [Mass/volume] in Serum or Plasma --trough
  74982-0: FLUoxetine [Mass/volume] in Serum or Plasma --trough
  75030-7: FDA product label Wholesale drug distributors and third-party logistics facility registration
  75362-4: Tapentadol glucuronide [Mass/volume] in Urine by Screen method
  75368-1: Buprenorphine [Mass/volume] in Serum, Plasma or Blood
  77730-0: oxyCODONE [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
  77732-6: oxyCODONE+oxyMORphone [Presence] in Serum, Plasma or Blood by Screen method
  77761-5: ARIPiprazole [Mass/volume] in Urine by Confirmatory method
  77882-9: Dehydroaripiprazole cutoff [Mass/volume] in Urine for Confirmatory method
  77961-1: cloZAPine [Mass/volume] in Urine by Confirmatory method
  97212-5: 7-Aminoclonazepam [Presence] in Cord tissue by Screen method
  97251-3: Flunitrazepam [Presence] in Cord tissue by Confirmatory method
  97240-6: diazePAM [Presence] in Cord tissue by Screen method
  96854-5: Used marijuana in past 3 months
  72617-4: Propoxyphene [Presence] in Saliva (oral fluid) by Screen method
  72626-5: Methadone [Presence] in Saliva (oral fluid) by Screen method
  72629-9: Secobarbital [Presence] in Saliva (oral fluid) by Confirmatory method
  72632-3: Butalbital [Presence] in Saliva (oral fluid) by Confirmatory method
  72751-1: oxyCODONE [Mass/volume] in Saliva (oral fluid) by Screen method
  72756-0: ALPRAZolam [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  72757-8: Benzodiazepines [Mass/volume] in Saliva (oral fluid) by Screen method
  72760-2: fentaNYL [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  72763-6: 6-Monoacetylmorphine (6-MAM) [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  72768-5: Zolpidem phenyl-4-carboxylate [Mass/volume] in Urine by Confirmatory method
  72773-5: O-desmethylvenlafaxine/Creatinine [Mass Ratio] in Urine
  72783-4: JWH-018 pentanoate (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine
  74951-5: Deprecated E-10-Hydroxynortriptyline [Mass/volume] in Serum or Plasma --trough
  74968-9: Deprecated Norsertraline [Mass/volume] in Serum or Plasma --trough
  74981-2: Pimozide [Mass/volume] in Serum or Plasma --trough
  75226-1: 8-Hydroxyamoxapine [Presence] in Urine
  75229-5: DULoxetine [Presence] in Urine
  75232-9: Norcitalopram [Presence] in Urine
  75234-5: O-desmethylvenlafaxine [Presence] in Urine
  75347-5: Tapentadol [Mass/volume] in Serum, Plasma or Blood
  75367-3: Buprenorphine [Mass/mass] in Meconium by Confirmatory method
  75370-7: Norbuprenorphine [Mass/volume] in Serum, Plasma or Blood
  77758-1: 7-Hydroxyquetiapine cutoff [Mass/volume] in Urine for Confirmatory method
  77760-7: ARIPiprazole cutoff [Mass/volume] in Urine for Confirmatory method
  77773-0: Morphine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
  77877-9: Ziprasidone [Mass/volume] in Urine by Confirmatory method
  77884-5: Dehydroaripiprazole [Mass/volume] in Urine by Confirmatory method
  77886-0: Nortriptyline cutoff [Mass/volume] in Urine for Confirmatory method
  97288-5: Normeperidine [Presence] in Cord tissue by Screen method
  97260-4: LORazepam [Presence] in Cord tissue by Screen method
  97295-0: oxyCODONE Free [Presence] in Cord tissue by Screen method
  97231-5: clonazePAM [Presence] in Cord tissue by Confirmatory method
  97224-0: Butalbital [Presence] in Cord tissue by Screen method
  74655-2: Norsertraline [Mass/volume] in Urine
  74658-6: oxyCODONE+oxyMORphone [Presence] in Saliva (oral fluid) by Confirmatory method
  74678-4: Carboxy tetrahydrocannabinol [Presence] in Saliva (oral fluid) by Confirmatory method
  74810-3: Acetyl fentanyl [Presence] in Urine by Confirmatory method
  74817-8: Desomorphine [Mass/volume] in Urine by Confirmatory method
  74924-2: Nortriptyline [Mass/volume] in Serum or Plasma --trough
  74933-3: Deprecated N-desalkylflurazepam [Mass/volume] in Serum or Plasma --trough
  74947-3: Deprecated Norclomipramine [Mass/volume] in Serum or Plasma --trough
  77324-2: Flurazepam [Moles/volume] in Specimen
  77332-5: Morphine [Moles/volume] in Specimen
  77447-1: Nordiazepam [Moles/volume] in Specimen
  77573-4: FDA product label Withdrawal of wholesale drug distributors and third-party logistics facility report
  58366-6: LORazepam/Creatinine [Mass Ratio] in Urine
  58371-6: Carisoprodol/Creatinine [Mass Ratio] in Urine
  58372-4: Meprobamate/Creatinine [Mass Ratio] in Urine
  58374-0: Meprobamate [Mass/volume] in Urine by Confirmatory method
  58382-3: Norfentanyl/Creatinine [Mass Ratio] in Urine
  58386-4: Meperidine/Creatinine [Mass Ratio] in Urine
  58389-8: Normeperidine [Mass/volume] in Urine by Confirmatory method
  97591-2: Norbuprenorphine free [Presence] in Cord tissue by Confirmatory method
  96863-6: Used prescription opiate pain reliever not as prescribed or not prescribed for you in past 3 months
  58364-1: 7-Aminoclonazepam/Creatinine [Mass Ratio] in Urine
  58380-7: fentaNYL/Creatinine [Mass Ratio] in Urine
  58388-0: Normeperidine [Presence] in Urine by Confirmatory method
  58390-6: 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP)/Creatinine [Mass Ratio] in Urine
  58391-4: Codeine/Creatinine [Mass Ratio] in Urine
  58393-0: HYDROcodone/Creatinine [Mass Ratio] in Urine
  58428-4: 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Urine by Confirmatory method
  58430-0: oxyCODONE+oxyMORphone [Presence] in Urine by Screen method
  61407-3: Amitriptyline/Creatinine [Mass Ratio] in Urine
  61413-1: Desipramine [Mass/volume] in Urine by Confirmatory method
  61427-1: Nortriptyline [Presence] in Urine by Confirmatory method
  64127-4: Methylenedioxyethylamphetamine/Creatinine [Mass Ratio] in Urine
  64133-2: PHENobarbital/Creatinine [Mass Ratio] in Urine
  64139-9: Butalbital/Creatinine [Mass Ratio] in Urine
  6895-7: Butalbital [Mass/volume] in Serum or Plasma
  6896-5: cloZAPine [Mass/volume] in Serum or Plasma
  6897-3: Norsertraline [Mass/volume] in Serum or Plasma
  69026-3: Opiates panel - Meconium by Confirmatory method
  74062-1: Generic or investigational drug name of Medication
  74157-9: Cannabinoids [Presence] in Serum, Plasma or Blood by Screen method
  74372-4: Acetyl fentanyl [Mass/volume] in Urine
  74380-7: HYDROmorphone [Mass/volume] in Unknown substance
  97582-1: Buprenorphine free [Presence] in Cord tissue by Screen method
  97262-0: Methylenedioxyamphetamine [Presence] in Cord tissue by Screen method
  97233-1: Cocaethylene [Presence] in Cord tissue by Confirmatory method
  97323-0: oxyCODONE Free [Presence] in Cord tissue by Confirmatory method
  97585-4: Carboxy tetrahydrocannabinol [Presence] in Cord tissue by Confirmatory method
  97258-8: Hydroxytriazolam [Presence] in Cord tissue by Screen method
  97274-5: Methamphetamine [Presence] in Cord tissue by Screen method
  97250-5: Flunitrazepam [Presence] in Cord tissue by Screen method
  97310-7: Zolpidem [Presence] in Cord tissue by Screen method
  97308-1: Triazolam [Presence] in Cord tissue by Screen method
  97266-1: Methylenedioxymethamphetamine [Presence] in Cord tissue by Screen method
  97296-8: oxyMORphone Free [Presence] in Cord tissue by Screen method
  97584-7: Carboxy tetrahydrocannabinol [Presence] in Cord tissue by Screen method
  97261-2: LORazepam [Presence] in Cord tissue by Confirmatory method
  97161-4: Amphetamines panel - Urine by Confirmatory method
  97271-1: Meprobamate [Presence] in Cord tissue by Confirmatory method
  97255-4: HYDROcodone Free [Presence] in Cord tissue by Confirmatory method
  97279-4: Midazolam [Presence] in Cord tissue by Confirmatory method
  97237-2: Codeine Free [Presence] in Cord tissue by Confirmatory method
  94298-7: O-desmethylvenlafaxine [Presence] in Serum or Plasma by Screen method
  9809-5: Propoxyphene [Presence] in Gastric fluid
  9815-2: Lithium [Mass/volume] in Red Blood Cells
  80533-3: Methamphetamine [Mass/mass] in Hair
  80538-2: Methylphenidate [Mass/mass] in Hair
  80539-0: Morphine [Mass/mass] in Hair
  80542-4: Norcitalopram [Mass/volume] in DBS
  80543-2: Norclozapine [Mass/volume] in DBS
  80609-1: Linezolid [Mass/volume] in DBS
  86224-3: ALPRAZolam/Creatinine [Mass Ratio] in Urine by Confirmatory method
  58394-8: HYDROmorphone/Creatinine [Mass Ratio] in Urine
  61408-1: Cyclobenzaprine/Creatinine [Mass Ratio] in Urine
  61412-3: Desipramine [Presence] in Urine by Confirmatory method
  61422-2: Norhydrocodone [Mass/volume] in Urine by Confirmatory method
  61423-0: Noroxycodone/Creatinine [Mass Ratio] in Urine
  64130-8: diazePAM/Creatinine [Mass Ratio] in Urine
  64138-1: Methylenedioxyamphetamine/Creatinine [Mass Ratio] in Urine
  66129-8: fentaNYL+Norfentanyl [Presence] in Urine by Confirmatory method
  66130-6: fentaNYL+Norfentanyl [Presence] in Serum or Plasma by Confirmatory method
  66469-8: How old were you when you first used a needle to inject any drug not prescribed by a doctor [PhenX]
  69024-8: Methylenedioxyethylamphetamine [Mass/mass] in Meconium by Confirmatory method
  69033-9: Buprenorphine and Norbuprenorphine panel - Urine
  74083-7: Norolanzapine [Moles/volume] in Serum or Plasma
  74095-1: Didesmethylcitalopram [Mass/volume] in Serum or Plasma
  74167-8: Opiates [Mass/volume] in Saliva (oral fluid) by Screen method
  74204-9: Drug use [NTDS]
  77207-9: Naloxone [Mass/volume] in Urine by Confirmatory method
  97191-1: carBAMazepine [Moles/volume] in Serum or Plasma --peak
  97587-0: Tetrahydrocannabinol [Presence] in Cord tissue by Confirmatory method
  97281-0: Morphine Free [Presence] in Cord tissue by Confirmatory method
  97215-8: Acetyl fentanyl [Presence] in Cord tissue by Confirmatory method
  97154-9: Ecgonine methyl ester [Presence] in Urine by Confirmatory method
  97309-9: Triazolam [Presence] in Cord tissue by Confirmatory method
  97284-4: Norfentanyl [Presence] in Cord tissue by Screen method
  97241-4: diazePAM [Presence] in Cord tissue by Confirmatory method
  96858-6: Used cocaine, crack, or methamphetamine at least once a week in past 3 months
  97225-7: Butalbital [Presence] in Cord tissue by Confirmatory method
  97242-2: Dihydrocodeine Free+Hydrocodol Free [Presence] in Cord tissue by Screen method
  97223-2: Benzoylecgonine [Presence] in Cord tissue by Confirmatory method
  97222-4: Benzoylecgonine [Presence] in Cord tissue by Screen method
  97301-6: PHENobarbital [Presence] in Cord tissue by Confirmatory method
  97219-0: ALPRAZolam [Presence] in Cord tissue by Confirmatory method
  83314-5: Sexual activity while intoxicated AndOr high on drugs in the past year
  91572-8: Used erectile dysfunction drug in past 12 months
  94055-1: Bacterial inhA gene drug resistance mutation [Identifier] by Molecular method
  94056-9: Bacterial fabG1 gene drug resistance mutation [Identifier] by Molecular method
  94106-2: Temazepam glucuronide [Presence] in Urine by Screen method
  94108-8: 1-Hydroxymidazolam [Presence] in Urine by Screen method
  94112-0: 7-Aminoclonazepam [Presence] in Urine by Screen method
  96366-0: Naltrexone [Presence] in Saliva (oral fluid) by Confirmatory method
  96368-6: Pregabalin [Presence] in Saliva (oral fluid) by Confirmatory method
  96370-2: Sertraline [Presence] in Saliva (oral fluid) by Confirmatory method
  78848-9: JWH-210 5-Hydroxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method
  78866-1: Norbuprenorphine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
  78868-7: Norhydrocodone cutoff [Mass/volume] in Urine for Confirmatory method
  78882-8: Sertraline cutoff [Mass/volume] in Urine for Confirmatory method
  97256-2: HYDROmorphone Free [Presence] in Cord tissue by Screen method
  97210-9: 6-monoacetylmorphine free [Presence] in Cord tissue by Screen method
  97226-5: Carisoprodol [Presence] in Cord tissue by Screen method
  97220-8: Amphetamine [Presence] in Cord tissue by Screen method
  96855-2: Have you had a strong desire or urge to use marijuana at least once a week or more often in past 3 months [TAPS]
  72377-5: Nordiazepam [Mass/volume] in Saliva (oral fluid)
  72384-1: Meperidine+Normeperidine [Presence] in Urine by Confirmatory method
  72401-3: Propoxyphene [Presence] in Blood by Screen method
  72452-6: Secobarbital [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  72453-4: PHENobarbital [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  72454-2: Butalbital [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  72460-9: JWH-073 3-hydroxybutyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
  72472-4: UR-144 pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
  72475-7: Methadone+Metabolite [Presence] in Saliva (oral fluid) by Confirmatory method
  72618-2: Propoxyphene + Norpropoxyphene [Presence] in Saliva (oral fluid)
  72619-0: Norpropoxyphene [Mass/volume] in Saliva (oral fluid)
  72634-9: Temazepam [Presence] in Saliva (oral fluid)
  72734-7: Methadone [Mass/volume] in Saliva (oral fluid) by Screen method
  72735-4: Methamphetamine [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  72738-8: Temazepam [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  72750-3: oxyCODONE [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  72765-1: Phencyclidine [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  72769-3: Zolpidem phenyl-4-carboxylate/Creatinine [Mass Ratio] in Urine
  72778-4: JWH-073 butanoate (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method
  72787-5: Deprecated 6-Beta naltrexone [Mass/volume] in Urine by Confirmatory method
  74956-4: Deprecated chlordiazePOXIDE [Mass/volume] in Serum or Plasma --trough
  74964-8: Gabapentin [Mass/volume] in Serum or Plasma --trough
  74975-4: Nordiazepam [Mass/volume] in Serum or Plasma --trough
  75233-7: Norsertraline [Presence] in Urine
  75235-2: Vilazodone [Presence] in Urine
  77729-2: oxyMORphone [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
  77733-4: Gamma hydroxybutyrate [Presence] in Specimen by Screen method
  77755-7: 6-Monoacetylmorphine (6-MAM) cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
  77762-3: Alpha hydroxyalprazolam cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
  77770-6: HYDROmorphone cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
  77775-5: Norfentanyl cutoff [Mass/volume] in Urine for Confirmatory method
  77778-9: Noroxycodone cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
  77791-2: Benzoylecgonine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
  77883-7: QUEtiapine cutoff [Mass/volume] in Urine for Confirmatory method
  15371-8: Deprecated Morphine
  96857-8: Used cocaine, crack, or methamphetamine in past 3 months
  97192-9: carBAMazepine [Moles/volume] in Serum or Plasma --trough
  97265-3: Methylenedioxyethylamphetamine [Presence] in Cord tissue by Confirmatory method
  97269-5: Meperidine [Presence] in Cord tissue by Confirmatory method
  69022-2: Methamphetamine [Mass/mass] in Meconium by Confirmatory method
  69027-1: Morphine [Mass/mass] in Meconium by Confirmatory method
  6906-2: Sertraline [Mass/volume] in Serum or Plasma
  71568-0: These symptoms have led to my using drugs [M3]
  71743-9: FDA product label Generic drug facility identification submission
  74056-3: Clinical drug component - RxNorm RXCUI of Medication
  74110-8: traMADol [Presence] in Saliva (oral fluid) by Screen method
  74137-1: Norfentanyl [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
  74168-6: Barbiturates [Mass/volume] in Saliva (oral fluid) by Screen method
  74239-5: HEDIS 2014 Value Set - carBAMazepine Level
  74377-3: Baclofen [Mass/volume] in Unknown substance
  77767-2: Codeine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
  77771-4: JWH-081 5-hydroxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method
  77774-8: Norbuprenorphine cutoff [Mass/volume] in Urine for Confirmatory method
  77779-7: Noroxycodone cutoff [Mass/volume] in Urine for Confirmatory method
  77781-3: Pregabalin cutoff [Mass/volume] in Urine for Confirmatory method
  77790-4: Cocaine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
  77878-7: Ziprasidone cutoff [Mass/volume] in Urine for Confirmatory method
  77879-5: Tapentadol cutoff [Mass/volume] in Urine for Confirmatory method
  15365-0: Deprecated Codeine
  15406-2: Deprecated Methamphetamine
  97273-7: Methadone [Presence] in Cord tissue by Confirmatory method
  97647-2: Asenapine [Presence] in Urine by Confirmatory method
  97304-0: Temazepam [Presence] in Cord tissue by Screen method
  97302-4: Tapentadol [Presence] in Cord tissue by Screen method
  97227-3: Carisoprodol [Presence] in Cord tissue by Confirmatory method
  97214-1: Acetyl fentanyl [Presence] in Cord tissue by Screen method
  97159-8: 2-Hydroxyethylflurazepam [Mass/volume] in Urine by Confirmatory method
  97244-8: 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Cord tissue by Screen method
  96873-5: Illegal or recreational drug(s) used in past 3 months
  9426-8: Barbiturates [Mass/volume] in Urine
  9428-4: Benzodiazepines [Mass/volume] in Urine
  94293-8: Citalopram+Escitalopram [Mass/volume] in Serum or Plasma by Confirmatory method
  94295-3: DULoxetine [Presence] in Serum or Plasma by Screen method
  9438-3: Morphine [Presence] in Gastric fluid
  9746-9: Dantrolene [Mass/volume] in Serum or Plasma
  9777-4: Nalbuphine [Mass/volume] in Specimen
  9814-5: Dextroamphetamine [Mass/volume] in Serum or Plasma
  80532-5: Methadone [Mass/volume] in Blood
  80535-8: Methylenedioxyethylamphetamine [Mass/mass] in Hair
  80537-4: Methylenedioxymethamphetamine [Mass/mass] in Hair
  80556-4: cloZAPine [Mass/volume] in DBS
  80558-0: Amitriptyline [Mass/volume] in DBS
  86223-5: Acetyl norfentanyl [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
  86231-8: Midazolam/Creatinine [Mass Ratio] in Urine by Confirmatory method
  88715-8: Norquetiapine [Mass/volume] in Serum or Plasma by Confirmatory method
  9396-3: SUFentanil [Mass/volume] in Urine
  94060-1: Bacterial gyrA gene drug resistance mutation [Identifier] by Molecular method
  94061-9: Bacterial gidB gene drug resistance mutation [Identifier] by Molecular method
  94062-7: Bacterial rrs gene drug resistance mutation [Identifier] by Molecular method
  94063-5: Bacterial rpsL gene drug resistance mutation [Identifier] by Molecular method
  94065-0: Bacterial rpoB gene drug resistance mutation [Identifier] by Molecular method
  94107-0: Oxazepam glucuronide [Presence] in Urine by Screen method
  9415-1: Carbamazepine 10,11-Epoxide [Mass/volume] in Serum or Plasma
  96371-0: Tapentadol [Presence] in Saliva (oral fluid) by Confirmatory method
  79165-7: OXcarbazepine trough and 10-hydroxycarbazepine panel - Serum or Plasma
  79251-5: diazePAM cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
  79254-9: LORazepam cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
  60105-4: OLANZapine [Mass/volume] in Blood
  60136-9: PARoxetine [Mass/volume] in Blood
  60150-0: Pentazocine [Mass/volume] in Body fluid
  60209-4: Venlafaxine [Mass/volume] in Body fluid
  60285-4: Amoxapine [Moles/volume] in Specimen
  60296-1: cloBAZam [Moles/volume] in Specimen
  74381-5: Midazolam [Mass/volume] in Unknown substance
  74388-0: Normirtazapine [Mass/volume] in Body fluid
  74390-6: Baclofen [Mass/mass] in Specimen
  76910-9: I used alcohol and other drugs together to get high in past 30D [PROMIS]
  77205-3: Buprenorphine [Presence] in Meconium by Screen method
  77206-1: Norbuprenorphine [Presence] in Saliva (oral fluid) by Confirmatory method
  97272-9: Methadone [Presence] in Cord tissue by Screen method
  97235-6: Cocaine [Presence] in Cord tissue by Confirmatory method
  98415-3: Sertraline/Creatinine [Mass Ratio] in Urine by Confirmatory method
  97249-7: fentaNYL [Presence] in Cord tissue by Confirmatory method
  97294-3: Oxazepam [Presence] in Cord tissue by Confirmatory method
  96865-1: Has anyone expressed concern about your use of an opiate pain reliever in past 3 months [TAPS]
  97322-2: Oxazepam [Presence] in Cord tissue by Screen method
  86448-8: FDA product label Human salvaged drug
  86454-6: N-nortramadol [Presence] in Urine
  86609-5: Noroxymorphone/Creatinine [Mass Ratio] in Urine by Confirmatory method
  86753-1: Number of days antidepressant received in last 7 days or since admission/reentry if less than 7 days [CMS Assessment]
  89306-5: Nortapentadol [Presence] in Urine by Screen method
  9427-6: Barbiturates [Mass/volume] in Gastric fluid
  94292-0: Citalopram+Escitalopram [Presence] in Serum or Plasma by Screen method
  94294-6: Norcitalopram [Presence] in Serum or Plasma by Screen method
  94299-5: Vilazodone [Presence] in Serum or Plasma by Screen method
  9726-1: Mescaline [Mass/volume] in Urine
  9737-8: Propoxyphene [Mass/volume] in Gastric fluid
  9778-2: Phenelzine [Mass/volume] in Serum or Plasma
  9834-3: HYDROmorphone [Presence] in Urine
  80534-1: Methylenedioxyamphetamine [Mass/mass] in Hair
  80536-6: Methylenedioxyethylamphetamine [Mass/volume] in Blood
  80544-0: Nortriptyline [Mass/volume] in DBS
  80551-5: Tetrahydrocannabinol [Mass/mass] in Hair
  80645-5: Maprotiline+normaprotiline [Mass/volume] in Serum or Plasma
  83312-9: Exchanged drugs AndOr money for sex in the past year
  83313-7: Injection drug use in the past year
  86229-2: HYDROcodone [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
  86230-0: HYDROmorphone [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
  88706-7: Linezolid 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
  94057-7: Bacterial ahpC gene drug resistance mutation [Identifier] by Molecular method
  94059-3: Bacterial pncA gene drug resistance mutation [Identifier] by Molecular method
  94103-9: Zolpidem phenyl-4-carboxylate [Presence] in Urine by Screen method
  94109-6: LORazepam glucuronide [Presence] in Urine by Screen method
  94111-2: 7-Aminoflunitrazepam [Presence] in Urine by Screen method
  94114-6: cloBAZam [Presence] in Urine by Screen method
  94115-3: Alpha hydroxyalprazolam glucuronide [Presence] in Urine by Screen method
  96602-8: Methadone and EDDP panel - Serum or Plasma
  97264-6: Methylenedioxyethylamphetamine [Presence] in Cord tissue by Screen method
  97650-6: Desmethylcyclobenzaprine [Presence] in Urine by Confirmatory method
  97289-3: Normeperidine [Presence] in Cord tissue by Confirmatory method
  97213-3: 7-Aminoclonazepam [Presence] in Cord tissue by Confirmatory method
  97306-5: traMADol [Presence] in Cord tissue by Screen method
  97257-0: HYDROmorphone Free [Presence] in Cord tissue by Confirmatory method
  96872-7: Used other illegal or recreational drug in past 3 months TAPS
  97291-9: Noroxycodone [Presence] in Cord tissue by Confirmatory method
  60323-3: Nordoxepin [Moles/volume] in Specimen
  60337-3: Venlafaxine [Moles/volume] in Specimen
  65405-3: Have you ever lost consciousness from a drug overdose [PhenX]
  73189-3: Propoxyphene+Acetaminophen induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73190-1: Propoxyphene induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73222-2: oxyCODONE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73224-8: OXcarbazepine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73225-5: OXcarbazepine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73302-2: Linezolid induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73330-3: Ipratropium induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73331-1: Ipratropium induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73357-6: Haloperidol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73375-8: FLUoxetine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73412-9: Diphenoxylate and Atropine (Lomatil) induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73487-1: carBAMazepine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73493-9: Butalbital+Acetylsalicylate+Caffeine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73533-2: Amitriptyline induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73536-5: ALPRAZolam induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  78702-8: Multiple drug resistant gram negative organism [Identifier] in Specimen by Culture
  78751-5: 11-Hydroxy delta-9 tetrahydrocannabinol [Mass/mass] in Hair
  78771-3: 9-Hydroxyrisperidone [Mass/mass] in Hair
  78781-2: ALPRAZolam cutoff [Mass/volume] in Urine for Confirmatory method
  78783-8: AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method
  78786-1: Amitriptyline [Mass/volume] in Blood
  78803-4: Barbital [Mass/mass] in Hair
  78808-3: Benzodiazepines [Presence] in Serum or Plasma by Screen method >200 ng/mL
  78823-2: DULoxetine [Presence] in Urine by Confirmatory method
  78827-3: fentaNYL cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
  78841-4: JWH-122 5-hydroxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method
  78847-1: JWH-210 5-carboxypentyl (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method
  78849-7: JWH-210 5-Hydroxypentyl (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method
  78856-2: Meprobamate [Mass/volume] in Blood by Confirmatory method
  78859-6: Mirtazapine [Presence] in Urine by Confirmatory method
  78873-7: oxyCODONE [Z-score] in Urine
  97280-2: Morphine Free [Presence] in Cord tissue by Screen method
  97590-4: Norbuprenorphine free [Presence] in Cord tissue by Screen method
  97160-6: Norclobazam [Mass/volume] in Urine by Confirmatory method
  51984-3: Meperidine+Normeperidine [Presence] in Serum or Plasma by Screen method
  57746-0: Gamma hydroxybutyrate [Presence] in Urine by Confirmatory method
  8177-8: Cannabinoids [Presence] in Unknown substance
  8185-1: Benzoylecgonine [Presence] in Gastric fluid by Screen method
  8196-8: Cocaine [Presence] in Unknown substance by Confirmatory method
  81970-6: Codeine IgE Ab RAST class [Presence] in Serum
  8211-5: Opiates [Presence] in Gastric fluid by Confirmatory method
  82143-9: Did you live with anyone who used illegal street drugs or who abused prescription medications--before 18 years old [ACE.BRFSS]
  8214-9: Opiates [Presence] in Meconium
  87428-9: Drugs of abuse screen W Reflex confirm panel - Urine
  87488-3: AM694 N-5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
  70143-3: Cannabinoids [Mass/volume] in Urine by Screen method
  70145-8: Cannabinoids [Presence] in Urine by Screen method >50 ng/mL
  72379-1: Cannabinoids synthetic [Presence] in Specimen by Screen method
  72387-4: Methadone [Presence] in Saliva (oral fluid) by Confirmatory method
  72402-1: oxyCODONE [Presence] in Blood by Screen method
  72433-6: Gamma hydroxybutyrate [Moles/volume] in Cerebral spinal fluid
  72465-8: JWH-073 butanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
  72469-0: RCS-4 5-carboxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
  72473-2: JWH-398 5 hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
  72476-5: Methadone panel - Saliva (oral fluid) by Confirmatory method
  72610-9: diazePAM [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  72611-7: diazePAM [Presence] in Saliva (oral fluid)
  72612-5: ALPRAZolam [Presence] in Saliva (oral fluid)
  72633-1: Benzodiazepines [Presence] in Saliva (oral fluid) by Screen method
  72658-8: PARoxetine [Mass/volume] in Serum or Plasma --trough
  72739-6: Nordiazepam [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  72740-4: traMADol [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  72745-3: Norfentanyl [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  72749-5: Meperidine [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  72754-5: LORazepam [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  72761-0: Carisoprodol [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  72762-8: Buprenorphine [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  72766-9: oxyMORphone [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  72784-2: PARoxetine [Mass/volume] in Urine by Confirmatory method
  75021-6: OLANZapine panel - Serum or Plasma
  75227-9: Baclofen [Mass/volume] in Urine
  75228-7: Carisoprodol+Meprobamate [Mass/volume] in Urine by Confirmatory method
  75231-1: Nefazodone [Presence] in Urine
  77752-4: 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) cutoff [Mass/volume] in Urine for Screen method
  77756-5: 7-Aminoclonazepam cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
  77759-9: 9-Hydroxyrisperidone cutoff [Mass/volume] in Urine for Confirmatory method
  77766-4: clonazePAM cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
  77788-8: cloZAPine cutoff [Mass/volume] in Urine for Confirmatory method
  77881-1: risperiDONE cutoff [Mass/volume] in Urine for Confirmatory method
  77887-8: OLANZapine cutoff [Mass/volume] in Urine for Confirmatory method
  97232-3: Cocaethylene [Presence] in Cord tissue by Screen method
  77329-1: Temazepam [Moles/volume] in Specimen
  77330-9: Protriptyline [Moles/volume] in Specimen
  77334-1: Norpropoxyphene [Moles/volume] in Specimen
  77337-4: Trimipramine+Nortrimipramine [Moles/volume] in Specimen
  58361-7: Norbuprenorphine/Creatinine [Mass Ratio] in Urine
  58362-5: Norbuprenorphine [Presence] in Urine by Confirmatory method
  58369-0: Temazepam/Creatinine [Mass Ratio] in Urine
  58381-5: fentaNYL [Mass/volume] in Urine by Confirmatory method
  58383-1: Norfentanyl [Mass/volume] in Urine by Confirmatory method
  58384-9: 6-Monoacetylmorphine (6-MAM)/Creatinine [Mass Ratio] in Urine
  58396-3: oxyMORphone/Creatinine [Mass Ratio] in Urine
  58398-9: Propoxyphene/Creatinine [Mass Ratio] in Urine
  61418-0: Imipramine [Presence] in Urine by Confirmatory method
  61425-5: Noroxycodone [Mass/volume] in Urine by Confirmatory method
  64125-8: Pregabalin [Mass/volume] in Urine by Confirmatory method
  64126-6: Drugs identified in Meconium by Confirmatory method
  64129-0: N-desalkylflurazepam/Creatinine [Mass Ratio] in Urine
  64135-7: Secobarbital/Creatinine [Mass Ratio] of Urine
  66127-2: Amphetamine [Presence] in Serum or Plasma by Confirmatory method
  66131-4: Norbuprenorphine [Presence] in Serum or Plasma by Confirmatory method
  66474-8: Have you ever been in a drug treatment or drug rehabilitation program [PhenX]
  69011-5: Cocaethylene [Mass/mass] in Meconium by Confirmatory method
  69025-5: Methylenedioxymethamphetamine [Mass/mass] in Meconium by Confirmatory method
  74108-2: Meperidine [Presence] in Saliva (oral fluid) by Screen method
  74252-8: HEDIS 2014 Value Set - PHENobarbital Level
  74378-1: Meperidine [Mass/volume] in Unknown substance
  74385-6: Normirtazapine [Mass/mass] in Hair
  77201-2: Buprenorphine+Norbuprenorphine [Presence] in Saliva (oral fluid) by Confirmatory method
  97230-7: clonazePAM [Presence] in Cord tissue by Screen method
  97228-1: chlordiazePOXIDE [Presence] in Cord tissue by Screen method
  97259-6: Hydroxytriazolam [Presence] in Cord tissue by Confirmatory method
  97253-9: Flurazepam [Presence] in Cord tissue by Confirmatory method
  97298-4: Phencyclidine [Presence] in Cord tissue by Screen method
  97586-2: Tetrahydrocannabinol [Presence] in Cord tissue by Screen method
  97300-8: PHENobarbital [Presence] in Cord tissue by Screen method
  97275-2: Methamphetamine [Presence] in Cord tissue by Confirmatory method
  97311-5: Zolpidem [Presence] in Cord tissue by Confirmatory method
  97303-2: Tapentadol [Presence] in Cord tissue by Confirmatory method
  97243-0: Dihydrocodeine Free+Hydrocodol Free [Presence] in Cord tissue by Confirmatory method
  98416-1: traZODone/Creatinine [Mass Ratio] in Urine by Confirmatory method
  91571-0: Frequency of drug injection in past 12 months
  9394-8: risperiDONE+9-Hydroxyrisperidone [Mass/volume] in Serum or Plasma
  94105-4: Alpha hydroxytriazolam [Presence] in Urine by Screen method
  94116-1: ALPRAZolam [Presence] in Urine by Screen method
  94117-9: Benzodiazepines panel [Presence] - Urine by Screen method
  9418-5: Hydroxybupropion [Mass/volume] in Serum or Plasma
  96363-7: Dextrorphan+Levorphanol [Presence] in Saliva (oral fluid) by Confirmatory method
  9652-9: N-desalkylflurazepam [Mass/volume] in Serum or Plasma
  9697-4: Deprecated carBAMazepine 10,11-Epoxide [Mass/volume] in Serum or Plasma
  60294-6: chlorproMAZINE [Moles/volume] in Specimen
  60309-2: Imipramine [Moles/volume] in Specimen
  60326-6: OXcarbazepine [Moles/volume] in Specimen
  60332-4: QUEtiapine [Moles/volume] in Specimen
  65538-1: Did you take medication or use drugs or alcohol more than once for the worry or the problems it was causing [CIDI-SF]
  73210-7: Perphenazine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73220-6: oxyCODONE+Acetylsalicylate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73340-2: HYDROmorphone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73345-1: HYDROcodone+Chlorpheniramine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73347-7: HYDROcodone+Acetaminophen induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73348-5: HYDROcodone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73356-8: Haloperidol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73383-2: fentaNYL induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73424-4: Amphetamine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73457-4: chlordiazePOXIDE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73482-2: Carisoprodol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73486-3: carBAMazepine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73497-0: buPROPion induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73515-9: Atomoxetine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73532-4: Amitriptyline induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  73537-3: ALPRAZolam induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
  78757-2: 2-Oxo-3-Hydroxy-Lysergate diethylamide [Presence] in Urine by Screen method
  78762-2: 7-Aminoflunitrazepam [Mass/mass] in Hair
  78785-3: Amitriptyline [Mass/mass] in Hair
  78794-5: ARIPiprazole [Mass/volume] in Blood
  78820-8: Cyclobenzaprine cutoff [Mass/volume] in Urine for Confirmatory method
  78821-6: Desipramine cutoff [Mass/volume] in Urine for Confirmatory method
  78825-7: Ecgonine methyl ester [Mass/mass] in Hair
  78829-9: Gamma hydroxybutyrate [Mass/mass] in Hair
  78834-9: Hydroxylurasidone cutoff [Mass/volume] in Urine for Confirmatory method
  78845-5: JWH-200 6-Hydroxyindole (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method
  78857-0: Methadone [Z-score] in Urine
  78880-2: RCS-4 5-hydroxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method
  78884-4: Lurasidone [Mass/volume] in Urine by Confirmatory method
  78893-5: Tricyclic antidepressants [Presence] in Gastric fluid
  97252-1: Flurazepam [Presence] in Cord tissue by Screen method
  97254-7: HYDROcodone Free [Presence] in Cord tissue by Screen method
  97286-9: Norhydrocodone [Presence] in Cord tissue by Screen method
  8192-7: Benzoylecgonine [Presence] in Urine by SAMHSA confirm method
  8194-3: Cocaine [Mass/volume] in Unknown substance
  8213-1: Opiates [Mass/volume] in Meconium
  85099-0: Norescitalopram [Mass/volume] in Serum or Plasma
  87492-5: AB-PINACA pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
  89968-2: Norolanzapine [Mass/volume] in Urine by Confirmatory method
  89969-0: Norolanzapine [Presence] in Urine by Screen method
  89974-0: 7-Hydroxyfluphenazine [Presence] in Urine by Screen method
  89977-3: 7-Hydroxychlorpromazine [Presence] in Urine by Screen method
  89982-3: 9-Hydroxyrisperidone [Presence] in Serum or Plasma by Screen method
  89985-6: ARIPiprazole [Presence] in Serum or Plasma by Screen method
  92648-5: Gabapentin [Presence] in Urine by Confirmatory method
  8140-6: Amphetamines [Presence] in Gastric fluid
  8147-1: Amphetamines [Mass/volume] in Serum or Plasma
  8150-5: Amphetamines [Mass/volume] in Urine
  8164-6: Tetrahydrocannabinol [Presence] in Gastric fluid by Confirmatory method
  8166-1: Tetrahydrocannabinol [Mass/volume] in Meconium
  8170-3: Cannabinoids [Mass/volume] in Serum or Plasma
  8172-9: Cannabinoids [Presence] in Serum or Plasma by Screen method
  8174-5: Tetrahydrocannabinol [Presence] in Urine by SAMHSA confirm method
  91043-0: Opiates [Presence] in Body fluid by Screen method
  91044-8: oxyCODONE+oxyMORphone [Presence] in Body fluid by Screen method
  93308-5: Genetic variation's effect on risk of adverse drug reaction
  93495-0: 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Urine by Screen method
  9352-6: Amphetamines [Mass/mass] in Hair
  93676-5: Are you concerned about someone in your home using drugs or alcohol [WellRx]
  93720-1: traMADol [Mass/mass] in Meconium by Confirmatory method
  93721-9: O-nortramadol [Mass/mass] in Meconium by Confirmatory method
  97283-6: Nordiazepam [Presence] in Cord tissue by Confirmatory method
  87497-4: Meperidine [Presence] in Serum, Plasma or Blood by Screen method
  89972-4: Loxapine [Mass/volume] in Urine by Confirmatory method
  89973-2: 7-Hydroxyfluphenazine [Mass/volume] in Urine by Confirmatory method
  89975-7: Norclozapine [Mass/volume] in Urine by Confirmatory method
  89976-5: 7-Hydroxychlorpromazine [Mass/volume] in Urine by Confirmatory method
  89979-9: Ziprasidone [Presence] in Serum or Plasma by Screen method
  89980-7: Thiothixene [Presence] in Serum or Plasma by Screen method
  89983-1: OLANZapine [Presence] in Serum or Plasma by Screen method
  89988-0: Vilazodone [Mass/volume] in Urine by Confirmatory method
  89991-4: Citalopram+Escitalopram [Presence] in Urine by Screen method
  89992-2: Hydroxybupropion [Presence] in Urine by Screen method
  92639-4: O-nortramadol [Mass/volume] in Urine by Confirmatory method
  92650-1: PARoxetine [Presence] in Urine by Confirmatory method
  92653-5: traZODone [Presence] in Urine by Confirmatory method
  92654-3: 9-Hydroxyrisperidone [Mass/volume] in Urine by Confirmatory method
  8144-8: Amphetamines [Presence] in Meconium
  8145-5: Amphetamines [Presence] in Meconium by Confirmatory method
  8146-3: Amphetamines [Presence] in Meconium by Screen method
  8149-7: Amphetamines [Presence] in Serum or Plasma by Screen method
  8151-3: Amphetamines [Presence] in Urine by SAMHSA confirm method
  8152-1: Amphetamines [Presence] in Urine by SAMHSA screen method
  8162-0: Tetrahydrocannabinol [Mass/volume] in Gastric fluid
  8163-8: Tetrahydrocannabinol [Presence] in Gastric fluid
  8169-5: Tetrahydrocannabinol [Presence] in Meconium by Screen method
  8173-7: Deprecated Tetrahydrocannabinol [Mass/volume] in Urine
  89600-1: FDA product label FDA-initiated compliance action drug registration and listing inactivation
  94732-5: DULoxetine [Presence] in Saliva (oral fluid) by Confirmatory method
  93474-5: Synthetic opioids panel - Urine by Confirmatory method
  93496-8: Nortriptyline [Presence] in Urine by Screen method
  9358-3: Lithium [Mass/volume] in Saliva (oral fluid)
  79574-0: Folate and tryptophan and metabolites pattern [Interpretation] in Cerebral spinal fluid Narrative
  8215-6: Opiates [Presence] in Meconium by Confirmatory method
  8221-4: Opiates [Presence] in Urine by SAMHSA confirm method
  8223-0: Opiates [Mass/volume] in Unknown substance
  8228-9: Phencyclidine [Presence] in Gastric fluid
  8232-1: Phencyclidine [Presence] in Meconium
  82374-0: Norbuprenorphine [Presence] in Serum or Plasma by Screen method
  87761-3: Atomoxetine/Creatinine [Mass Ratio] in Urine by Confirmatory method
  87812-4: Flunitrazepam [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  87813-2: Flurazepam [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  87814-0: Midazolam [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  87815-7: fentaNYL [Presence] in Saliva (oral fluid) by Screen method
  87817-3: Propoxyphene [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  87823-1: Naltrexone [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  88110-2: OXcarbazepine [Moles/volume] in Serum or Plasma --trough
  90468-0: Hydroxyaripiprazole [Presence] in Urine by Screen method
  92904-2: N-nortramadol [Mass/volume] in Urine by Confirmatory method
  93121-2: Gabapentin [Presence] in Tissue by Screen method
  95506-2: Methamphetamine substance involvement score [NIDA]
  95797-7: Norfentanyl [Presence] in Urine by Screen method
  87493-3: AB-FUBINACA oxobutanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
  87494-1: AB-CHMINACA hydroxycyclohexyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
  89965-8: Trifluoperazine [Presence] in Urine by Screen method
  89970-8: Molindone [Presence] in Urine by Screen method
  89978-1: ARIPiprazole [Presence] in Urine by Screen method
  89987-2: Vortioxetine [Presence] in Urine by Screen method
  89989-8: Vilazodone [Presence] in Urine by Screen method
  92651-9: Pregabalin [Presence] in Urine by Confirmatory method
  95135-0: Noroxycodone [Mass/volume] in Urine
  8139-8: Amphetamines [Mass/volume] in Gastric fluid
  8142-2: Amphetamines [Presence] in Gastric fluid by Screen method
  8143-0: Amphetamines [Mass/volume] in Meconium
  8154-7: Amphetamines [Presence] in Unknown substance
  8168-7: Tetrahydrocannabinol [Presence] in Meconium by Confirmatory method
  94731-7: Narcotics and opioids [Presence] in Saliva (oral fluid) by Confirmatory method
  96289-4: Morphine IgE Ab [Units/volume] in Serum
  8217-2: Opiates [Mass/volume] in Serum or Plasma
  8220-6: Opiates [Mass/volume] in Urine
  8234-7: Phencyclidine [Presence] in Meconium by Screen method
  82369-0: Buprenorphine [Presence] in Serum or Plasma by Screen method
  8239-6: Phencyclidine [Mass/volume] in Unknown substance
  85384-6: Amisulpride [Mass/volume] in Serum or Plasma
  87778-7: Molindone/Creatinine [Mass Ratio] in Urine by Confirmatory method
  87810-8: Methylenedioxymethamphetamine [Presence] in Saliva (oral fluid) by Screen method
  87820-7: Zolpidem [Presence] in Saliva (oral fluid) by Screen method
  88096-3: Known bacterial drug resistant infection
  90470-6: Norfluvoxamine [Presence] in Urine by Screen method
  92816-8: Phencyclidine [Mass/mass] in Meconium by Confirmatory method
  95530-2: Prescription drug use for non-medical reasons in the past year
  95798-5: Normeperidine [Presence] in Urine by Screen method
  95799-3: O-nortramadol [Presence] in Urine by Screen method
  95931-2: Drug given for pulmonary vasodilator test [Identifier]
  9626-3: Propoxyphene + Norpropoxyphene [Mass/volume] in Serum or Plasma
  9628-9: O-desmethylvenlafaxine [Mass/volume] in Serum or Plasma
  79572-4: Folate and tryptophan and metabolites panel - Cerebral spinal fluid
  8219-8: Opiates [Presence] in Serum or Plasma by Screen method
  8225-5: Opiates [Presence] in Unknown substance by Confirmatory method
  8231-3: Phencyclidine [Mass/volume] in Meconium
  8233-9: Phencyclidine [Presence] in Meconium by Confirmatory method
  8235-4: Phencyclidine [Presence] in Serum or Plasma by Confirmatory method
  8237-0: Phencyclidine [Presence] in Urine by SAMHSA confirm method
  8238-8: Phencyclidine [Presence] in Urine by SAMHSA screen method
  8242-0: Phencyclidine [Presence] in Unknown substance by Screen method
  87760-5: N-nortramadol/Creatinine [Mass Ratio] in Urine by Confirmatory method
  87779-5: Pimozide/Creatinine [Mass Ratio] in Urine by Confirmatory method
  87788-6: Milnacipran/Creatinine [Mass Ratio] in Urine by Confirmatory method
  87806-6: Methylphenidate [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  90469-8: Norfluvoxamine [Mass/volume] in Urine by Confirmatory method
  93153-5: Drug classes of medications taken
  95504-7: Cocaine substance involvement score [NIDA]
  95510-4: Street opioids substance involvement score [NIDA]
  87490-9: ADB-PINACA pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
  87550-0: Haloperidol and reduced haloperidol panel - Serum or Plasma
  89964-1: Ziprasidone [Presence] in Urine by Screen method
  89966-6: Norquetiapine [Mass/volume] in Urine by Confirmatory method
  89967-4: Norquetiapine [Presence] in Urine by Screen method
  89971-6: 8-Hydroxyloxapine [Presence] in Urine by Screen method
  89984-9: Molindone [Presence] in Serum or Plasma by Screen method
  89990-6: fluvoxaMINE [Mass/volume] in Urine by Confirmatory method
  92652-7: Sertraline [Presence] in Urine by Confirmatory method
  95389-3: Have you used an illegal drug or a prescription medication for nonmedical reasons in the past 3 months Caregiver [SEEK]
  95433-9: During the past 3 months, how often have you used methamphetamine
  95438-8: During the past 3 months, how often have you used prescription opioids
  95451-1: During the past 3 months, how often has your use of cocaine led to health, social, legal or financial problems [NIDA]
  95453-7: During the past 3 months, how often has your use of methamphetamine led to health, social, legal or financial problems [NIDA]
  95457-8: During the past 3 months, how often has your use of street opioids led to health, social, legal or financial problems [NIDA]
  8148-9: Amphetamines [Presence] in Serum or Plasma by Confirmatory method
  8155-4: Amphetamines [Presence] in Unknown substance by Confirmatory method
  8156-2: Amphetamines [Presence] in Unknown substance by Screen method
  81754-4: Nortapentadol [Mass/volume] in Urine by Confirmatory method
  94728-3: DULoxetine [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  94729-1: Cyclobenzaprine [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  9351-8: ALPRAZolam [Presence] in Urine
  9357-5: Disulfiram [Mass/volume] in Urine
  93723-5: FDA product label Indexing - drug interactions
  9627-1: Imipramine+Desipramine [Mass/volume] in Serum or Plasma
  96277-9: carBAMazepine IgE Ab [Units/volume] in Serum
  8224-8: Opiates [Presence] in Unknown substance
  82370-8: Norbuprenorphine [Presence] in Gastric fluid by Screen method
  82375-7: Norbuprenorphine [Presence] in Specimen by Screen method
  8240-4: Phencyclidine [Presence] in Unknown substance
  82525-7: Hepatitis C virus genotype and drug resistance panel
  87775-3: Metaxalone/Creatinine [Mass Ratio] in Urine by Confirmatory method
  87780-3: Ziprasidone/Creatinine [Mass Ratio] in Urine by Confirmatory method
  87808-2: chlordiazePOXIDE [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  87822-3: Naltrexone [Presence] in Saliva (oral fluid) by Screen method
  88022-9: 5-F PB-22 3-carboxyindole (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
  90467-2: Hydroxyaripiprazole [Mass/volume] in Urine by Confirmatory method
  93154-3: Drug classes that have an indication documented [CMS Assessment]
  93155-0: IRF-PAI v4.0, LCDS v5.00 - High risk drug classes - use and indication [CMS Assessment]
  95489-1: Have you ever tried and failed to control, cut down or stop using street opioids [NIDA]
  95511-2: Prescription opioids substance involvement score [NIDA]
  95531-0: Illegal drug use in the past year
  77880-3: risperiDONE [Mass/volume] in Urine by Confirmatory method
  77888-6: OLANZapine [Mass/volume] in Urine by Confirmatory method
  97299-2: Phencyclidine [Presence] in Cord tissue by Confirmatory method
  97293-5: O-desmethyltraMADol [Presence] in Cord tissue by Confirmatory method
  97236-4: Codeine Free [Presence] in Cord tissue by Screen method
  74832-7: OLANZapine [Mass] of Dose
  74945-7: clomiPRAMINE+Norclomipramine [Mass/volume] in Serum or Plasma --trough
  77325-9: N-desalkylflurazepam [Moles/volume] in Specimen
  77327-5: Triazolam [Moles/volume] in Specimen
  77333-3: Imipramine+Desipramine [Moles/volume] in Specimen
  77647-6: FDA product label Animal compounded drug label
  58357-5: Amphetamine/Creatinine [Mass Ratio] in Urine
  58360-9: Buprenorphine/Creatinine [Mass Ratio] in Urine
  58395-5: oxyCODONE/Creatinine [Mass Ratio] in Urine
  58397-1: Phencyclidine/Creatinine [Mass Ratio] in Urine
  58401-1: Tapentadol [Presence] in Urine by Confirmatory method
  58403-7: Tricyclic antidepressants/Creatinine [Mass Ratio] in Urine
  58427-6: Carisoprodol [Mass/volume] in Urine by Confirmatory method
  58429-2: 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/volume] in Urine by Confirmatory method
  58439-1: Clinical research drug XXX [Mass/volume] in Urine
  61197-0: oxyCODONE+oxyMORphone [Presence] in Urine by Confirmatory method
  61414-9: Doxepin/Creatinine [Mass Ratio] in Urine
  61416-4: Doxepin [Mass/volume] in Urine by Confirmatory method
  61417-2: Imipramine/Creatinine [Mass Ratio] in Urine
  61428-9: Nortriptyline [Mass/volume] in Urine by Confirmatory method
  61429-7: Tapentadol/Creatinine [Mass Ratio] in Urine
  64128-2: Amobarbital/Creatinine [Mass Ratio] in Urine
  64131-6: Dihydrocodeine/Creatinine [Mass Ratio] in Urine
  64132-4: PENTobarbital/Creatinine [Mass Ratio] in Urine
  64137-3: Pregabalin [Presence] in Urine by Screen method
  66472-2: During your life, altogether how many times have you injected drugs not prescribed by a doctor [PhenX]
  69010-7: Benzoylecgonine [Mass/mass] in Meconium by Confirmatory method
  6902-1: Deprecated Methadone
  74130-6: 6-Monoacetylmorphine (6-MAM) [Mass/volume] in Serum, Plasma or Blood
  74131-4: Morphine [Mass/volume] in Serum, Plasma or Blood
  74169-4: Cocaine [Mass/volume] in Saliva (oral fluid) by Screen method
  74366-6: Clorazepate [Mass/volume] in Serum or Plasma --trough
  74367-4: Deprecated Norfluoxetine [Mass/volume] in Serum or Plasma --trough
  74389-8: Normirtazapine [Mass/volume] in Blood
  97238-0: N-desalkylflurazepam [Presence] in Cord tissue by Screen method
  97307-3: traMADol [Presence] in Cord tissue by Confirmatory method
  96856-0: Has anyone expressed concern about your use of marijuana in past 3 months [TAPS]
  97190-3: carBAMazepine [Mass/volume] in Serum or Plasma --peak
  97287-7: Norhydrocodone [Presence] in Cord tissue by Confirmatory method
  97583-9: Buprenorphine free [Presence] in Cord tissue by Confirmatory method
  97211-7: 6-monoacetylmorphine free [Presence] in Cord tissue by Confirmatory method
  97282-8: Nordiazepam [Presence] in Cord tissue by Screen method
  97297-6: oxyMORphone Free [Presence] in Cord tissue by Confirmatory method
  94054-4: Bacterial katG gene drug resistance mutation [Identifier] by Molecular method
  94058-5: Bacterial embB gene drug resistance mutation [Identifier] by Molecular method
  94064-3: Bacterial eis gene drug resistance mutation [Identifier] by Molecular method
  94104-7: Zolpidem [Presence] in Urine by Screen method
  94110-4: 2-Hydroxyethylflurazepam [Presence] in Urine by Screen method
  86226-8: Codeine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
  86232-6: Norsufentanil [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
  91384-8: Age when first used marijuana
  91532-2: Age when first injected non-prescription drug
  9393-0: risperiDONE [Mass/volume] in Serum or Plasma
  96359-5: 7-Aminoclonazepam [Presence] in Saliva (oral fluid) by Confirmatory method
  96364-5: Gabapentin [Presence] in Saliva (oral fluid) by Confirmatory method
  96367-8: Pregabalin [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  97292-7: O-desmethyltraMADol [Presence] in Cord tissue by Screen method
  41036-5: Cocaine [Presence] in Blood by Confirmatory method
  41038-1: Codeine [Mass/volume] in Blood
  43629-5: 8-Hydroxyamoxapine [Presence] in Serum or Plasma
  43719-4: Acetaminophen+oxyCODONE [Presence] in Serum or Plasma
  43720-2: Acetaminophen+Codeine [Presence] in Serum or Plasma
  43860-6: Amphetamine+Methamphetamine [Presence] in Gastric fluid by Screen method
  8176-0: Cannabinoids [Mass/volume] in Unknown substance
  8179-4: Cannabinoids [Presence] in Unknown substance by Screen method
  8182-8: Benzoylecgonine [Mass/volume] in Gastric fluid
  8186-9: Benzoylecgonine [Mass/volume] in Meconium
  8187-7: Benzoylecgonine [Presence] in Meconium
  81923-5: Tryptophan intake 24 hour Measured
  85094-1: Escitalopram and norescitalopram panel - Serum or Plasma
  87484-2: BB-22 3-carboxyindole (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
  87487-5: MAB-CHMINACA butanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
  92638-6: Sertraline [Mass/volume] in Urine by Confirmatory method
  95431-3: During the past 3 months, how often have you used cocaine
  95437-0: During the past 3 months, how often have you used street opioids
  8141-4: Amphetamines [Presence] in Gastric fluid by Confirmatory method
  81629-8: Gamma hydroxybutyrate [Presence] in Specimen by Confirmatory method
  8165-3: Tetrahydrocannabinol [Presence] in Gastric fluid by Screen method
  8171-1: Cannabinoids [Presence] in Serum or Plasma by Confirmatory method
  89495-6: Drug use by Mother --during pregnancy
  94855-4: carBAMazepine hypersensitivity genotype panel - Blood or Tissue
  93470-3: Furanylfentanyl [Mass/volume] in Urine by Confirmatory method
  93473-7: Beta hydroxythiofentanyl [Mass/volume] in Urine by Confirmatory method
  9630-5: Venlafaxine [Mass/volume] in Serum or Plasma
  8222-2: Opiates [Presence] in Urine by SAMHSA screen method
  8227-1: Phencyclidine [Mass/volume] in Gastric fluid
  8229-7: Phencyclidine [Presence] in Gastric fluid by Confirmatory method
  8241-2: Phencyclidine [Presence] in Unknown substance by Confirmatory method
  85497-6: clozapine N-oxide [Mass/volume] in Serum or Plasma
  87774-6: tiZANidine/Creatinine [Mass Ratio] in Urine by Confirmatory method
  87777-9: 8-Hydroxyloxapine/Creatinine [Mass Ratio] in Urine by Confirmatory method
  87781-1: ARIPiprazole/Creatinine [Mass Ratio] in Urine by Confirmatory method
  87807-4: Naloxone [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  87811-6: Meprobamate [Presence] in Saliva (oral fluid) by Screen method
  87818-1: Tapentadol [Presence] in Saliva (oral fluid) by Screen method
  87819-9: Tapentadol [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  90369-0: Sample collection timing related to drug dose
  90471-4: 9-Hydroxyrisperidone [Presence] in Urine by Screen method
  9313-8: Butorphanol [Mass/volume] in Body fluid
  95483-4: Have you ever tried and failed to control, cut down or stop using cocaine [NIDA]
  94113-8: Norclobazam [Presence] in Urine by Screen method
  96369-4: Sertraline [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  9696-6: 8-Hydroxyloxapine [Mass/volume] in Serum or Plasma
  9698-2: Deprecated Norclomipramine [Mass/volume] in Serum or Plasma
  97263-8: Methylenedioxyamphetamine [Presence] in Cord tissue by Confirmatory method
  97290-1: Noroxycodone [Presence] in Cord tissue by Screen method
  97648-0: Iloperidone [Presence] in Urine by Confirmatory method
  95075-8: Cannabidiol/Tetrahydrocannabinol [Ratio] in Urine by Confirmatory method
  95458-6: During the past 3 months, how often has your use of prescription opioids led to health, social, legal or financial problems [NIDA]
  8153-9: Amphetamines [Mass/volume] in Unknown substance
  8167-9: Tetrahydrocannabinol [Presence] in Meconium
  8175-2: Tetrahydrocannabinol [Presence] in Urine by SAMHSA screen method
  94727-5: Gabapentin [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  80199-3: Nonsteroidal antiinflammatory drugs [Presence] in Body fluid by Screen method
  80200-9: Nonsteroidal antiinflammatory drugs [Presence] in Urine by Screen method
  82916-8: Flurazepam [Mass/volume] in Serum or Plasma --trough
  82969-7: PENTobarbital [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
  90746-9: 5F-ADB-M7 (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method
  91027-3: Buprenorphine-3-glucuronide [Presence] in Urine by Screen method
  91028-1: Barbiturates [Presence] in Body fluid by Screen method
  91030-7: Methadone+Metabolite [Presence] in Meconium by Screen method
  91049-7: Cocaine+Benzoylecgonine [Presence] in Tissue by Screen method
  91055-4: Drugs of abuse panel - Tissue
  93464-6: p-Fluorofentanyl [Mass/volume] in Urine by Confirmatory method
  93468-7: Acrylfentanyl [Mass/volume] in Urine by Confirmatory method
  93494-3: Buprenorphine [Presence] in Urine by Screen method
  9353-4: Baclofen [Mass/volume] in Serum or Plasma
  96111-0: Linezolid [Susceptibility] by Genotype method
  8216-4: Opiates [Presence] in Meconium by Screen method
  8218-0: Opiates [Presence] in Serum or Plasma by Confirmatory method
  8226-3: Opiates [Presence] in Unknown substance by Screen method
  8230-5: Phencyclidine [Presence] in Gastric fluid by Screen method
  8236-2: Phencyclidine [Presence] in Serum or Plasma by Screen method
  82371-6: Norbuprenorphine [Presence] in Urine by Screen method
  82372-4: Buprenorphine [Presence] in Gastric fluid by Screen method
  82373-2: Buprenorphine [Presence] in Specimen by Screen method
  87764-7: Pregabalin/Creatinine [Mass Ratio] in Urine by Confirmatory method
  87773-8: Baclofen/Creatinine [Mass Ratio] in Urine by Confirmatory method
  87776-1: Zaleplon/Creatinine [Mass Ratio] in Urine by Confirmatory method
  87805-8: Methylphenidate [Presence] in Saliva (oral fluid) by Screen method
  87809-0: Benzoylecgonine [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  87816-5: 6-Monoacetylmorphine (6-MAM) [Presence] in Saliva (oral fluid) by Screen method
  87821-5: Zolpidem [Mass/volume] in Saliva (oral fluid) by Confirmatory method
  88023-7: XLR-11 N-(4-hydroxypentyl) (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
  95796-9: Opioids panel - Urine by Screen method
  100032-2: Axis III Drug taking behavior score [Mainz Pain Staging System]
  98960-8: Dehydroaripiprazole [Presence] in Urine by Confirmatory method
  98961-6: Lurasidone [Presence] in Urine by Confirmatory method
  98962-4: Cariprazine [Presence] in Urine by Confirmatory method
  98963-2: Cariprazine [Mass/volume] in Urine by Confirmatory method
  98964-0: Brexpiprazole [Presence] in Urine by Confirmatory method
  98965-7: Brexpiprazole [Mass/volume] in Urine by Confirmatory method
  98966-5: Antipsychotics drug panel - Urine by Confirmatory method 
  98983-0: Methocarbamol [Mass/volume] in Urine by Confirmatory method
  98984-8: OXcarbazepine [Mass/volume] in Urine by Confirmatory method
  99079-6: Acrylfentanyl [Presence] in Urine by Confirmatory method
  99080-4: O-nortramadol [Presence] in Urine by Confirmatory method
  99081-2: Furanylfentanyl [Presence] in Urine by Confirmatory method
  99107-5: Stimulants drug panel - Urine by Screen method 
  99262-8: Designer benzodiazepines [Presence] in Urine by Confirmatory method
  99263-6: Delorazepam [Mass/volume] in Urine by Confirmatory method
  99271-9: Flualprazolam [Mass/volume] in Urine by Confirmatory method
  99272-7: Alpha-hydroxy flualprazolam [Mass/volume] in Urine by Confirmatory method
  99273-5: Meclonazepam [Mass/volume] in Urine by Confirmatory method
  99282-6: FDA product label FDA-initiated compliance action drug registration and listing inactivation - animal drug
  99615-7: Current anti-inflammatory drug use
  99780-9: Multidrug resistant gram-negative organism classification [Type]
  94759-8: SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
  94306-8: SARS-CoV-2 (COVID-19) RNA panel - Specimen by NAA with probe detection
  95209-3: SARS-CoV+SARS-CoV-2 (COVID-19) Ag [Presence] in Respiratory specimen by Rapid immunoassay
